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1 Introduction	
1.1 Dietary	fibres	
Although	it	is	generally	accepted	that	dietary	fibres	exert	health-promoting	effects,	their	intake	in	most	westernised	societies	is	critically	low	(Stephen	et	al.	2017).	And	this	is	not	the	only	‘fibre	gap’:	While	epidemiological	studies	clearly	demonstrated	a	relation	between	fibres	and	non-communicable	diseases,	the	cellular	and	molecular	mechanisms	 are	 not	 yet	 sufficiently	 understood	 (Jones	 2014).	 Filling	 this	 gap	 of	knowledge	will	provide	a	basis	for	specific	recommendations	on	fibre	consumption	to	further	improve	public	health	nutrition	(Jones	2014).		
1.1.1 Definition	and	classification	of	dietary	fibres	Due	 to	 their	 heterogeneity,	 defining	 dietary	 fibres	 has	 been	 a	 matter	 of	 many	discussions	and	has	evolved	over	the	years	(Jones	2014;	Stephen	et	al.	2017).	One	of	the	most	 common	 definitions	 describes	 dietary	 fibres	 as	 carbohydrate	 polymers	consisting	of	ten	or	more	(three	or	more,	according	to	local	jurisdiction)	monomeric	units,	which	are	not	degraded	by	endogenous	enzymes	in	the	human	intestinal	tract	and	 belong	 to	 either	 (1)	edible,	 naturally	 occurring	 carbohydrate	 polymers,	(2)	carbohydrate	polymers	which	 are	 isolated	 from	 food	 raw	material	 and	which	have	 been	 shown	 to	 have	 a	 beneficial	 health	 effect	 or	 (3)	synthetic	 carbohydrate	polymers	 with	 a	 proven	 beneficial	 health	 effect	 (FAO/WHO	 codex	 alimentarius	commission	2009).	This	definition	comprises	a	highly	heterogeneous	group	of	substances.	Hence	fibres	can	 be	 classified	 according	 to	 several	 characteristics	 including	 main	 sources,	chemical	structure	as	well	as	physicochemical	and	physiological	properties	(Stephen	et	 al.	 2017).	 Classifications	 frequently	 used	 distinguish	 between	 (1)	non-starch	polysaccharides	as	cellulose,	hemicellulose,	pectin	and	hydrocolloids,	(2)	resistant	oligosaccharides	such	as	 inulin,	galacto-	and	 fructo-oligosaccharides,	 (3)	resistant	starch	 and	 (4)	natural	 occurring	 lignin	 or	 between	 water-soluble	 and	 -insoluble	fibres	 (European	 Food	 Safety	 Authority	 2010).	 Of	 note,	 the	 latter	 classification	demands	caution	as	solubility	is	sometimes	paralleled	with	the	physiological	effect,	
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i.e.	 microbial	 utilisation,	 which	 is	 not	 always	 correct	 (European	 Food	 Safety	Authority	2010;	Brotherton	2015).		
1.1.2 Nutritional	situation	Geography	and	culture	must	always	be	considered	when	it	comes	to	examination	of	the	 human	 nutrition.	 In	 the	 last	 hundred	 years,	 industrialised	 western	 societies	developed	 some	 common	 dietary	 habits	 (Cordain	 et	 al.	 2005).	 The	 so-called	‘westernised	diet’	is	generally	characterised	by	the	intake	of	processed	food,	which	is	accompanied	by	a	high	energy	density,	saturated	fats,	simple	carbohydrates	and	low	amounts	of	dietary	fibre	(Statovci	et	al.	2017).	In	 particular,	 the	 nutritional	 situation	 regarding	 fibre	 is	 alarming.	 The	 German	Society	of	Nutrition	recommends	an	intake	of	30	g	dietary	fibre	per	day	for	adults	(DGE,	 Om GE,	 SGE	 2019).	 However,	 approximately	 only	 32	%	 of	 men	 and	 25	%	 of	women	 meet	 this	 recommendation	 (Max	 Rubner-Institut	 &	 Bundesinstitut	 für	Ernährung	 und	 Lebensmittel	 2008),	 which	 reflects	 the	 situation	 of	 fibre	consumption	 in	most	westernised	societies	(Jones	2014;	Stephen	et	al.	2017).	By	contrast,	 fibre	 intake	of	rural-living,	agricultural	societies	exceeds	that	of	western	societies	 to	 a	 considerable	 degree	 due	 to	 the	 high	 consumption	 of	 whole	 grain	cereals,	legumes,	vegetables	and	fruit,	all	rich	in	dietary	fibre	(Filippo	et	al.	2017).	Denis	 Burkitt	 (Figure	 1)	 was	 the	 first	 who	described	 the	 ‘fibre	hypothesis’	based	on	his	research	 studies	 in	 rural	 Africa	 and	work	 of	colleagues,	 including	 Cleave,	 Walker,	Campbell,	 Trowell,	 Painter	 and	 Cummings	(Cummings	 and	 Engineer	 2018).	 Burkitt’s	hypothesis	proposed	an	association	between	a	diet	low	in	fibre	and	a	heightened	incidence	of	non-communicable	‘civilization	diseases’,	such	as	 coronary	 heart	 disease,	 diabetes	 and	certain	 gastrointestinal	 disorders	 (Burkitt	1975;	Burkitt	and	Trowell	1977).	It	was	a	shift	in	 paradigm	 to	 designate	 diet	 as	 a	 common	 Figure	1.	‘The	Fibre	Man’.	by	Brian	Kellock	(1985)	
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cause	for	this	group	of	diseases,	but	nowadays	numerous	epidemiological	studies	have	confirmed	this	hypothesis	(Cummings	and	Engineer	2018;	O'Keefe	2019).		
1.1.3 General	health	benefits	of	dietary	fibre	Due	to	their	heterogeneity,	not	all	fibres	fulfil	all	functions,	which	means	that	some	physiological	 effects	 are	 shared	 by	 various	 types	 of	 fibre	 and	 others	 are	 unique	(Jones	 2014).	 The	 specific	 mechanism	 of	 action	 is	 dependent	 on	 their	physicochemical	properties,	such	as	solubility,	viscosity	and	organic	acid	absorption,	and	mainly	related	to	colonic	functions,	blood	cholesterol	and	glucose	homeostasis	(Guillon	and	Champ	2000;	Stephen	et	al.	2017).	Many	 fibres	 form	 gels	 and	 increase	 the	 chymus	 viscosity,	 thereby	 promoting	saturation	 and	 delay	 of	 gastric	 emptying.	 Consequently,	 the	 postprandial	 glucose	level	increases	much	slower	than	in	the	absence	of	dietary	fibre.	Due	to	their	bulking	effect,	fibres	also	regulate	the	transit	time	in	the	lower	gastrointestinal	tract,	thus	preventing	diarrhea	and	constipation.	Their	influence	on	blood	cholesterol	is	among	others	 based	 on	 the	 binding	 of	 primary	 bile	 acids,	 which	 are	 consequently	 not	reabsorbed	in	the	ileum	(FAO/WHO	1998;	Anderson	et	al.	2009).	Since	dietary	fibres	are	neither	digested	nor	absorbed	by	the	host,	they	reach	lower	regions	 of	 the	 intestine,	 where	 they	 are	 metabolically	 accessible	 for	 intestinal	microbes.	Many	fibres	fulfil	the	qualifications	of	prebiotics,	i.e.	food	ingredients	that	selectively	 promote	 the	 growth	 and/or	 activity	 of	 beneficial	 microbes	 thereby	improving	 health	 (Gibson	 and	 Roberfroid	 1995).	 In	 this	 function,	 dietary	 fibres	prevent	dysbiotic	compositional	alterations,	such	as	the	loss	of	overall	diversity	or	individual	 beneficial	 bacteria	 and	 the	 preponderance	 of	 potential	 harmful	pathobionts	(Petersen	and	Round	2014;	Sonnenburg	and	Sonnenburg	2014).	Additionally,	fermentation	of	dietary	fibres	not	only	fuels	the	microbial	diversity,	but	also	leads	to	the	production	of	various	bioactive	metabolites	(Nicholson	et	al.	2012).	A	 major	 group	 of	 fermentation	 products	 are	 short-chain-fatty	 acids	 (SCFA),	including	 acetate,	 propionate	 and	 butyrate,	 which	 serve	 as	 energy	 sources	 of	colonocytes,	but	also	as	signalling	molecules	(Koh	et	al.	2016).	Especially	butyrate	has	 been	 shown	 to	 impact	 on	 several	 physiological	 pathways	 involved	 in	 cell	proliferation,	 apoptosis	 and	 immune	 responses	 (Daly	 and	 Shirazi-Beechey	 2006;	Furusawa	et	al.	2013;	Arpaia	et	al.	2013).	
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1.1.4 Dietary	cellulose	–	simple	raw	material	of	life	Cellulose	is	the	most	abundant	organic	substance	on	earth	(Hon	1994).	All	plant	cell	walls	 are	mainly	 composed	 of	 this	macromolecule,	 which	 exclusively	 consists	 of	unbranched	 β-1,4-linked	 glucose	monomers.	 Depending	 on	 the	 botanical	 source,	500-15,000	 molecules	 build	 up	 to	 such	 glucose	 chains,	 eighteen	 of	 which	 are	organised	 as	 semi-crystalline	 elementary	 microfibrils.	 These	 microfibrils	 are	embedded	in	a	gel-matrix	of	hemicellulose,	pectin,	lignin	and	some	proteins,	which	together	provide	the	strong	structure	and	toughness	of	plant	cell	walls	(O'Sullivan	1997;	Höfte	and	Voxeur	2017).	Dietary	 cellulose	 belongs	 to	 the	 class	 of	 insoluble	 fibre,	 which	 accounts	 for	 the	majority	of	total	fibre	intake	(Lairon	et	al.	2005;	Dong	et	al.	2019).	Main	sources	are	cereals	 and	 legumes,	 but	 also	 vegetables,	 fruit	 and	 nuts.	 Cellulose	 and	modified	cellulose	analogues	are	also	used	by	the	 food	 industry,	 for	 instance	as	additive	 in	instant	and	dairy	products	(Stephen	et	al.	2017).	Cellulose	 is	 a	 very	 stable	molecule	 and	 its	 final	 degradation	 to	 glucose	 is	 largely	dependent	on	microorganisms	that	produce	cellulose-degrading	enzymes	(Weimer	1992).	These	so-called	cellulases	are	glycoside	hydrolases,	which	cleave	the	β-1,4-glycosidic	bonds	of	cellulose	(Figure	2).	They	can	be	further	classified	into	(1)	endo-β-(1,4)-glucanases	(EC	3.2.1.4),	(2)	exo-β-(1,4)-glucanases	(EC	3.2.1.91),	(3)	exo-β-(1,4)-glucosidase	(EC	3.2.1.74)	and	β-glucosidase	(EC	3.2.1.21)	(Ezeilo	et	al.	2017).	Moreover,	 cellobiose	 phosphorylases	 (EC	 2.4.1.20)	 contribute	 to	 the	 final	degradation	 of	 cellobiose	 by	 a	 phosphorolytic	 cleavage	 into	 α-D-glucose	1-phosphate	 and	 D-glucose	 (Alexander	 1968).	 The	 forestomach	 (rumen)	 of	ruminants	 harbours	 various	 cellulase-producing	 bacteria,	 such	 as	 Ruminococcus	
albus,	 Ruminococcus	 flavefaciens	 and	 Fibrobacter	 succinogenes	 (Hungate	 1966;	Russell	et	al.	2009).	This	symbiosis	 facilitates	 the	conversion	of	 low-quality	plant	material	 into	 energy-supplying	metabolites	 (Cammack	 et	 al.	 2018).	 Thus,	 by	 the	domestication	 of	 animals,	 ruminal	 cellulose	 digestion	 has	 become	 the	 ‘world’s	largest	 commercial	 fermentation	 process’	 in	 that	 it	 provides	 meat	 and	 milk	 for	human	nutrition	(Weimer	1992).		
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Figure	2.	Enzymatic	cellulose	degradation.	The	scheme	of	cellulose	degrading	pathways	including	enzymes	(EC	numbers)	and	intermediates.		In	contrast	to	ruminants,	the	upper	intestine	of	mono-gastric	mammals	is	entirely	devoid	of	cellulolytic	bacteria.	Thus,	cellulose	reaches	lower	parts	of	the	gut	and	is	utilised	 by	 the	 resident	 bacteria	 to	 a	 certain	 degree	 (Wolin	 1981).	 However,	 the	observed	 fermentability	 by	 the	 intestinal	 microbiota	 in	 men	 varies	 widely	 and	contributes	 very	 little	 to	 short	 chain	 fatty	 acid	 production	 (Slavin	 et	 al.	 1981;	Kelleher	 et	 al.	 1984;	 Cummings	 1984;	 Vince	 et	 al.	 1990;	 Chassard	 et	 al.	 2012).	Therefore,	 cellulose	 is	 often	 considered	 as	 bulking	 material,	 improving	gastrointestinal	 transit	 and	 postprandial	 glucose	 homeostasis,	 rather	 than	 a	substrate	for	microbial	metabolism	(Sonnenburg	and	Sonnenburg	2014).	Besides,	 recent	 research	 revealed	 that	 cellulose	 also	 has	 an	 impact	 on	 intestinal	homeostasis	 by	 shaping	 the	 microbiota	 and	 influencing	 the	 course	 of	 certain	diseases	(Nagy-Szakal	et	al.	2013;	Berer	et	al.	2018).	Very	little	is	known	about	the	mechanisms	of	these	effects	at	cellular	and	molecular	levels.	Consequently,	there	is	no	 health	 claim	 or	 recommendation	 specifically	 concerning	 dietary	 cellulose	(Stephen	et	al.	2017).	
1.2 The	intestinal	homeostasis	
The	surface	of	 the	 intestine	 is	about	32	m2,	a	 large	surface	exposing	our	self	 to	a	tremendous	 number	 of	 foreign	 dietary	 and	 microbial	 antigens	 (Helander	 and	Fändriks	 2014).	 In	 addition	 to	 the	 digestion	 and	 absorption	 of	 nutrients,	 the	intestine	 must	 distinguish	 between	 tolerance	 of	 harmless	 antigens	 and	 defence	against	 pathogens	 to	 maintain	 homeostasis.	 Cellular	 key	 players	 that	 fulfil	 this	demanding	task	are	intestinal	epithelial	and	immune	cells,	but	also	the	symbiotic	gut	microbiota	(Kayama	and	Takeda	2012).		
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1.2.1 Intestinal	epithelial	cells	(IECs)	The	intestinal	epithelium	consists	of	a	single	layer	of	various	cell	types,	which	are	organised	 in	 invaginations	called	Lieberkühn	crypts	and	additionally	 in	 the	small	intestine	 in	 villi	 that	 protrude	 into	 the	 lumen	 to	 increase	 the	 absorptive	 surface	(Haber	et	al.	2017;	Allaire	et	al.	2018).	As	adaption	to	the	harsh	environment	in	the	gut,	the	epithelium	renews	every	3-7	days,	which	is	driven	by	stem	cells	protected	at	the	bottom	of	the	crypts	(Barker	2014).		
1.2.1.1 Absorptive	enterocytes	The	majority	of	IEC	are	absorptive	enterocytes	or	colonocytes	(Cheng	and	Leblond	1974;	 Haber	 et	 al.	 2017).	 The	 apical	 membrane	 of	 these	 cells	 is	 organised	 in	microvilli	and	contains	transmembrane	mucins,	such	as	mucin	3	(Khatri	et	al.	2001).	This	 so-called	 brush	 border	 provides	 a	 microenvironment	 for	 efficient	 nutrient	degradation	and	uptake,	whilst	preventing	harmful	 contact	 to	bacteria,	 fungi	 and	viruses	 (Snoeck	 et	 al.	 2005).	 In	 order	 to	 seal	 the	 paracellular	 space,	 IEC	 are	connected	 by	 specialised	 intercellular	 junctions	 consisting	 of	 desmosomes,	adherence	and	tight	junctions.	The	most	apical	tight	junctions	selectively	permit	the	transport	of	some	soluble	molecules,	but	prevent	the	invasion	of	large	molecules	and	microorganisms	 (Zihni	 et	 al.	 2016).	 Tight	 junctions	 are	 composed	 of	 several	cytoplasmatic	and	transmembrane	proteins,	including	claudins,	occludin	and	zonula	occludens	(Stevenson	et	al.	1986;	Furuse	et	al.	1993;	1998).		
1.2.1.2 Secretory	intestinal	epithelial	cells	Apart	 from	 absorptive	 enterocytes,	 the	 epithelium	 harbours	 various	 specialised	secretory	IECs	which	play	an	important	role	in	protecting	barrier	integrity	(Allaire	et	 al.	 2018).	 Goblet	 cells	 produce	 secretory	 O-glycosylated	 proteins,	 so-called	mucins,	with	mucin	2	(Muc2)	most	abundantly	produced	in	the	gut	(Johansson	and	Hansson	 2016).	 Mucins	 bind	 water	 and	 form	 a	 viscous	 gel,	 the	 mucus,	 which	provides	 a	 physical	 segregation	 of	 the	 epithelium	 and	 intestinal	 microbes	(Johansson	 et	 al.	 2008).	 Additionally,	 goblet	 cells	 secrete	 trefoil	 factor	3	 (TFF3),	which	 is	 essential	 for	 epithelial	 restitution	 after	 injury	 (Suemori	 et	 al.	 1991;	Mashimo	et	al.	1996).	Paneth	cells	in	small	intestinal	crypts	secrete	a	broad	range	of	antimicrobial	substances,	including	α-defensins	(cryptdins	in	mice),	lysozyme	and	
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the	 regenerating	 islet-derived	 protein	 (REG)	 3α	 (REG3g	 in	 mice)	 (Bevins	 and	Salzman	2011).	The	latter,	a	C-type	lectin,	directly	binds	microbial	peptidoglycan	and	disturbs	the	cell	wall	integrity	of	gram-positive	bacteria,	which	significantly	limits	their	attachment	to	the	epithelium	(Cash	2006;	Vaishnava	et	al.	2011).	Moreover,	it	has	also	been	shown	to	protect	from	infections	with	gram-negative	bacteria	(Loonen	et	al.	2014).	Together,	absorptive	IECs,	secretory	goblet	and	Paneth	cells	provide	a	strong	physical	and	biochemical	barrier	which	prevents	adverse	contact	between	host	 and	 microbe.	 Finally,	 it	 should	 be	 noted	 that	 despite	 specialisation	 some	functions	 are	 shared	 by	 several	 IEC	 types.	 For	 instance,	 REG3g	 is	 produced	 by	enterocytes,	Paneth	cells	as	well	as	goblet	cells	(Burger-van	Paassen	et	al.	2012).	In	addition	to	the	cell	types	mentioned	above,	other	specialised	secretory	cell	types	are	 the	 enteroendocrine	 cells	 which	 secrete	 several	 hormones	 such	 as	cholecystokinin	and	serotonin,	and	tuft	cells	which	are	enriched	in	markers	related	to	taste-transduction	(Isomäki	1973;	Sjölund	et	al.	1983).	Although	their	abundance	is	only	about	1	%	of	all	 IEC,	both	cell	 types	play	important	roles	 in	the	mediation	between	 luminal	 stimuli	 and	 the	 host’s	 immune,	 nervous	 and	 endocrine	 system	(Gerbe	et	al.	2012;	Worthington	et	al.	2018;	Haber	et	al.	2017).	Finally,	microfold	cells	(M	cells)	are	IEC	specialised	in	the	sampling	of	luminal	antigens	(Mabbott	et	al.	2013).	 They	 are	 situated	 in	 the	 epithelium	 overlying	 lymph	 follicles,	 so-called	Peyer’s	Patches,	which	are	unique	 to	 the	 small	 intestine	 (Owen	and	 Jones	1974).	Peyer’s	Patches	are	part	of	the	gut-associated	lymphoid	tissue	(GALT),	an	organised	lymphoid	 structure	 of	 the	 gastrointestinal	 tract,	 and	 provide	 an	 environment	 in	which	M	cells	can	efficiently	transmit	luminal	signals	to	nearby	professional	antigen-presenting	cells	(Mowat	2003).	Taken	together,	the	epithelium	is	not	only	a	physical	barrier,	but	also	a	sensor	of	the	intestinal	environment	(Allaire	et	al.	2018).		
1.2.2 Intestinal	immune	system	The	intestinal	immune	system	is	the	largest	immune	compartment	of	the	body	and	comprises	 many	 cell	 types:	 Luminal	 antigens	 sampled	 by	 IEC	 and	 professional	antigen-presenting	cells	in	the	epithelium	are	presented	to	adaptive	immune	cells,	especially	CD4+	(cluster	of	differentiation	4+)	T	cells	and	B	cells	in	draining	lymph	nodes	 and	 the	 GALT.	 Thereby,	 their	 differentiation	 and	 function	 are	 modulated	depending	on	the	specific	stimulus	(Mowat	2003).	
	I n t r o d u c t i o n 	 	 	 8	|	P a g e 	
1.2.2.1 Innate	immune	system	Despite	 the	 potent	 intestinal	 barrier	 provided	 by	 IECs,	 some	 pathogens	 and	opportunistically	 invasive	 commensals	 or	 bacterial	 constituents	 can	 reach	 the	mucosal	surface	(Allaire	et	al.	2018).	IECs	are	able	to	sense	pathogen-	and	microbe-associated	 molecular	 patterns	 (PAMPs/MAMPs)	 via	 cellular	 pattern	 recognition	receptors	 (PRRs),	 such	 as	 Toll-like	 receptors	 (TLR)	 and	 nucleotide	 binding	 and	oligomerization	domain-like	receptors	(NLRs)	(Parlato	and	Yeretssian	2014;	Abreu	2010).	 According	 to	 their	 polarised	 structure,	 IECs	 are	 equipped	 with	 different,	spatial	segregated	PRRs	(Lee	et	al.	2008).	Whereas	the	binding	of	antigens	to	apical	receptors	provokes	anti-inflammatory	mechanisms,	for	example	the	expression	of	antimicrobial	 peptides	 (Lee	 et	 al.	 2006),	 the	 stimulation	 of	 basolateral	 or	intracellular	PRRs	elicits	pro-inflammatory	responses	via	activation	of	NF-κB	and	subsequent	production	of	cytokines	(Gewirtz	et	al.	2001;	Barnich	et	al.	2005).	IECs	 are	 in	 close	 interaction	 with	 professional	 antigen-presenting	 cells,	 such	 as	macrophages	and	dendritic	cells	which	are	also	endowed	with	PRRs.	Macrophages	are	 highly	 phagocytic	 effector	 cells	 that	 engulf	 dead	 cells	 but	 also	 invading	microorganisms,	thus	playing	an	important	role	in	the	first	line	of	defence	(Wang	et	al.	 2019b).	 Intestinal	 macrophages	 are	 hyporesponsive	 to	 TLR	 stimulation	 and	produce	 a	 lot	 of	 IL-10	 under	 homeostatic	 conditions,	 which	 serves	 as	 an	 anti-inflammatory	mediator	by	promoting	local	regulatory	T	(Treg)	cells	(Denning	et	al.	2007;	 Ueda	 et	 al.	 2010).	 Furthermore,	 dendritic	 cells	 also	 sample	 antigens	 via	several	 mechanisms,	 for	 example,	 by	 trans-epithelial	 dendrites	 or	 via	 Peyer’s	Patches’	M	cells	and	are	specialised	in	presenting	them	to	lymphocytes,	which	can	induce	 either	 a	 tolerogenic	 or	 an	 inflammatory	 immune	 reaction	 (Kayama	 and	Takeda	2012;	Rescigno	et	al.	2001).		
1.2.2.2 Adaptive	immune	system	Adaptive	immune	cells	exist	 in	the	epithelium	and	the	underlying	lamina	propria.	Whereas	 lymphocytes	 found	 in	 the	 epithelium	 are	 mainly	 CD8+	 intraepithelial	T	cells,	the	underlying	lamina	propria	harbours	CD4+	and	CD8+	T	cells	at	a	ratio	of	about	 2/1	 (Mowat	 and	 Agace	 2014).	 Moreover,	 the	 intestinal	 lamina	 propria	comprises	the	majority	of	plasma	cells	in	the	body	of	which	around	80	%	produce	sIgA	(secretory	IgA)	(Brandtzaeg	2010).	SIgA	plays	a	critical	role	in	the	symbiotic	
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relationship	between	host	and	microbe,	for	instance	by	blocking	the	attachment	of	bacteria	and	bacterial	products	to	IEC	through	binding	and	steric	hindrance	(Mantis	et	al.	2011).	Apart	 from	a	certain	plasticity,	 following	activation	naive	CD4+	TH	cells	 (T	helper	cells)	differentiate	into	functional	distinct	effector	subsets,	including	TH1,	TH2	and	TH17	 and	 T-regulatory	 (Treg)	 cells	 (Brucklacher-Waldert	 et	 al.	 2014).	 TH1	 cells	differentiate	 in	 response	 to	 viruses	 and	 intracellular	 bacteria	 and	 secrete	 IFN-g,	while	 IL-4	 producing	 TH2	 cells	 are	 important	 in	 the	 humoral	 immunity	 against	extracellular	parasites,	such	as	helminths.	As	parasites	are	usually	absent	in	healthy	human	and	laboratory	animals,	the	intestine	is	largely	devoid	of	TH2	cells	(Maynard	and	Weaver	2009).	TH17	cells	are	highly	abundant	in	the	intestinal	lamina	propria	and	 play	 an	 important	 role	 in	 both	 protection	 of	 mucosal	 surfaces	 against	extracellular	bacteria	and	fungi	as	well	as	maintaining	homeostasis	(Curtis	and	Way	2009;	 Omenetti	 and	 Pizarro	 2015).	 Their	 differentiation	 is	 dependent	 on	 the	transcription	factor	RORgt	and	is	homeostatically	induced	by	certain	members	of	the	microbiota,	 especially	 SFB	 (segmented	 filamentous	 bacteria)	 (Ivanov	 et	 al.	 2006;	2008;	2009).	TH17	cells	secrete	IL-17	and	IL-22	(Park	et	al.	2005;	Liang	et	al.	2006).	Whereas	 IL-17	 rather	 has	 a	 pro-inflammatory	 character,	 IL-22	 improves	 the	epithelial	 barrier	 integrity	 by	 promoting	 the	 antimicrobial	 host	 response,	 tissue	repair	and	wound	healing	(Eyerich	et	al.	2017).	Another	CD4+	subset	is	the	FOXP3-expressing	regulatory	T	cell	which	secretes	the	anti-inflammatory	cytokine	IL-10.	The	colon	harbours	the	highest	frequency	of	these	cells	 of	 which	 one	 fraction	 is	 derived	 from	 the	 thymus	 (tTreg	cells)	 and	 another	fraction	is	differentiated	in	the	periphery	(pTreg	cells)	(Tanoue	et	al.	2016).	Beside	TH17	cells,	also	some	Treg	cells	express	RORgt	following	induction	by	the	microbiota	or	inflammatory	stimuli	(Sefik	et	al.	2015;	Yang	et	al.	2018;	Ohnmacht	et	al.	2015).	The	function	of	these	Treg17	cells	(RORgt+	FOXP3+	CD4+	T	cells)	is	still	under	debate.	Recently	 it	was	 shown	 that	 they	exert	 anti-inflammatory	 functions	during	 colitis,	nevertheless,	they	are	able	to	secrete	IL-17	(Sefik	et	al.	2015;	Yang	et	al.	2016).		
1.2.2.3 Non-classical	lymphocytes	There	 is	 another	 rather	 recently	 recognized	group	of	 innate	 immune	cells,	which	should	be	shortly	mentioned.	Innate	lymphoid	cells	(ILCs)	mimic	the	phenotype	of	
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CD4+	TH	cells,	including	the	expression	transcription	factors,	surface	markers	and	effector	cytokines	(Eberl	et	al.	2015).	However,	they	are	not	endowed	with	specific	antigen	 receptors	 and	 they	 do	 not	 undergo	 clonal	 selection	 and	 expansion	 after	stimulation	as	classical	lymphocytes	do	(Eberl	et	al.	2015).	ILCs	provide	an	immune	response	 adapted	 to	 the	 infection	 or	 injury	 prior	 to	 the	 action	 of	 the	 adaptive	immune	cells,	but	also	play	an	important	role	for	tissue	homeostasis	(Klose	and	Artis	2016).	For	instance,	ILC3	express	the	transcription	factor	RORgt	and	secrete	IL-17	and	IL-22	dependent	on	the	stimulus	as	their	TH17	T	cells	counterpart	(Buonocore	et	al.	2010;	Castleman	et	al.	2019).		
1.2.3 Intestinal	microbiota	Microorganisms,	 including	 bacteria,	 fungi	 and	 protozoans,	 colonise	 all	 epithelial	barrier	sites	of	the	mammalian	body	(Coates	et	al.	2019).	However,	within	the	adult	intestinal	microbiota,	bacteria	are	the	most	abundant	and	diverse	microorganisms	(Rajilić-Stojanović	and	Vos	2014).		
1.2.3.1 Development	of	the	intestinal	microbiota	Apart	from	the	prenatal	exposure	to	bacterial-derived	substances,	the	foetus	has	no	contact	 to	 bacteria	 during	 pregnancy	 (Mesa	 et	 al.	 2020).	 The	 colonisation	 with	diverse	 bacteria	 starts	 during	 birth.	 In	 vaginally	 delivered	 new-borns,	 the	 first	bacteria	of	the	intestinal	microbiota	originate	from	the	maternal	vaginal	tract,	such	as	Streptococcus	 in	mice	 and	Lactobacillus	 and	Prevotella	 in	 human	 (Dominguez-Bello	et	al.	2010;	Pantoja-Feliciano	et	al.	2013).	During	breastfeeding,	the	microbiota	is	 dominated	 by	 Firmicutes	 species,	 especially	 of	 the	 Lactobacillaceae	 and	
Streptococcaceae	 family	 in	 human	 and	 mice	 (Yatsunenko	 et	 al.	 2012;	 Pantoja-Feliciano	et	al.	2013).	 In	addition,	Bifidobacterium	 species	are	highly	abundant	 in	suckling	infants,	but	not	in	mice	(Stewart	et	al.	2018;	Levi	Mortera	et	al.	2019).	Some	studies	suggest	that	the	intestinal	microbiota	stabilises	within	the	first	three	to	four	years	of	life	(Stewart	et	al.	2018;	Yatsunenko	et	al.	2012).	Indeed,	the	overall	diversity	of	the	microbiota	increases	consecutively	to	weaning	and	the	intake	of	solid	food	(Koenig	et	al.	2011;	Pantoja-Feliciano	et	al.	2013).	At	the	taxonomic	level,	the	abundance	 of	 Lachnospiraceae	 and	 Ruminococcaceae	 increases,	 whereas	
Enterobacteriaceae,	Bifidobacteriaceae	 and	Clostridiaceae	 decrease	 (Yassour	 et	 al.	
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2016).	Only	a	few	studies	examined	the	microbiota	in	childhood	beyond	three	years	(Derrien	et	al.	2019).	These	studies	revealed	functional	and	taxonomical	differences	between	 the	 infant	 and	 adult	 microbiota	 suggesting	 that	 the	 maturation	 of	 the	microbiota	takes	longer	than	previously	thought	(Hollister	et	al.	2015;	Odamaki	et	al.	2016;	Derrien	et	al.	2019).	The	adult	microbiota	 is	 stable	over	a	 long	period	of	 time	 (Faith	et	al.	2013).	The	dominant	 phyla	 are	 Bacteroidetes	 and	 Firmicutes	 as	 well	 as	 Verrucomicrobia,	Actinobacteria	 and	 Proteobacteria	 at	 lower	 abundances	 (Human	 Microbiome	Project	 Consortium	 2012;	 Martinez-Guryn	 et	 al.	 2019).	 A	 peak	 in	 the	 ratio	 of	Firmicutes	 to	 Bacteroidetes	 is	 characteristic	 for	maturation	 of	 the	microbiota	 in	adulthood	(Mariat	et	al.	2009).	Although	the	intestinal	microbiota	of	adults	is	highly	individual	 at	 strain	 level,	 there	 is	 more	 similarity	 from	 a	 functional	 point	 of	perspective	(Human	Microbiome	Project	Consortium	2012).	The	microbiota	changes	again	during	aging,	which	is	reflected	by	a	decrease	of	the	Firmicutes/Bacteroidetes	ratio	and	an	increasing	abundance	of	the	genus	Alistipes	in	 men	 and	mice	 (Mariat	 et	 al.	 2009;	 Claesson	 et	 al.	 2011;	 Langille	 et	 al.	 2014;	Bischoff	2016;	Fransen	et	al.	2017).	However,	due	to	a	broad	range	of	cofounding	factors,	it	is	difficult	to	dissect	these	changes	in	human	studies	(An	et	al.	2018).	It	is	still	under	debate,	whether	 the	overall	diversity	 is	 impaired	and	which	phyla	are	dominant	in	the	aging	human	microbiota	(An	et	al.	2018).		
1.2.3.2 Anatomy	and	physiology	of	the	intestinal	microbiota	There	is	a	high	regional	specialisation	of	structural	and	functional	properties	of	the	intestinal	epithelium	and	 immune	system	(Mowat	and	Agace	2014).	According	 to	this,	 the	 intestine	 offers	 diverse	 ecological	 niches,	 which	 also	 result	 in	 regional	differences	 of	 the	 intestinal	 microbiota	 (Martinez-Guryn	 et	 al.	 2019).	 The	 most	important	factors	defining	these	niches	are	the	partial	oxygen	pressure,	bile	acids,	dietary	 and	 immune	 factors	 (Maslowski	 and	 Mackay	 2011;	 Ridlon	 et	 al.	 2014;	Friedman	et	al.	2018).	Starting	from	the	mouth,	the	diversity	and	bacterial	load	increases	from	the	proximal	to	the	distal	gastrointestinal	tract	(Martinez-Guryn	et	al.	2019).	The	small	intestinal	microbiota	has	a	high	abundance	of	aerotolerant	Lactobacillaceae	(Firmicutes)	and	bacterial	 species	 of	 the	 Proteobacteria	 and	Actinobacteria	 phyla	 (Gu	 et	 al.	 2013;	
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Friedman	 et	 al.	 2018).	 By	 contrast,	 obligate	 anaerobe	 bacteria,	 such	 as	
Lachnospiraceae	and	Ruminococcaceae	 (Firmicutes),	as	well	as	Prevotellaceae	and	
Rikenellaceae	(Bacteroidetes)	peak	in	the	caecum	and	colon	(Nava	et	al.	2011;	Gu	et	al.	2013).	Remarkably,	in	addition	to	this	horizontal	distribution	from	proximal	to	distal,	there	is	also	a	distinct	distribution	between	the	crypts,	mucus	and	gut	lumen	(Pédron	et	al.	2012;	Li	et	al.	2017).	The	 intestinal	 microbiota,	 sometimes	 referred	 to	 as	 the	 ‘forgotten	 organ’,	 has	important	physiological	impact	on	the	host	(O'Hara	and	Shanahan	2006).	The	early	hygiene	 hypothesis	 proposed	 that	 children	who	 are	more	 frequently	 exposed	 to	infections	 are	 at	 a	 lower	 risk	 of	 developing	 allergies	 (Strachan	 1989).	 This	hypothesis	was	further	expanded	for	autoimmune	diseases	and	the	observation	that	not	 only	 pathogens	 but	 also	 commensals	 exert	 protective	 immunomodulatory	effects	 (Bach	 2018).	 Today,	 it	 is	 well	 known	 that	 the	 gut	microbiota	 is	 critically	involved	 in	 the	 physiological	maturation,	 i.e.	 imprinting,	 of	 the	mucosal	 immune	system	(Al	Nabhani	and	Eberl	2020).	The	absence	or	impairment	of	early	imprinting	increases	 the	 susceptibility	 for	 allergy	 or	 intestinal	 inflammation	 later	 in	 life	(Kronman	et	al.	2012;	Al	Nabhani	et	al.	2019;	Metzler	et	al.	2019).	Not	only	direct	interactions	 but	 also	 bacteria-derived	 metabolites	 contribute	 to	 this	 crosstalk	between	host	and	microbe	(McDermott	and	Huffnagle	2014;	Kayama	and	Takeda	2020).	Along	 the	 gastrointestinal	 tract,	 the	 caecum	 and	 colon	 are	 the	 major	 sites	 for	bacterial	fermentation	of	undigested	carbohydrates	and	other	metabolic	processes.	Especially	Bacteroidales	and	Clostridiales	species	are	able	to	degrade	dietary	fibre	and	produce	SCFAs,	which	have	various	physiological	functions	(Koh	et	al.	2016,	as	mentioned	above).	Another	group	of	bacterial-derived	metabolites	are	 secondary	bile	acids	which	are	generated	from	primary	bile	acids.	Primary	bile	acids	are	cholic	acid	 (CA)	 and	 chenodeoxycholic	 acid	 (CDCA)	 (in	 rodents	 also	 muricholic	 acids,	MCAs).	 They	 are	 synthesised	 in	 the	 liver	 of	 the	 host	 from	 cholesterol	 and	 are	conjugated	to	glycine	or	taurine	prior	to	secretion	into	the	duodenum	(Wahlström	et	al.	2016).	A	small	proportion	of	primary	bile	acids	which	is	not	reabsorbed	in	the	ileum	 reaches	 the	 caecum	 and	 colon,	 where	 it	 undergoes	 bacterial	 conversion	–	mainly	deconjugation,	oxidation	and	dehydroxylation	–	into	secondary	bile	acids	(Ridlon	et	 al.	 2006).	Bile	 acids	 are	not	only	 emulsifiers	 supporting	digestion	and	
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absorption	of	dietary	 fats	and	fat-soluble	vitamins,	but	also	 function	as	signalling	molecules	with	several	functions,	for	instance	in	epithelial	proliferation	and	host’s	metabolism	 (Aguiar	 Vallim	 et	 al.	 2013;	 Barrasa	 et	 al.	 2013).	 However,	 high	concentration	of	 bile	 acids	has	been	 shown	 to	 induce	DNA	damage	 and	promote	tumour	growth	(Barrasa	et	al.	2013).	Further,	bile	acids	are	in	a	complex,	mutually	relation	with	the	intestinal	microbiota	in	that	bacteria	shape	the	pool	of	bile	acid	in	terms	of	composition	and	size	and,	in	turn,	bile	acids	influence	the	growth	of	bacteria	(Wahlström	et	 al.	 2016).	Thus,	 besides	 the	 competition	 for	 limited	nutrients	 and	space,	 secondary	 bile	 acids	 are	 a	mechanism	 of	 how	 the	 gut	microbiota	 provide	resistance	against	colonisation	of	pathogens	and	expansion	of	pathobionts	(Pickard	et	al.	2017).	Of	note,	SCFAs	and	secondary	bile	acids	are	only	a	few	representatives	of	the	numerous	substances	produced	by	intestinal	microbes.	There	are	many	more	potentially	bioactive	metabolites,	including	vitamins,	lipids	and	indoles	(Nicholson	et	al.	2012).		
1.2.4 Disorder	of	the	intestinal	homeostasis	Perturbation	of	 the	commensal	relationship	between	host	and	microbe	may	have	adverse	consequences,	such	as	 intestinal	 inflammation	(Maloy	and	Powrie	2011).	Acute	colitis	 induced	by	pathogens,	diet	or	stress	affects	almost	everyone	at	 least	once	in	life.	The	disease	is	characterised	by	abdominal	pain	and	diarrhea,	however,	in	 many	 cases	 it	 is	 self-limiting	 or	 easy	 to	 treat	 (Vargas-Robles	 et	 al.	 2019).	 By	contrast,	chronic	inflammatory	bowel	diseases	(IBD)	including	Crohn‘s	disease	and	ulcerative	colitis	are	more	severe	forms	of	colitis.	The	highest	prevalence	of	IBD	was	reported	in	Europe	and	America	(Ng	et	al.	2017).	There	is	no	curative	therapy	for	these	pathologies	that	are	associated	with	serious	long-term	consequences,	such	as	malnutrition	and	colorectal	cancer	(Guan	2019).	The	pathology	of	these	diseases	is	not	yet	clearly	understood,	but	is	considered	to	be	 multi-dimensional	 (Guan	 2019).	 On	 the	 host’s	 site,	 genetic	 abnormalities	 in	around	240	loci	are	known	to	increase	the	risk	for	IBD	(Lange	et	al.	2017).	Many	of	these	genes	encode	proteins	of	the	antimicrobial	host	defence	or	immune	system,	as	shown	for	defects	of	Mucin	2	and	IL-10	(Kühn	et	al.	1993;	Glocker	et	al.	2009;	van	der	Sluis	et	al.	2006).	Furthermore,	an	adverse	and	harmful	immune	reaction	may	also	be	induced	upon	intestinal	dysbiosis	(Petersen	and	Round	2014;	Belkaid	and	
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Harrison	2017).	It	has	indeed	been	shown	that	the	gut	microbiota	of	IBD	patients	differ	 in	 various	ways	 from	 that	 of	 a	 healthy	 subject,	 including	 alterations	 of	 the	diversity,	 the	 taxonomical	 composition,	 transcriptional	 and	 metabolic	 profiles	(Lloyd-Price	et	al.	2019).	However,	it	is	still	not	clear,	whether	dysbiosis	is	cause	or	consequence	of	IBD,	since	chronic	inflammation	can	also	shape	the	microbiota	(Ni	et	 al.	 2017).	 Additionally,	 environmental	 factors,	 including	 nutrition,	 stress	 or	smoking,	play	a	role	in	the	pathogenesis	of	IBD.	In	particular,	a	diet	low	in	fibre	is	associated	with	an	increased	risk	for	IBD	as	well	as	colorectal	cancer	(Bingham	et	al.	2003;	 Gonzalez	 and	 Riboli	 2010;	 Hou	 et	 al.	 2011;	 Ananthakrishnan	 et	 al.	 2013).	Possible	mechanistical	 links	are,	among	others,	the	binding	of	potentially	harmful	substances,	such	as	secondary	bile	acids,	the	promotion	of	beneficial	microbes	and	their	fermentation	to	SCFAs	(Zeng	et	al.	2019).	Despite	consensus	about	their	role	in	prevention,	in	the	nutritional	therapy	of	IBD,	fibre	are	still	a	matter	of	debate,	since	a	 high	 fibre	 intake	 might	 increase	 the	 risk	 to	 develop	 an	 ileus	 in	 the	 inflamed	intestine	(Wedlake	et	al.	2014).	
1.3 Objective	
Industrialisation	did	not	only	change	economy	and	technology,	but	also	social	 life	style,	 including	 nutrition.	 Whereas	 raw	 plant-based	 food	 predominated	 the	preindustrial	 diet,	 the	 modern	 ‘westernised	 diet’	 is	 characterised	 by	 processed	groceries	that	often	have	a	high	energy	density	and	low	fibre	content	(Cordain	et	al.	2005).	Today,	there	is	a	substantial	 ‘fibre	gap’	between	recommendations	and	the	actual	consumption	(Jones	2014).	However,	a	diet	low	in	fibre	has	been	shown	to	be	associated	 with	 many	 civilization	 diseases,	 such	 as	 inflammatory	 bowel	 disease	(O'Keefe	 2019).	 The	 mechanisms	 of	 such	 health-promoting	 effects	 are	 still	 not	entirely	understood,	especially	with	respect	to	insoluble	fibres,	such	as	cellulose.	The	 purpose	 of	 the	 present	 study	was	 to	 investigate	 comprehensive	 cellular	 and	molecular	 effects	 of	 dietary	 cellulose	 on	 the	 intestinal	 homeostasis,	 including	microbiota,	immune	system	and	epithelium,	in	health	and	disease.	Furthermore,	this	study	 should	 shed	 light	 on	 a	 selected	 host-microbe	 interaction,	 which	 might	 be	causally	related	to	the	mechanism	of	health-promoting	effects	of	cellulose.		
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2 Material	and	methods	
2.1 Material	
2.1.1 Mice	and	experimental	diets	
2.1.1.1 Mice	strains	
Strain	 Hygiene	
status	
Origin	 Maintenance	
C57BL/6	 SFP	 Charles	River	Laboratories	Institute	for	Medical	Microbiology	and	Hospital	Hygiene,	University	Marburg	C57BL/6	 gnotobiotic,	OMM12	 Institute	for	Laboratory	Animal	Science	and	Central	Animal	Facility,	Hannover	Medical	School	
Institute	for	Medical	Microbiology	and	Hospital	Hygiene,	University	Marburg	C57BL/6	 germ-free	 Institute	for	Medical	Microbiology	and	Hospital	Hygiene,	University	Marburg	
Institute	for	Medical	Microbiology	and	Hospital	Hygiene,	University	Marburg		
2.1.1.2 Experimental	diets	
Diet	 Product	identification	 Company	control	diet,	CD	 S7242-E014	 sniff	Spezialdiäten	GmbH	fibre	free	diet,	FFD	 S7242-E018	 sniff	Spezialdiäten	GmbH	conventional	chow	 LASQCdiet®	Rod16-R	 LASvendi			 	
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2.1.1.3 Ingredients	and	composition	of	purified	diets	
	 Control	diet	 Fibre	free	diet	
Ingredients	(%)	 	 	Sucrose	 44.1	 46.1	Corn	starch	 20.0	 25.0	Amino	acid	mixture	 17.5	 17.5	Cellulose	 7.0	 0.0	Corn	oil	 5.0	 5.0	Additives	 6.4	 6.4	
Composition	(%)	 	 	NfE	 66.9	 73.9	Crude	protein	 15.2	 15.2	Crude	fibre	 7.0	 0.0	Crude	fat	 5.0	 5.0	Crude	ash	 4.0	 4.0	Water	 1.9	 1.9		
2.1.2 Bacteria	
Strain	 Origin	
Alistipes	finegoldii	17242	 DSMZ,	Braunschweig	
Escherichia	coli	DH5α	 Institute	of	Medical	Microbiology	and	Hygiene,	Marburg		
2.1.3 Enzymes	
Enzyme	 Origin	BamHI	 Fermentas,	Vilnius,	Litauen	HindIII	 Fermentas,	Vilnius,	Litauen	Lysozyme,	chicken	egg	white	 Merck,	Sigma-Aldrich,	Darmstadt	MfeI	 Fermentas,	Vilnius,	Litauen	NcolI	 Fermentas,	Vilnius,	Litauen	NotI	 Fermentas,	Vilnius,	Litauen	Ribonuclease	 VWR	Funding,	Amresco,	West	Chester,	USA		
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2.1.4 Consumables	and	equipment	
Consumables,	
equipment	
Type	 Company	
Anaerobic	culture	system	 Anaerocult®	A	anaerobic	jar	 Merck,	Millipore,	Darmstadt	GasPak™	EZ	anaerobe	container	system	 BD,	Heidelberg	Capillary	Electrophoresis	(CE)	system	
Agilent	1600A	 Agilent	Technologies,	Santa	Clara,	USA	Fused	CE	silica	capillary	(ID	50µM,	100	cm)	 Agilent	Technologies,	Santa	Clara,	USA	Cell	counter	 Cell	counting	slides	 BioRad,	Hercules,	USA	TC20™	Automated	Cell	Counter	 BioRad,	Hercules,	USA	Cell	homogenisators	and	dissociaters	 Bead	Beater	 MP	Biomedicals,	Eschwege	GentleMACS™	Octo	dissociator	 Miltenyi	Biotec,	Bergisch	Gladbach	Glass	beads,	0.1	mm	 Carl	Roth,	Karlsruhe	NucleoSpin®	bead	tubes	 Macherey-Nagel,	Düren	Precellys®	Evolution	homogenizer	 Bertin	Instruments,	Montigny-le-Bretonneux,	France	Ultra-Turrax®	T10	basic	 IKA,	Staufen	im	Breisgau	Cell	strainers	 Easystrainer™,	100	µm	 Greiner,	Kremsmünster,	Austria	Pre-separation	cell	strainer,	30	µm	 Miltenyi	Biotec,	Bergisch	Gladbach	Centrifuges	 Megafuge™	 Heraeus,	Hanau		 Microstar	17R,	Ministar	 Avantor,	VWR,	Pennsylvania,	USA	Flow	cytometer	 Attune™	NxT	 Thermo	Fisher	Scientific,	Waltham,	USA	Gel	documentation	system		
	 Herolab,	Wiesloch	
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Consumables,	
equipment	
Type	 Company	
Heater	and	shaker	 IKA	KS260	 IKA,	Staufen	Thermomixer	comfort	 Eppendorf,	Hamburg	Unitexer	1	 LCG	Labware,	Meckenheim	Incubator	 HERAcell™	240i	 Heraeus,	Hanau	Inoculation	loop	 10	µl	 Sarstedt,	Nümbrecht	Mass	spectrometer	(MS)	 Agilent	6120	single	quadrupole	MS	 Agilent	Technologies,	Santa	Clara,	USA	amaZon	ETD	ion	trap	 Bruker	Daltonics,	Billerica,	USA	LTQ	FT	Ultra	MS	 Thermo	Fisher	Scientific,	Waltham,	USA	maXis™	 Bruker	Daltonics,	Billerica,	USA	Microplate	reader	 FLUOstar	omega®	 BMG	Labtech,	Ortenberg	Microscope	 Leica	DM	5500	wide	field	microscope	 Leica	Mikrosystems,	Wetzlar	NanoDrop	system	 1000	 Thermo	Fisher	Scientific,	Waltham,	USA	Digital	pH	meter	 inoLab®	pH	Level	2	 Xylem,	WTW,	Weilheim	Pipettes	 Eppendorf	Research®	plus	 Eppendorf,	Hamburg		 TipOne®	filter	tips	 Starlab,	Hamburg	Power	supply	 Standard	Power	Pack	P25	 Biometra,	Göttingen	(RT-)	PCR	systems	 LightCycler®	480	Instrument	II	 Roche	Molecular	Systems,	Basel,	Switzerland	Thermal	Cycler	C1000	Touch™	BioRad,	Hercules,	USA	StepOnePlus™	Real-time	PCR	System	 Thermo	Fisher	Scientific,	Applied	Biosystems,	Waltham,	USA	Scales	 Adventurer®	Analytical	AV812M,	Explorer®	Analytical	EP114CM	
Ohaus,	Nänikon,	Switzerland	
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Consumables,	
equipment	
Type	 Company	
Sequencing	system	 MiSeq	sequencing	system	 Illumina,	San	Diego,	USA	Sterile	filters	 Filtropur	BT50	filters,	0.22	µm	 Sarstedt,	Nümbrecht		 Syringe	filters,	0.2	µm	 Thermo	Fisher	Scientific,	Waltham,	USA	Syringes	and	needles	 Syringe,	1.0	ml	 B.	Braun,	Melsungen	Gavage	needle	 Thermo	Fisher	Scientific,	Waltham,	USA	Tubes	and	dishes	 Biosphere®	plus	SafeSeal	tube,	1.5	ml,	2.0	ml	 Sarstedt,	Nümbrecht	Centrifuge	tube,	15	ml,	50	ml	 Sarstedt,	Nümbrecht	Cell	culture	dishes,	24	wells	 Sarstedt,	Nümbrecht	C	tubes	 Miltenyi	Biotec,	Bergisch	Gladbach	DNA	LoBind	tubes,	1.5	ml	 Eppendorf,	Hamburg	Microplates,	polystyrene	 Greiner,	Kremsmünster,	Austria	Microplates,	polypropylene	 Greiner,	Kremsmünster,	Austria	Reaction	tubes,	0.5	ml,	1.5	ml,	2.0	ml	 Eppendorf,	Hamburg	Petri	dishes	 Greiner,	Kremsmünster,	Austria	(Ultra)	High	Performance	Liquid	Chromatography	((U)HPLC)	system	
Acquity™	UPLC	 Waters,	Milford,	USA	Acquity™	UPLC	BEH™	C8	column	 Waters,	Milford,	USA	Agilent	1100	HPLC	system	 Agilent	Technologies,	Santa	Clara,	USA	NUCLEODUR®	125/2	C18ec	HPLC	column	 Macherey-Nagel,	Düren	
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Consumables,	
equipment	
Type	 Company	
Water	purification	system	 Milli-Q®	Integral	and	Synthesis	 Merck,	Millipore,	Darmstadt		
2.1.5 Chemicals	and	reagents	
Chemical,	reagent	 Company	1	kb	Plus	DNA	ladder	 Thermo	Fisher	Scientific,	Waltham,	USA	4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic	acid	(HEPES)	 Roth,	Karlsruhe	Acetic	acid,	0.1	%,	pH	4.2	 Biosolve,	Valkenswaard,	Netherlands	Acetonitrile	(LC-MS	CHROMASOLV®)	 FLUKA,	Sigma	Aldrich,	St	Louis,	USA	Agarose	 Biozym,	Hessisch	Oldendorf	Ammonium	acetate	 Merck,	Sigma-Aldrich,	Darmstadt	Ammonium	chloride	(NH4Cl2)	 Merck,	Sigma-Aldrich,	Darmstadt	Ampicillin	 Merck,	Sigma-Aldrich,	Darmstadt	Attune™	Bleach,	Focussing	Fluid,	Performance	Tracking	Beads,	Shutdown	Solution,	Wash	Solution	
Thermo	Fisher	Scientific,	Waltham,	USA	
β-Mercaptoethanol	(β-ME)	 Merck,	Sigma-Aldrich,	Darmstadt	Brain-Heart-Infusion	(BHI)	broth	 Thermo	Fisher	Scientific,	Waltham,	USA	Brefeldin	A	 BioLegend	Bovine	serum	albumin	(BSA)	 Merck,	Sigma-Aldrich,	Darmstadt	Butyric	acid-4,4,4-d3,	98	atom	%	D	 Merck,	Sigma-Aldrich,	Darmstadt	Carmine	powder	 Merck,	Sigma-Aldrich,	Darmstadt	Cellotetraose	 Biozol,	Toronto	Research	Chemicals	Chloroform,	99	%	 Alfa	Aesar	Columbia	agar	plate,	5	%	sheep	blood	 BD,	Heidelberg	CompBead	Anti-Mouse	Ig,	κ/Negative	Control	Compensation	Particles	Set	 BD,	Heidelberg	
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Chemical,	reagent	 Company	CompBead	Anti-Rat	and	Anti-Hamster	Ig	κ	/Negative	Control	Compensation	Particles	Set	
BD,	Heidelberg	
Deuterated	bile	acids	 Merck,	Sigma-Aldrich,	Darmstadt	Dextran	sulphate	sodium	salt	(DSS),	colitis	grade	36,000-50,000	 MP	Biomedicals,	Eschwege	Dithiothreitol	(DTT)	 Enzo	life	science,	Lörrach	DNA	stabilization	buffer	 Stratec	Biomedical,	Birkenfeld	Ethanol,	absolute	 Carl	Roth,	Karlsruhe	Ethidium	bromide	solution,	1	%	 Carl	Roth,	Karlsruhe	Ethylenediaminetetraacetic	acid	(EDTA),	0.5	M,	pH	8.0	 Promega,	Madison,	USA	Extrazol	 Biolab	Innovative	Research	Technologies,	Gdańsk,	Poland	Foetal	calf	serum	(FCS)	 Thermo	Fisher	Scientific,	Gibco,	Waltham,	USA	Formaldehyde	solution,	36.5-38.0	%	 Merck,	Sigma-Aldrich,	Darmstadt	Glacial	acetic	acid	 Merck,	Darmstadt	HALTTM	Protease	Inhibitor	Cocktail,	100	x	Thermo	Fisher	Scientific,	Waltham,	USA	Hank’s	Salt	 Biochrom,	Berlin	Hank’s	balances	salt	solution	(HBSS),	w/o:	Ca2+	and	Mg2+,	w/o:	Phenol	red,	w:	0.35	g/L	NaHCO3	
Pan	Biotech,	Aidenbach	
HBSS,	(10x)	w:	Ca	and	Mg,	w/o:	Phenol	red,	w/o:	NaHCO3	 Pan	Biotech,	Aidenbach	Ionomycin	 Merck,	Sigma-Aldrich,	Darmstadt	Isopropanol	(2-propanol)	 Merck,	Sigma-Aldrich,	Darmstadt	Luria-Bertani	(LB)	agar	powder	 Thermo	Fisher	Scientific,	Gibco,	Waltham,	USA	LB	broth	 Thermo	Fisher	Scientific,	Gibco,	Waltham,	USA	L-Glutamine,	200	mM	 Biochrom,	Berlin	
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Chemical,	reagent	 Company	Mayer’s	Hämalaun	 Carl	Roth,	Karlsruhe	MEM	non-essential	amino	acids	(NEAS),	100	x	 Merck,	Sigma-Aldrich,	Darmstadt	Methanol	 Carl	Roth,	Karlsruhe	Milk	powder	 Carl	Roth,	Karlsruhe	Sodium	azide	 Merck,	Sigma-Aldrich,	Darmstadt	Sodium	chloride	(NaCl2)	 Merck,	Sigma-Aldrich,	Darmstadt	Sodium	chloride,	0.9	%-solution	 Braun,	Melsungen	Sodium	bicarbonate	(NaHCO3)	 Merck,	Sigma-Aldrich,	Darmstadt	Paraffine	 Carl	Roth,	Karlsruhe	Penicillin-streptomycin	solution	 AppliChem,	Darmstadt	Periodic	acid	solution,	0.5	%	 Merck,	Millipore,	Darmstadt	Phenol:Chloroform:Isoamyl	Alcohol,	25:24:1,	[v/v]	 Merck,	Sigma-Aldrich,	Darmstadt	PhiX	standard	library	 Illumina,	San	Diego,	USA	Phorbol-12-myristat-13-acetate	(PMA)	 Merck,	Sigma-Aldrich,	Darmstadt	Phosphate-buffered	saline	(PBS)	w/o	Ca2+	and	Mg2+	 Bio&SELL,	Nürnberg	ProLong™	Gold	Antifade	Mountant	with	DAPI	 Thermo	Fisher	Scientific,	Molecular	BioProducts	Waltham,	USA	RNase	Away	Surface	Docontaminant	 Thermo	Fisher	Scientific,	Molecular	BioProducts,	Waltham,	USA	Roswell	Park	Memorial	Institute	1640	(RPMI)	medium	 Merck,	Sigma-Aldrich,	Darmstadt	ROTI®histol	 Carl	Roth,	Karlsruhe	Saponin	 Merck,	Sigma-Aldrich,	Darmstadt	SCFA	standards	(acetic,	propionic,	butyric	acid)	 Merck,	Sigma-Aldrich,	Darmstadt	Schiff ’s	reagent	 Merck,	Millipore,	Darmstadt	Schaedler	agar	plate,	5	%	sheep	blood	 BD,	Heidelberg	Sodium	dodecyl	sulphate	(SDS)	 Merck,	Sigma-Aldrich,	Darmstadt	Sulfuric	acid	(H2SO4)	 Fluka,	Munich	
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Chemical,	reagent	 Company	TMB	Substrate	Reagent	Set	(RUO)	 BD,	Heidelberg	Triethlyamine	 Merck,	Sigma-Aldrich,	Darmstadt	Tris-base	 Carl	Roth,	Karlsruhe	Tris-HCl	 Carl	Roth,	Karlsruhe	Triton	X-100	 Merck,	Sigma-Aldrich,	Darmstadt	Trypan	blue	 BioRad,	Hercules,	USA	t-RNA	from	baker’s	yeast	 Roche,	Basel,	Switzerland	Tween-20	 Merck,	Sigma-Aldrich,	Darmstadt	Water,	sterile	and	pyrogen-free	(Ampuwa)	 Fresnius	Kabi,	Bad	Homburg	vor	der	Höhe	Water,	PCR-grade	 B.	Braun,	Melsungen	Xylene	 Merck,	Darmstadt		
2.1.6 Buffers	and	media	
Buffer,	media	 Composition	Ammonium	chloride	solution	 9.1	g/L	NH4Cl2,	20	mM	HEPES,	H2O	dest.	Balanced	salt	solution	(BSS)	 9.9	g/l	Hank’s	Salt,	1.425	g/l	NaHCO3,	10	mM	HEPES,	H20	dest.	(pH	7.2)	Cellotetraose	standard	 400	µg/ml,	protein	isolation	buffer	Digestion	Solution	 5	%	[v/v]	FCS,	HBSS	(w)	Enzyme-linked	immunosorbent	assay	(ELISA)	capture	antibody	solution	
α-mouse	lipocalin-2	or	α-mouse	IL-18	antibody	in	1	x	PBS;	α-mouse	IgA	antibody	in	ELISA	coating	buffer	ELISA	coating	buffer	 7.13	g/l	NaHCO3,	1.59	g/l	Na2CO3,	H2O	dest.,	pH	8.2	ELISA	detection	antibody	solution	 α-mouse	lipocalin-2	biotin-conjugated	or	α-mouse	IgA	peroxidase-conjugated	antibody	in	ELISA	reagent	diluent;	α-mouse	IL-18	HRP-conjugated	antibody	in	0.5	%	[w/v]	BSA/ELISA	wash	buffer	ELISA	enzyme	solution	 1:200	streptavidin-HRP	in	ELISA	reagent	diluent	
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Buffer,	media	 Composition	ELISA	isolation	buffer	 0.01	%	[w/v]	sodium	azide,	1	%	[v/n]	100	x	HALTTM	Protease	Inhibitor	Cocktail,	2	%	[w/v]	milk	powder,	1	x	PBS	ELISA	reagent	diluent	 1	%	[w/v]	BSA,	1	x	PBS	(lipocalin-2);	2	%	[w/v]	BSA,	ELISA	wash	buffer	(IL-18);	10	%	[v/v]	FCS,	1	x	PBS	(sIgA)	ELISA	stop	solution	 2	N	H2SO4	ELISA	substrate	solution	 1:1	mixture	of	Color	Reagent	A	(H2O2)	and	Color	Reagent	B	(3,3',	5,5'-tetramethylbenzidine)	ELISA	top	standard	 1000	pg/ml	lipocalin-2	standard;	1500	pg/ml	IL-18	standard;	1	µg/ml	sIgA	standard	ELISA	wash	buffer	 0.05	%	[v/v]	Tween-20,	1	x	PBS	(lipocalin-2,	sIgA);	0.05	%	[v/v]	Tween-20,	20	mM	Tris,	150	mM	NaCl	(pH	7.2-7.4;	IL-18)	Ethanol,	75	%	 75	%	[v/v]	ethanol	absolute,	PCR-grade	water	Foetal	calf	serum	 heat	inactivated	(30	min,	56°C)	FISH	hybridisation	buffer	 0.9	M	NaCl2,	20	mM	Tris-HCl	(pH	7.4),	0.05	%	[w/v]	SDS,	aqua	dest.	FISH	hybridisation	solution	 0.5	pmol/µl	FISH	probe	in	FISH	hybridisation	buffer	FISH	wash	buffer	 0.9	M	NaCl2,	20	mM	Tris-HCl	(pH	7.4),	0.006	%	[w/v]	SDS,	aqua	dest.	Formaldehyde,	2	%	 2	%	[v/v]	formaldehyde,	1	x	PBS	HBSS	(w)	 10	mM	HEPES,	HBSS	w	Ca2+	and	Mg2+	HBSS	(w/o)	 10	mM	HEPES,	HBSS	w/o	Ca2+	and	Mg2+	LB	agar	 15	g/l	LB	agar	powder,	H20	dest.	LB	broth	 20	g/l	LB	broth	powder,	H20	dest.	LegendplexTM	bead	mix	 1:13	dilution	of	individual	beads	in	LegendplexTM	assay	buffer	LegendplexTM	wash	buffer	 5	%	[v/v]	20	x	LegendplexTM	wash	buffer,	H2O	dest.	
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Buffer,	media	 Composition	Lysozyme	solution	 20	mM	Tris-HCl	[pH	7.4],	2	mM	EDTA,	1.2	%	[v/v]	Triton	X-100,	H2O	dest.	Methacarn	solution	 60	%	[v/v]	methanol,	30	%	[v/v]	chloroform,10	%	[v/v]	glacial	acetic	acid	PBS,	10	x	 PBS	powder	w/o	Ca2+	and	Mg2+,	H2O	dest.	PBS,	1	x	 10	%	[v/v]	10	x	PBS,	H2O	dest.	PBS/1	%	FCS	 1	%	[v/v]	FCS,	1	x	PBS	PB	buffer	 0.5	%	[v/v]	FCS,	1	x	PBS	Predigestion	solution	 5	mM	EDTA,	5	%	[v/v]	FCS,	1	mM	DTT,	HBSS	(w/o)	Protein	isolation	buffer	 1	%	[v/v]	100	x	HALTTM	Protease	Inhibitor	Cocktail,	1	x	PBS	RPMI-complete	medium	(RPMI-cm)	 10	%	[v/v]	FCS,	50	µM	β-ME,	60	mg/ml	penicillin,	100	mg/ml	streptomycin,	1	%	[v/v]	NEAS,	40	mM	L-glutamine,	RPMI	Restimulation	medium	 50	ng/ml	PMA,	750	ng/ml	ionomycin,	5	µg/ml	brefeldin	A,	RPMI-cm	Saponin	buffer	 0.3	%	[w/v]	saponin,	2	%	[v/v]	FCS,	1	x	PBS		
2.1.7 Kits	
Kit	 Company	AMP	+	Mass	Spectrometry	Kit	 Cayman	Chemical,	Ann	Arbor,	MI,	USA	AMPure	XD	for	PCR	Purification	 Beckmann	Coulter,	Brea,	USA	eBioscience™	Foxp3/Transcription	Factor	fixation/permeabilization	concentrate	and	diluent	
Thermo	Fisher	Scientific,	Waltham,	Massachusetts,	USA	
CloneJET	PCR	Cloning	Kit	 Thermo	Fisher	Scientific,	Waltham,	Massachusetts,	USA	Haemoccult®	 Beckmann	Coulter,	Brea,	USA	Mouse	IL-18	ELISA	Pair	Set	 Sino	Biologicals	KOD	Hot	Start	Polymerase	Kit	 Novagen,	Merck,	Darmstadt	
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Kit	 Company	Lamina	Propria	Dissociation	Kit,	mouse	 Miltenyi	Biotec	Germany,	Bergisch	Gladbach	LightCycler®	480	Probes	Master	 Roche	Molecular	Systems,	Baser,	Switzerland	Lipocalin-2/NGAL	DuoSet	ELISA,	mouse	 R&D	Systems,	Minneapolis,	Minnesota,	USA	Legendplex™	TH17	panel	(8-plex),	mouse	BioLegend,	San	Diego,	USA	NucleoSpin	Gel	and	PCR	Clean-up	Kit	 Macherey-Nagel,	Düren	NucleoSpin	gDNA	Clean-up	Kit	 Macherey-Nagel,	Düren	NucleoSpin	Plasmid	Kit	 Macherey-Nagel,	Düren	QIAmp	DNA	stool	mini	kit	 Quiagen	GmbH,	Hilden	qPCR	Core	kit	for	SYBR®	Green	I	 Eurogentec,	Lüttich,	Belgium	RevertAid	First	Strand	cDNA	Synthesis	Kit	 Thermo	Fisher	Scientific,	Waltham,	Massachusetts,	USA	TURBO	DNA-free™	Kit,	invitrogen	 Thermo	Fisher	Scientific,	Waltham,	Massachusetts,	USA	Zombie	NIR™	Fixable	Viability	Kit	 BioLegend,	San	Diego,	USA		
2.1.8 Antibodies	
2.1.8.1 Antibodies	for	ELISA	
Antibody	 Conjugate	 Clone	 Working	
Concentration	
Company	
rabbit	α-mouse	IgA	 	 polyclonal	 1	µg/ml	 Rockland,	#	610-4106	rabbit	α-mouse	IgA	 HRP	 polyclonal	 50	ng/ml	 Rockland,		#	610-4306	rabbit	α-mouse	IL-18	 	 monoclonal	 2	µg/ml	 Sino	Biologicals,	#	50073-R169	rabbit	α-mouse	IL-18	 HRP	 monoclonal	 250	ng/ml	 Sino	Biologicals,	#	50073-R167	
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Antibody	 Conjugate	 Clone	 Working	
Concentration	
Company	
rat	α-mouse	lipocalin-2	 	 polyclonal	 4	µg/ml	 R&D	systems,	#	842440	rat	α-mouse	lipocalin-2	 biotin	 polyclonal	 500	ng/ml	 R&D	systems,	#	842441		
2.1.8.2 Antibodies	for	FACS	
Antibody	 Conjugate	 Clone	 Dilution	 Company	rat	α-mouse	CD45	 Brilliant	Violet	510™	 30-F11	 1:800	 BioLegend,	#	103138	rat	α-mouse	CD4	 V450	 RM4-5	 1:500	 BD,	#	560468	rat	α-mouse	CD4	 FITC	 GK1.5	 1:300	 eBioscience,	#	11-0041-82	mouse	α-mouse	RORγt	 Alexa	Fluor®	647	 Q31-378	 1:200	 BD,		#	562682	rat	α-mouse	FOXP3	 PE	 FJK-16s	 1:200	 eBioscience,	#	12-5773-82	rat	α-mouse	IL-17A	 APC	 eBio17B7	 1:400	 eBioscience,	#	17-7177-81	rat	α-mouse	IFN-γ	 PerCP-Cy5.5	 XMG1.2	 1:400	 BioLegend,	#	505822	rat	α-mouse	IL-4	 PE	 11B11	 1:300	 eBioscience,	#	12-7041-41			 	
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2.1.9 Primer	and	probes	
2.1.9.1 Primer	for	SYBR®	green-based	RT-qPCR	
Primer	 	 Sequence	(5’-3’)	 Company	Gapdh	 fwd	 GGG	AAG	CTC	ACT	GGC	ATG	G	 biomers,	Kim	et	al.	2009,	mod.		 rev	 CTT	CTT	GAT	GTC	ATC	ATA	CTT	GGC	Reg3g	 fwd	 CAA	GAT	GCT	TCC	CCG	TAT	AAC	C	 biomers		 rev	 AGC	TGC	TAC	GTG	AAG	ATG	G	 	TFF3	 fwd	 GCT	AAT	GCT	GTT	GGT	GGT	CC	 biomers		 rev	 TCC	GAT	GTG	ACA	GAG	GGG	TA	 	Muc2	 fwd	 CTT	CTG	TGC	CAC	CCT	CGT	 biomers,	Rosenholm	et	al.	2016		 rev	 TTC	GGG	ATC	TGG	CTT	Muc3	 fwd	 AAT	AGC	ACC	CAA	GAC	GAC	AG	 biomol		 rev	 TGG	ATC	TTT	GCT	GGT	ACT	CC	 	Cldn8	 fwd	 CTG	GAG	GAG	CAC	TGT	TCT	GT	 biomol		 rev	 TGG	CTG	GTT	TGG	TGA	TTT	AT	 	Ocln	 fwd	 ATC	CAC	CTA	TCA	CTT	CAG	A	 biomers,	Pearce	et	al.	2018		 rev	 TAA	TCT	CCC	ACC	ATC	CTC	Tjp1	 fwd	 CCA	CCT	CTG	TCC	AGC	TCT	TC	 biomol		 rev	 CAC	CGG	AGT	GAT	GGT	TTT	CT	 	Ki67	 fwd	 CTC	CAC	GAA	CCT	CAA	AGA	GA	 biomol		 rev	 TGT	GGA	TTC	CTT	CAC	ACT	TT	 		
2.1.9.2 Primer	and	probes	for	hydrolysis	probe-based	RT-qPCR	
Primer	 Sequence	(5’-3’)	 Company	AF17242	 fwd	 GGT	AAT	ACG	GAG	GAT	CCA	AG	 biomers		 rev	 CCG	CAA	CTA	CTC	TCT	AGT	TC		 probe	 FAM-TGC	GTA	GGC	GGT	TTG	ATA	AGT	TAG	AGG-TAMRA	Isol46_Exonucl.2_fwd	 CGG	ATC	GTA	AAG	CTC	TGT	TGT	AAG	 biomers,	Brugiroux	 et	 al.	2016	Isol46_Exonucl.3_rev	 GCT	ACC	GTC	ACT	CCC	ATA	GCA	Probe3_Isol46	 FAM-AAG	AAC	GGC	TCA	TAG	AGG-BHQ1	
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Primer	 Sequence	(5’-3’)	 Company	sol49_Exonucl._fwd	 GCA	CTG	GCT	CAA	CTG	ATT	GAT	G	 biomers,	Brugiroux	 et	 al.	2016	Isol49_Exonucl._rev	 CCG	CCA	CTC	ACT	GGT	GAT	C	Probe_Isol49	 HEX-CTT	GCA	CCT	GAT	TGA	CGA-BHQ1	YL58_Exonucl._fwd	 GAAGAGCAAGTCTGATG	TGAAAGG	 biomers,	Brugiroux	 et	 al.	2016	YL58_Exonucl._rev	 CGG	CAC	TCT	AGA	AAA	ACA	GTT	TCC	Probe_YL58	 FAM-TAA	CCC	CAG	GAC	TGC	ATB-HQ1	YL27_Exonucl.2_fwd	 TCA	AGTCAG	CGG	TAA	AAA	TTC	G	 biomers,	Brugiroux	 et	 al.	2016	YL27_Exonucl.2_rev	 CCC	ACT	CAA	GAA	CAT	CAG	TTT	CAA	Probe2_YL27	 HEX-CAA	CCC	CGT	CGT	GCC-BHQ1	YL31_Exonucl.2_fwd	 AGG	CGG	GAT	TGC	AAG	TCA	 biomers,	Brugiroux	 et	 al.	2016	YL31_Exonucl.3_rev	 CCA	GCA	CTC	AAG	AAC	TAC	AGT	TTC	A	Probe2_YL31	 FAM-CAA	CCT	CCA	GCC	TGC-BHQ1	YL32_Exonucl.2_fwd	 AAT	ACC	GCA	TAA	GCG	CAC	AGT	 biomers,	Brugiroux	 et	 al.	2016	YL32_Exonucl.2_rev	 CCA	TCT	CAC	ACC	ACC	AAA	GTT	TT	Probe2_YL32	 HEX-CGC	ATG	GCA	GTG	TGT-BHQ1	KB1_Exonucl._fwd	 CTT	CTT	TCC	TCC	CGA	GTG	CTT	 biomers,	Brugiroux	 et	 al.	2016	KB1_Exonucl._rev	 CCC	CTC	TGA	TGG	GTA	GGT	TAC	C	Probe_KB1	 FAM-CAC	TCA	ATT	GGA	AAG	AGG	AG-BHQ1	YL2_Exonucl._fwd	 GGG	TGA	GTA	ATG	CGT	GAC	CAA	 biomers,	Brugiroux	 et	 al.	2016	YL2_Exonucl._rev	 CGG	AGC	ATC	CGG	TAT	TAC	CA	Probe_YL2	 HEX-CGG	AAT	AGC	TCC	TGG	AAA-BHQ1	KB18_Exonucl.2_fwd	 TGG	CAA	GTC	AGT	AGT	GAA	ATC	CA	 biomers,	Brugiroux	 et	 al.	2016	KB18_Exonucl.2_rev	 TCA	CTC	AAG	CTC	GAC	AGT	TTC	AA	Probe2_KB18	 FAM-CTT	AAC	CCA	TGA	ACT	GCB-HQ1	YL44_Exonucl._fwd	 CGG	GAT	AGC	CCT	GGG	AAA	 biomers,	Brugiroux	 et	 al.	2016	YL44_Exonucl._rev	 GCG	CAT	TGC	TGC	TTT	AAT	CTT	T	Probe_YL44				
HEX-TGG	GAT	TAA	TAC	CGC	ATA	GTA-BHQ1	
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Primer	 Sequence	(5’-3’)	 Company	YL45_Exonucl._fwd	 AGA	CGG	CCT	TCG	GGT	TGT	A	 biomers,	Brugiroux	 et	 al.	2016	YL45_Exonucl._rev	 CGT	CAT	CGT	CTA	TCG	GTA	TTA	TCA	A	Probe_YL45	 FAM-ACC	ACT	TTT	GTA	GAG	AAC	GA-BHQ1	Isol48_Exonucl._fwd	 GGC	AGC	ATG	GGA	GTT	TGC	T	 biomers,	Brugiroux	 et	 al.	2016	Isol48_Exonucl._rev	 TTA	TCG	GCA	GGT	TGG	ATA	CGT	Probe_Isol48	 HEX-CAA	ACT	TCC	GAT	GGC	GAC-BHQ1		
2.1.9.3 Primer	for	16S	rRNA	gene	amplicon	analysis	
Probe	 Sequence	(5’-3’)	 Source	341F	 CCT	ACG	GGN	GGC	WGC	AG	 Klindworth	et	al.	2013	785R	 GAC	TAC	HVG	GGT	ATC	TAA	TCC	 Klindworth	et	al.	2013		
2.1.9.4 Probes	for	fluorescence	in	situ	hybridisation	(FISH)	
Probe	 Sequence	(5’-3’)	 Source	AF17242	 Cy5-GGC	TCC	TAC	ACG	TAA	GAG	CGT	 biomers,	Moschen	et	al.	2016,	mod.	Eub338	 FITC-GCT	GCC	TCC	CGT	AGG	AGT	 biomers,	Amann	et	al.	1990		
2.1.10 Plasmids	
Plasmid	 Backbone	 Insert	 Restriction	
site	used	for	
linearisation	
Source	
pSAB7	 pJET	1.2	 ‘B.	caecimuris’	I48	 HindIII	 Brugiroux	et	al.	2016	pSAB3	 pJET	1.2	 ‘M.	intestinale’	YL27	 NotI	 Brugiroux	et	al.	2016	
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Plasmid	 Backbone	 Insert	 Restriction	
site	used	for	
linearisation	
Source	
pSAB9	 pJET	1.2	 E.	faecalis	KB1	 NotI	 Brugiroux	et	al.	2016	pSAB12	 pJET	1.2	 ‘A.	muris’	KB18	 HindIII	 Brugiroux	et	al.	2016	pSAB4	 pJET	1.2	 B.	coccoides	YL58	 HindIII	 Brugiroux	et	al.	2016	pSAB8	 pJET	1.2	 L.	reuteri	I49	 HindIII	 Brugiroux	et	al.	2016	pSAB6	 pJET	1.2	 C.	innocuum	I46	 NotI	 Brugiroux	et	al.	2016	pM1459-1	 pCR®2.1-TOPO®	 A.	muciniphila	YL44	 HindIII	 Brugiroux	et	al.	2016	pM1460-1	 pCR®2.1-TOPO®	 ‘T.	muris’	YL45	 NcolI	 Brugiroux	et	al.	2016	pM1452	 pCR®2.1-TOPO®	 B.	longum	YL2*	 HindIII	 Brugiroux	et	al.	2016	pM1457-1	 pCR®2.1-TOPO®	 C.	clostridioforme	YL32	 HindIII	 Brugiroux	et	al.	2016	pM1456-1	 pCR®2.1-TOPO®	 F.	plautii	YL31	 HindIII	 Brugiroux	et	al.	2016	p17242	 pJET	1.2	 A.	finegoldii	17242	 HindIII	 this	study		
2.1.11 Software	
Software	 Source	Adobe	Illustrator	CS5	 Adobe	Inc.	EDGAR	 Blom	et	al.	2009	EggNOG	4.5.1.	 Huerta-Cepas	et	al.	2016	FlowJo	10	 Becton	Dickinson	GmbH	GraphPad	Prism	8	 Graphpad	Software,	Inc.	
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Software	 Source	ImageJ	 National	Institutes	of	Health	imngs	 Lagkouvardos	et	al.	2016	KofamKoala	 Aramaki	et	al.	2019	Legendplex™	Data	Analysis	Software	 BioLegend	MS	Office	2016	 Microsoft	R,	RStudio	 RStudio	Inc.	StepOne	 Thermo	Fisher	
2.2 Methods	
2.2.1 Mice	maintenance	and	breeding	C57BL/6	wild	type	breeding	pairs	were	ordered	from	Charles	River	Laboratory	and	kept	 at	 the	 animal	 facility	 of	 the	 Biomedical	 Research	 Centre	 and	 the	 Centre	 for	Tumour	Biology	and	Immunology	of	the	Philipps-University	Marburg.	Animals	were	kept	 under	 specific-pathogen	 free	 conditions	 with	 12	hours	 light	 cycle,	 rodent	purified	diets	(sniff	Spezialdiäten	GmbH)	and	water	ad	libitum.	Mice	harbouring	the	OMM12	(Oligo-Mouse-Microbiota	12)	consortium	were	kindly	provided	 by	 Dr.	M.	 Basic	 (Hannover	 Medical	 School).	 Germ-free	 and	 gnotobiotic	C57BL/6	mice	 were	 bred	 in	 sterile	 plastic	 isolators	 at	 the	 animal	 facility	 of	 the	Biomedical	Research	Centre	and	the	Centre	for	Tumour	Biology	and	Immunology	of	the	 Philipps-University	 Marburg.	 They	 were	 kept	 under	 sterile	 conditions	 with	12	hours	 light	 cycle,	 autoclaved	 standard	 rodent	 diet	 LASQCdiet®	 Rod16-R	(LASvendi)	and	water	ad	 libitum.	For	some	experiments,	germ-free	mice	received	rodent	purified	diets	(sniff	Spezialdiäten	GmbH)	for	four	weeks	prior	to	analysis.		All	experiments	were	performed	in	accordance	with	the	animal	ethics	approved	by	Regierungspräsidium	Gießen	(Nr.	G	1/2018	and	G	72/2019).		
2.2.2 DSS-induced	acute	colitis	model	The	chemical	colitogenic	dextran	sulphate	sodium	(DSS;	MP	Biomedicals)	was	used	to	 induce	 an	 acute	 colitis.	 DSS	 is	 a	 sulphated	 polysaccharide,	 which	 acts	 as	anticoagulant	and	disrupts	the	intestinal	epithelial	barrier	leading	to	inflammation	(Okayasu	et	al.	1990;	Chassaing	et	al.	2014).	
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Mice	were	exposed	to	1.5	%	to	3.5	%	DSS	in	drinking	water	for	five	days.	After	five	days	DSS	was	replaced	by	unsupplemented	drinking	water.	Analysis	were	performed	on	 day	 five	 or	 six	 following	 colitis	 induction.	 Control	mice	 received	 conventional	drinking	water.	For	experiments	with	gnotobiotic	mice,	drinking	water	was	sterile-filtered	with	 a	 0.22	µm	 bottle	 top	 filter.	 The	 colitis	was	 quantified	 by	 the	 loss	 of	weight	and	colon	length,	diarrhea	as	well	as	micro-	and	macroscopic	observations.	The	diarrhea	score	was	set	as	follows:	0,	normal	stool;	1,	soft	stool	or	traces	of	blood;	2,	very	soft	stool	with	traces	of	blood;	3,	watery	stool,	rectal	bleeding.	Occult	blood	in	 faecal	 samples	 was	 confirmed	 by	 Haemoccult®	 test	 (Beckmann	 Coulter)	according	to	manufacturer’s	instructions.		
2.2.3 Intestinal	transit	time	The	 whole	 gut	 transit	 time	 was	 measured	 in	 accordance	 with	 the	 protocol	 of	Nagakura	and	colleagues	(Nagakura	et	al.	1996).	One	part	of	each	diet	was	mixed	with	five	parts	of	sterile	water	and	6	%	[w/v]	carmine	as	a	maker.	Mice	were	fasted	for	six	hours	prior	feeding	with	300	µl	of	the	marked	diet.	The	time	between	oral	administration	and	the	first	red-coloured	faecal	pellet	was	measured.		
2.2.4 Histology	
2.2.4.1 Fixation	and	embedding	The	water-free	methacarn	(methanol-Carnoy’s)	 fixation	was	used	 to	preserve	 the	intestinal	mucus	layer	during	histological	preparation	(Puchtler	et	al.	1970).	Mice	were	sacrificed	by	cervical	dislocation.	The	intestine	was	removed	and	1	cm	of	the	tissue	containing	a	faecal	pellet	was	transferred	into	20	ml	of	methacarn	solution	and	fixed	over	night	at	room	temperature.	The	tissue	was	washed	two	times	in	dry	methanol	 for	 30	min,	 two	 times	 in	 ethanol	 for	 15	min,	 once	 in	 ethanol/xylene	(1:1,	[v/v])	 for	15	min	and	 two	 times	 in	xylene	 for	15	min	prior	 to	embedding	 in	paraffine.		
2.2.4.2 PAS	staining	After	sectioning	 in	3-5	µm	thin	sections	dewaxing	was	accomplished	by	an	 initial	incubation	at	60°C	for	10	min	and	subsequent	incubation	in	xylene	prewarmed	at	
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60°C	for	10	min	and	ethanol	for	5	min.	The	sections	were	stained	with	periodic-acid-Schiff	(PAS)	as	follows:			
Solution	 Time	Periodic	acid,	0.5	%	[w/v]	 10	min	Running	water	 5-10	min	Schiff ’s	reagent	 20-30	min	Running	water	 20	min	Mayer’s	Hämalaun	 1-5	min	Running	water	 5	min		
2.2.4.3 Fluorescence	in	situ	hybridisation	(FISH)	Fluorescence	in	situ	hybridisation	means	the	detection	of	DNA	or	RNA	sequences	immediately	in	the	tissue	by	using	a	probe	which	is	linked	to	a	fluorochrome.	Here,	we	used	a	probe	that	binds	specific	to	the	16S	rRNA	gene	of	bacteria	to	measure	their	location	in	different	regions	of	the	gut.	After	 sectioning	 in	 3-5	µm	 thin	 sections	 dewaxing	 was	 accomplished	 by	 the	following	procedure:		
Solution	 Time	ROTI®histol,	60°C	prewarmed	 1	x	5	min	ROTI®histol	 2	x	5	min	Ethanol,	100	%	[v/v]	 2	x	3	min	Ethanol,	80	%	[v/v]	 1	x	3	min	Ethanol,	60	%	[v/v]	 1	x	3	min	Aqua	dest.	 1	x	30	sec		The	 samples	 were	 treated	 with	 50	µl	 4	%	 lysozyme	 solution	 (45	min,	 37°C)	 to	demask	 nucleic	 acids.	 After	 washing	 in	 aqua	 dest.	 and	 FISH	 wash	 buffer,	 50	 µl	hybridisation	 solution	was	added	and	 incubated	 for	3	hours	at	50°C.	 Slides	were	washed	at	37°C	and	120	rpm	for	5	x	5	min	with	FISH	wash	buffer,	preheated	at	50°C	for	the	first	wash	step.	The	slides	were	dried	at	RT	and	mounted	with	ProLong™	Gold	Antifade	Mountant	with	DAPI	(Thermo	Fisher	Scientific)	following	manufacturer’s	
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instructions	and	stored	at	4°C	over	night	in	the	dark.	The	samples	were	documented	at	 a	 Leica	 DM	 5500	 wide	 field	 microscope	 (Leica)	 and	 analysed	 with	 ImageJ	(National	Institutes	of	Health).	The	protocol	was	established	and	the	samples	were	documented	and	analysed	with	friendly	assistance	of	Kai	Binder.		
2.2.5 Cell	isolation	techniques	
2.2.5.1 Isolation	of	lymph	node	and	spleen	mononuclear	cells	Mice	 were	 sacrificed	 by	 cervical	 dislocation.	 Peyer’s	 Patches,	 lymph	 nodes	 and	spleen	 were	 harvested	 and	 stored	 in	 BSS	 on	 ice.	 For	 preparation	 of	 single	 cell	suspensions	organs	were	pulped	through	a	30	µm	cell	strainer	and	washed	with	BSS.	Cells	were	 centrifuged	 (300	x	g,	 4°C,	10	min)	 prior	 to	 cell	 counting	 and	 following	procedures.	To	 lyse	erythrocytes	 in	 splenic	 cell	 suspensions,	 they	were	 incubated	with	3.0	ml	ammonium	 chloride	 solution	 at	 RT	 for	 7	min.	 After	 washing	 with	 BSS	 and	centrifugation	 (300	x	g,	 4°C,	10	min)	 they	were	 counted	 and	used	 for	 subsequent	applications.		
2.2.5.2 Isolation	of	intestinal	lamina	propria	mononuclear	cells	Mice	were	sacrificed	by	cervical	dislocation.	Lamina	propria	mononuclear	cells	were	isolated	using	 the	Lamina	Propria	Dissociation	Kit	 (Miltenyi	Biotec)	 according	 to	manufacturer’s	instructions.		After	 sacrificing,	 the	 ileum	 (distal	 third	 of	 the	 small	 intestine)	 and	 colon	 were	surgically	removed.	Fat	and	Peyer’s	Patches	(ileum)	were	removed,	intestines	were	longitudinally	opened	and	washed	with	HBSS	(w/o)	to	clear	of	faeces.	The	gut	was	cut	 into	 pieces	 of	 0.5	cm	 length	 and	 stored	 in	 HBSS	(w/o)	 on	 ice.	 Samples	were	incubated	 twice	 at	 100	rpm	 and	 37	°C	 for	 20	min	 in	 20	ml	 predigestion	 solution	containing	EDTA	and	DTT.	Between	and	after	these	incubation	steps	the	intestines	were	vigorously	shaken	for	10	sec	and	filtered	on	a	100	µm	cell	strainer.	Thereafter	they	were	washed	in	20	ml	HBSS	(w/o)	at	100	rpm	and	37	°C	for	20	min.	The	tissue	was	transferred	into	2.35	ml	37°C-preheated	digestion	solution	in	C	tubes	(Miltenyi	Biotec)	 and	processed	by	gentleMACS	Octo	Dissociator	 (Miltenyi	Biotec,	program	37C_m_LPDK_1).	The	obtained	cell	suspension	was	filtered	on	a	100	µm	cell	strainer	
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and	washed	with	PB	buffer.	Cells	were	centrifuged	(300	x	g,	4°C,	10	min)	prior	to	cell	counting	and	following	procedures.		
2.2.5.3 Determination	of	cell	numbers	Trypan	blue	is	an	azo	dye,	which	can	pass	the	membrane	of	dead	cells.	Therefore,	it	is	used	to	distinguish	between	dead	and	live	cells.	To	calculate	absolute	live	and	dead	cell	numbers,	10	µl	of	cell	suspension	was	added	to	10	µl	trypan	blue	dye	(Biorad).	10	µl	of	this	mixture	was	transferred	into	a	cell	counting	 slide	 (Biorad)	 and	 measured	 with	 the	 TC20™	 automated	 cell	 counter	(Biorad).		
2.2.6 Colon	ex	vivo	explant	culture	After	sacrificing,	the	colons	of	the	mice	were	removed.	Approximately	1	cm	of	colon	tissue	was	cleared	of	faeces	and	weighted.	The	tissue	was	washed	in	1	ml	RPMI-cm	at	100	rpm	and	37°C	for	20	min.	Afterwards	the	gut	was	opened	longitudinally	and	incubated	 in	 20-50	µl/mg	 RPMI-cm	 in	 a	 24-well	 plate	 at	 37°C	 and	 5	%	 CO2	 for	24	hours.	 Supernatant	 was	 harvested	 and	 centrifuged	 with	 a	 microcentrifuge	 to	remove	debris.	The	aliquoted	supernatant	was	stored	at	-20°C.		
2.2.7 Microbiological	and	molecular	microbiological	methods	
2.2.7.1 Cultivation	and	application	of	Alistipes	finegoldii	17242	Culture	 plates	 and	 media	 were	 pre-reduced	 with	 Anaerocult®	 A	 (Merck)	 in	 an	anaerobic	 jar	 for	 at	 least	 one	 day	 prior	 to	 usage.	 The	 anaerobic	 bacterial	 strain	
Alistipes	finegoldii	17242	was	cultivated	on	Schaedler	blood	agar	under	anaerobic	conditions	 at	 37°C	 for	 three	 days.	 Bacterial	 cells	 were	 harvested	 and	 stored	 in	glycerol	stocks	at	-80	°C.	A.	finegoldii	17242	was	transferred	from	a	Schaedler	blood	agar	plate	or	glycerol	stock	to	a	flask	containing	BHI	medium	and	cultivated	under	anaerobic	 conditions	 at	 37°C	 for	 three	 to	 four	 days	 until	 bacterial	 growth	 was	observed.	200	µl	 of	 A.	finegoldii	 17242	 culture	 was	 administered	 orally	 by	 gavage	 to	 each	mouse.	Control	mice	received	200	µl	native	BHI	medium.	To	ensure	stabilisation	of	the	 intestinal	microbiota,	mice	were	 allowed	 to	 sit	 for	 three	 to	 four	weeks	 after	association.	
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2.2.7.2 DNA	isolation	from	faecal	and	caecal	samples	Fresh	 faecal	 samples	 or	 caecal	 content	 were	 processed	 immediately	 or	 stored	at	-80	°C	until	processing.	For	 RT-qPCR	 approaches	 genomic	 DNA	 was	 isolated	 using	 the	 QIAamp	 DNA	Stool	mini	Kit	(Qiagen)	following	the	manufacturer’s	instructions.	In	brief,	faecal	or	caecal	 samples	 were	 homogenised	 in	 InhibitEX	 Buffer	 (200	mg/ml)	 using	 an	inoculation	loop	and	mixed	vigorously	for	1	min.	The	suspension	was	heated	(70°C,	5	min)	and	centrifuged	(13,000	x	g,	RT,	1	min).	200	µl	of	the	supernatant	was	mixed	with	15	µl	proteinase	K	and	200	µl	Buffer	AL	and	samples	were	incubated	at	70°C	for	 10	min.	 After	 that,	 200	µl	 ethanol,	 absolute	 was	 added	 and	 the	 lysate	 was	transferred	onto	a	QIAamp	spin	column	and	centrifuged	(13,000	x	g,	RT,	1	min).	The	column	was	washed	twice	with	buffer	500	µl	Buffer	AW1	and	subsequently	500	µl	Buffer	 AW2,	 each	 wash	 step	 followed	 by	 centrifugation	 (13,000	x	g,	 RT,	 1	min).	Finally,	the	column	was	dried	by	one	more	centrifugation	(13,000	x	g,	RT,	3	min).	The	DNA	was	eluted	by	adding	of	100	µl	70°C-prewarmed	Buffer	ATE	and	centrifugation	(13,000	x	g,	RT,	1	min).	The	 concentration	and	purity	of	 the	DNA	were	measured	with	 the	NanoDrop	 system	 (Thermo	Fisher	Scientific).	DNA	samples	were	 stored	at	-20°C.	The	 DNA	 isolation	 for	 16S	rRNA	 gene	 amplicon	 analysis	 was	 performed	 in	collaboration	 with	 Prof.	 T.	 Clavel	 (University	 Aachen)	 and	 Prof.	 K.	 Neuhaus	(University	Munich)	as	published	previously	(Lagkouvardos	et	al.	2015;	Bazanella	et	al.	2017).	Frozen	caecal	samples	were	thawed	on	ice	and	homogenised	in	600	µl	DNA	stabilization	 buffer	 (Stratec	 Biomedical)	 and	 400	µl	 phenol/chloroform/isoamyl	alcohol	(25:24:1,	[v/v];	Sigma	Aldrich).	Bacterial	cells	were	lysed	by	using	500	mg	0.1	mm	glass	beads	and	a	bead	beater	(3	x	6.5	m/s	for	40	s).	Samples	were	heated	(95°C,	8	min)	and	centrifuged	(16,000	x	g,	4°C,	5	min).	150	µl	of	the	supernatant	was	treated	 with	 15	µl	 ribonuclease	 (0.1	µg/ml;	 Amresco)	 at	 37	°C	 for	 30	min.	 After	centrifugation	 (550	x	g,	 30	min)	 DNA	 was	 extracted	 with	 the	 NucleoSpin	 gDNA	Clean-up	Kit	(Macherey-Nagel),	according	to	manufacturer’s	 instructions.	 In	brief,	the	 DNA	 solution	 was	 mixed	 with	 450	µl	 Binding	 Buffer	 DB,	 loaded	 onto	 a	NucleoSpin®	gDNA	Clean-up	column	and	centrifuged	(11,000	x	g,	RT,	30	sec).	The	column	 was	 washed	 twice	 with	 700	µl	 Buffer	 DW,	 each	 wash	 step	 followed	 by	centrifugation	(11,000	x	g,	RT,	30	sec).	Finally,	 the	column	was	dried	by	one	more	
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centrifugation	 (11,000	x	g,	 RT,	 1	min).	 After	 transferring	 the	 column	 into	 a	 fresh	1.5	ml	microcentrifuge	tube,	50	µl	Buffer	DE	was	added	to	the	column	and	incubated	for	1	min	at	RT.	The	DNA	was	eluted	by	centrifugation	(11,000	x	g,	RT,	1	min).	The	concentration	 and	 purity	 of	 the	DNA	were	measured	with	 the	NanoDrop	 system	(Thermo	Fisher	Scientific).	DNA	samples	were	stored	at	-20°C.		
2.2.7.3 16S	rRNA	gene	amplicon	analysis	The	prokaryotic	16S	rRNA	gene	consists	of	around	1,500	base	pairs	and	has	some	hyper-variable	 regions,	 such	 as	 the	 V3/V4	 region,	 between	 more	 conservative	regions	(Kim	et	al.	2011).	16S	rRNA	gene	amplicon	analysis	of	the	variable	regions	is	 widely	 used	 to	 get	 insight	 into	 complex	 microbial	 communities,	 such	 as	 the	intestinal	microbiota.	First,	the	whole	genomic	DNA	is	isolated	from	the	sample.	The	library	preparation	includes	the	amplification	of	the	V3/V4	region,	the	addition	of	sequencing	 adaptors	 and	barcodes	which	 are	used	 to	 identify	 sequences	derived	from	a	certain	sample.	After	sequencing,	the	data	are	bioinformatically	processed	to	obtain	OTUs	(operational	taxonomic	units).	An	OTU	is	a	cluster	of	similar,	usually	97	%	identical	sequences.	The	16S	rRNA	gene	amplicon	analysis	was	performed	in	collaboration	with	Prof.	T.	Clavel	(University	Aachen)	and	Prof.	K.	Neuhaus	(University	Munich)	(Lagkouvardos	et	al.	2015;	Bazanella	et	al.	2017).	24	ng	of	genomic	DNA	was	used	for	amplification	(25	 cycles)	 of	 the	V3/V4	 region	of	 the	16S	rRNA	genes	with	 the	bacteria-specific	primers	 341F	 and	 785R	 (Klindworth	 et	 al.	 2013).	 Purification	 of	 amplicons	was	achieved	using	the	AMPure	XP	system	(Beckmann)	and	sequencing	was	performed	in	paired-end	modus	(PE275)	with	pooled	samples	in	a	MiSeq	system	(Illumina	Inc.)	according	 to	manufacturer’s	 instructions	and	a	 final	 concentration	of	10	pM	DNA	and	25	%	[v/v]	PhiX	standard	library.	Demultiplexing	and	OTU	(operational	taxonomic	unit)	clustering	from	the	raw	16S	rRNA	gene	amplicon	dataset	was	performed	with	imngs	(Integrated	Microbial	Next	Generation	Sequencing)	(Lagkouvardos	et	al.	2016).	The	similarity	cut-off	for	OTU	clustering	 in	 imngs	 is	set	to	97	%	identity.	The	parameters	for	the	 imngs	analysis	were	set	as	the	following:	two	allowed	mismatches	in	the	barcode,	minimum	fastq	quality	score	of	three	for	trimming	of	unpaired	reads,	350	to	550	base	pairs	length	for	amplicons	for	paired	overlapping	sequences,	maximum	of	four	expected	errors	
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in	paired	sequences,	ten	base	pairs	length	of	trimming	at	the	forward	and	reverse	side	of	 the	 sequences,	 0.5	%	 relative	 abundance	of	OTU	cut-off.	The	downstream	analysis	 of	 the	 generated	 OTU-table,	 which	 contains	 information	 about	 the	abundance	and	taxonomic	classification	of	each	OTU	in	each	sample,	was	performed	with	 the	R	script	 set	Rhea	 (Lagkouvardos	 et	 al.	 2017).	Rhea	 allows	 inter	 alia	 the	calculation	 of	 diversity,	 taxonomic	 composition,	 statistical	 comparisons	 and	correlations.		
2.2.7.4 Quantitative	PCR	for	OMM12	consortium	Hydrolysis	probe-based	RT-qPCR	assays	enables	the	quantification	of	the	increase	of	specific	DNA	sequences	during	PCR,	which	is,	in	theory,	exponentially.	The	probe	is	composed	of	an	oligo-nucleotide,	which	binds	to	the	sequence	amplified	specifically	by	the	primer,	a	fluorophore	at	the	5’-end	and	a	quencher	at	the	3’-end.	The	quencher	quenches	 the	 fluorescence	 emitted	 by	 the	 fluorophore.	 During	 amplification,	 the	DNA	 polymerase,	 which	 harbours	 also	 5’-3’-exonuclease	 activity,	 degrades	 the	probe,	thereby	releases	the	fluorophore	and	the	quencher.	The	fluorophore,	which	is	no	longer	next	to	the	quencher,	emits	a	detectable	signal.	The	more	specific	DNA	sequences	are	in	the	sample,	the	more	fluorophores	are	released	and	the	higher	is	the	fluorescent	signal.	An	advantage	of	this	method	is	the	ability	to	detect	more	than	one	template	per	reaction	by	using	probes	with	different	fluorophores.	Genomic	bacterial	DNA	was	isolated	from	faecal	and	caecal	samples	as	mentioned	above.	For	absolute	quantification	of	the	OMM12	consortium	and	A.	finegoldii	17242	within	 the	 intestinal	 microbiota	 we	 used	 the	 hydrolysis-probe-based	 RT-qPCR	published	by	Brugiroux	and	colleagues	 (Brugiroux	et	al.	2016).	Duplex	RT-qPCRs	were	run	using	the	LightCycler®	480	Probes	Master	(Roche)	and	a	LightCycler®	480	Instrument	II	(Roche)	with	the	following	features:		 	
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Component	 Volume	2	x	Probes	Master	 10	µl	forward	primer	1	(30	µM)	 0.2	µl	forward	primer	1	(30	µM)	 0.2	µl	probe	1	(25	µM),	FAM-labelled	 0.2	µl	forward	primer	2	(30	µM)	 0.2	µl	forward	primer	2	(30	µM)	 0.2	µl	probe	2	(25	µM),	HEX-labelled	 0.2	µl	template/standard	DNA	(4	ng/µl)	 2.5	µl	PCR	grade	water	 ad	20	µl	
	
Cycling	Conditions	 Temperature	and	time	1. polymerase	activation	 95°C,	2	min	2. denaturation	 95°C,	2	min	3. annealing	 43°C,	10	sec	4. extension	 70°C,	10	sec	
Repeats	of	steps	2-4	 40	cycles		The	absolute	quantification	of	the	copy	number	of	certain	sequences	in	an	unknown	sample	requires	standard	curves	of	the	fluorescent	intensity	dependent	on	known	DNA	concentrations.	For	standard	curve	preparation	the	concentration	of	sequence	copy	numbers	was	calculated	for	each	plasmid	(see	chapter	2.2.7.5).	Ten-fold	serial	dilutions	(108-10-2	copies/µl)	were	prepared	in	water	supplemented	with	100	ng/µl	yeast	t-RNA.	Standard	curves	measured	once	can	be	used	for	absolute	quantification	of	the	copy	number	in	template	DNA,	for	example	DNA	isolated	from	faecal	samples.	Just	one	single	standard	in	every	further	run	is	needed	to	reproduce	the	standard	curves	by	the	software	of	the	LightCycler®	480	Instrument	(Roche).		
2.2.7.5 Plasmids	The	absolute	quantification	of	a	DNA	template	via	quantitative	RT-qPCR	requires	a	standard	 with	 known	 concentration	 of	 the	 copy	 number.	 Therefore,	 plasmids	harbouring	a	sequence	of	the	bacterial	16S	rRNA	gene	were	prepared	to	serve	as	standard	for	RT-qPCR	assays.	
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Genomic	 DNA	 of	 A.	finegoldii	 17242	 was	 isolated	 from	 BHI	 cultures	 using	 the	QIAamp	DNA	Stool	mini	Kit	(Qiagen)	following	the	manufacturer’s	instructions	(see	above),	except	for	the	first	steps.	Bacterial	culture	was	centrifuged	(2,000	x	g,	4°C,	20	min)	and	the	pellet	was	resuspended	in	400	µl	InhibitEX	buffer.	After	 DNA	 isolation,	 a	 specific	 region	 of	 the	 16S	 rRNA	 gene	 of	 A.	finegoldii	 was	amplified	 using	 the	 AF17242	 primer	 and	 the	 KOD	 Hot	 Start	 Polymerase	 Kit	(Novagen)	according	to	manufacturer’s	instructions:		
Component	 Volume	10	x	Buffer	for	KOD	Hot	Start	DNA	Polymerase	 5.0	µl	MgCl2	(25	mM)	 3.0	µl	dNTPs	(2	mM	each)	 5.0	µl	sense	(5’)	primer	AF17242_for	(10	µM)	 1.5	µl	antisense	(3’)	primer	AF17242_rev	(10	µM)	 1.5	µl	template	DNA	(20	ng/µl)	 4.0	µl	KOD	Hot	Start	DNA	Polymerase	(1	U/µl)	 1.0	µl	PCR	grade	water	 ad	50	µl	
	
Cycling	Conditions	 Temperature	and	time	1. polymerase	activation	 95°C,	2	min	2. denaturation	 95°C,	2	min	3. annealing	 43°C,	10	sec	4. extension	 70°C,	10	sec	
Repeats	of	steps	2-4	 40	cycles		The	purity	of	the	template	was	proofed	by	agarose	gel	electrophoresis	with	a	1.5	%	agarose	gel	and	ethidium	bromide	staining.	The	DNA	 fragment	was	 then	 isolated	from	 the	 gel	 using	 the	 NucleoSpin	 Gel	 and	 PCR	 Clean-up	 Kit	 (Macherey-Nagel)	according	 to	 manufacturer’s	 instructions.	 In	 short,	 the	 band	 was	 cut	 out	 of	 the	agarose	gel,	mixed	with	Buffer	NTI	and	heated	to	melt	the	agarose	gel	(50°C,	5-10	min).	The	solution	was	transferred	to	a	NucleoSpin®	Gel	and	PCR	Clean-up	Column.	After	 several	 wash	 steps,	 the	 DNA	was	 eluted	 with	 Buffer	 NE.	 The	 yielded	 DNA	
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concentration	 and	 quality	 were	 measured	 by	 NanoDrop	 system	 (Thermo	 Fisher	Scientific).	To	generate	the	plasmid,	the	fragment	was	inserted	into	a	vector	using	the	CloneJET	PCR	Cloning	Kit	 (Thermo	 Scientific)	 following	manufacturer’s	 Sticky-End	 cloning	protocol.	In	brief,	the	PCR	product	was	incubated	with	the	blunting	reaction	mix	for	5	min	at	70°C.	After	chilling	on	ice,	the	vector	pJET1.2	and	ligase	were	added	and	the	ligation	mix	was	incubated	for	5	min	at	RT.	The	 prepared	 plasmid	 was	 transformed	 into	 E.	 coli	 DH5α	 via	 heat	 shock	 (42°C,	30	sec).	Bacteria	were	cultured	on	LB-Agar	plates	containing	ampicillin	(100	µg/ml)	at	37°C	overnight.	Several	clones	of	the	overnight	culture	were	picked	and	cultured	in	30	ml	LB	Medium	containing	ampicillin	(100	µg/ml)	at	37°C	overnight.	The	overnight	cultures	were	centrifuged	(3,000	x	g,	4°C,	10	min).	Plasmid	DNA	was	isolated	 using	 the	 NucleoSpin	 Plasmid	 Kit	 (Macherey-Nagel)	 according	 to	manufacturer’s	 instructions.	 In	short,	bacterial	cells	were	resuspended	and	 lysed,	following	 centrifugation	 (11,000	x	g,	 RT,	 10	min)	 to	 remove	 cell	 debris.	 The	supernatant	was	loaded	on	a	DNA-binding	column.	After	a	washing	procedure	and	drying	 of	 the	 membrane	 the	 DNA	 was	 eluted	 by	 addition	 of	 elution	 buffer	 and	centrifugation	(11,000	x	g,	RT,	1min).	To	validate	the	cloning,	plasmids	were	cleaved	by	two	restriction	enzymes	at	specific	recognitions	sites	in	the	insert	(MfeI)	and	in	the	vector	(BamHI).	Fragments	were	separated	by	agarose	gel	electrophoresis	with	a	1.5	%	agarose	gel	and	stained	by	ethidium	bromide.	Plasmids	containing	the	16S	rRNA	gene	of	OMM12	bacteria	were	kindly	provided	by	Prof.	B	Stecher	(Max	von	Pettenkofer-Institute	Munich).	The	dried	plasmids	were	solved	in	10	µl	water	and	transformed	into	E.	coli	DH5α	via	heat	shock	(42°C,	30	sec).	Bacteria	were	grown	and	plasmids	were	isolated	as	mentioned	above.	The	yielded	plasmids	were	linearised	by	cleaving	once	by	restriction	enzymes	(NotI,	NcoI,	HindIII).	The	DNA	concentration	was	measured	by	NanoDrop	system	(Thermo	Fisher	Scientific)	and	the	sequence	was	controlled	by	sequencing	(Seqlab).		
2.2.8 Flow	cytometry	Flow	cytometry	enables	the	simultaneous	analysis	of	multiple	parameters	of	single	cells,	for	example	the	expression	of	cell	surface	molecules	or	intracellular	cytokines	and	 transcription	 factors.	 Cell	 populations	 can	 be	 distinguished	 by	 cell	 size	 and	
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granularity,	both	measured	by	light	foreword	(FSC)	and	side	scattering	(SSC)	due	to	a	cell	in	the	light	beam.	Fluorescent	dyes	and	fluorochrome-conjugated	antibodies	are	used	to	investigate	certain	markers	as	well	as	viability	of	a	cell.		
2.2.8.1 Cell	surface	staining	Isolated	cells	 from	different	murine	organs	were	washed	with	1	x	PBS.	After	each	washing	 step	 cells	 were	 centrifuged	 (300	x	g,	 4°C,	 10	min).	 Supernatant	 was	discarded	and	cells	were	resuspended.	For	the	staining	of	certain	parameters	100	µl	1	x	PBS	 containing	 Zombi	 NIRTM	 fixable	 viability	 dye	 (BioLegend,	 1:2,000)	 and	appropriate	 diluted	 antibodies	 were	 added	 and	 incubated	 for	 20	min	 at	 4°C.	 To	remove	 unattached	 antibodies	 cells	 were	 washed	 with	 PBS/1	%	FCS	 prior	 to	intracellular	staining	or	flow	cytometry.		
2.2.8.2 Intracellular	staining	of	transcription	factors	Prior	 to	 intracellular	 staining	 cells	 must	 be	 fixed	 and	 permeabilised.	 Therefore,	following	cell	surface	staining,	cells	were	washed	with	1	x	PBS	and	fixed	using	the	Foxp3	Fixation/Permeabilization	Kit	(Thermo	Fisher	Scientific)	 for	20	min	at	4°C.	Following	washing	with	PBS/1	%	FCS	and	 saponin	buffer	 cells	were	 incubated	 in	100	µl	saponin	buffer	containing	appropriate	diluted	antibodies	for	40	min	at	4°C.	After	 further	 washing	 steps	 with	 saponin	 buffer	 and	 PBS/1	%	FCS	 cells	 were	analysed	by	flow	cytometry	using	the	Attune	NxT	Flow	Cytometer.	The	data	were	analysed	by	FlowJo	10	(BD)	following	the	gating	shown	in	Figure	3A.		
2.2.8.3 Intracellular	staining	of	cytokines	To	 measure	 the	 cytokine	 production,	 isolated	 cells	 were	 restimulated	 with	restimulation	 medium	 containing	 PMA	 and	 ionomycin,	 which	 lead	 to	 polyclonal	T	cell	activation,	and	brefeldin	A,	which	inhibits	the	transport	of	proteins	to	the	Golgi	apparatus	and	thus	the	secretion	of	produced	cytokines.	Isolated	cells	 from	different	organs	were	washed	with	RPMI-cm.	Afterwards	1	ml	restimulation	medium	was	added	and	cells	were	incubated	for	four	hours	at	37°C	and	 5	%	 CO2.	 Following	 incubation,	 cell	 surface	 staining	 was	 performed	 as	mentioned	 above.	 After	 washing	 with	 1	x	PBS,	 the	 cells	 were	 fixed	 in	2	%	formaldehyde	solution	for	30	min	at	room	temperature.	Following	washing	with	
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PBS/1	%	FCS	 and	 saponin	 buffer	 cells	 were	 incubated	 in	 100	µl	 saponin	 buffer	containing	 appropriate	 diluted	 antibodies	 for	 20	min	 at	 4°C.	 Flow	 cytometric	analysis	 was	 performed	 after	 further	 washing	 steps	 with	 saponin	 buffer	 and	PBS/1	%	FCS	 using	 the	 Attune	 NxT	 Flow	 Cytometer.	 The	 data	 were	 analysed	 by	FlowJo	10	(BD)	following	the	gating	shown	in	Figure	3B.		
	
Figure	3.	Gating	strategy	for	flow	cytometry	analysis.	(A)	FOXP3-	and	RORgt-expressing	subsets	were	gated	on	live	CD4+	CD45+	lymphocytes.	(B)	Subsets	of	IL-4-,	IL-17-	and	IFN-g-expressing	cells	were	gated	on	live	CD4+	lymphocytes.		
2.2.9 Immunoassays	
2.2.9.1 Enzyme-linked	immunosorbent	assay	(ELISA)	ELISA	is	an	antibody-based	assay	to	detect	and	quantify	proteins,	such	as	cytokines.	A	 coating	antibody	binds	 the	analyte	 to	 a	plate.	Hereafter,	 an	enzyme-conjugated	primary	 or	 a	 combination	 of	 a	 primary	 and	 secondary	 antibody,	 in	 which	 the	secondary	 antibody	 is	 conjugated,	 bind	 the	 analyte.	 For	 instance,	 the	 enzyme	horseradish	 peroxidase	 catalyses	 the	 oxidation	 of	 the	 colorimetric	 substrate	3,3',5,5'-tetramethylbenzidine	(TMB)	driven	by	H2O2	and	results	in	a	blue	coloration.	Addition	of	the	stop	solution	sulfuric	acid	changes	the	colour	from	blue	to	yellow.	By	using	a	standard	of	known	concentration,	the	absorbance	of	this	product	could	be	used	to	quantify	the	analyte.	
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To	quantify	 lipocalin-2,	 an	 innate	 immune-linked	protein	 (Chassaing	et	 al.	2012),	and	 IL-18	 in	 ex	 vivo	 colon	 culture	 supernatants	 the	 Mouse	 Lipocalin-2/NGAL	DuoSet®	ELISA	(R&D	Systems)	and	IL-18	ELISA	(Sino	Biologicals)	were	performed	according	to	manufacturer’s	instruction.	In	short,	50	µl/well	ELISA	capture	antibody	solution	was	added	to	a	polystyrene	96-well	microplate,	which	than	was	incubated	overnight	 at	 4°C.	 Afterwards	 and	 for	 each	 following	washing	 step,	 the	 plate	was	washed	 three	 times	 with	 ELISA	 washing	 buffer	 and	 dried	 by	 blotting	 on	 paper	towels.	Unspecific	antibody	binding	was	blocked	by	addition	of	300	µl/well	ELISA	reagent	diluent	and	 incubation	 for	at	 least	one	hour	at	RT.	 Samples	were	diluted	1:500	to	1:1,000	(lipocalin-2)	respectively	1:10	(IL-18)	in	ELISA	reagent	diluent.	The	eight-point	standard	curve	was	prepared	by	serial	2-fold	dilution	of	the	ELISA	top	standard.	50	µl/well	sample	or	standard	was	added	to	the	plate	and	incubated	for	two	hours	at	RT.	Following	washing,	50	µl/well	ELISA	detection	antibody	solution	was	added	and	incubated	for	two	(lipocalin-2)	respectively	one	hour	(IL-18)	at	RT.	Additionally	 for	 lipocalin-2	 ELISA,	 the	 plate	 was	 washed	 and	 50	µl/well	 ELISA	enzyme	 solution	 was	 added	 and	 incubated	 for	 20	min	 at	 RT	 in	 the	 dark.	 After	washing,	50	µl/well	ELISA	substrate	solution	was	added	and	incubated	for	20	min	at	RT	in	the	dark.	After	stopping	the	reaction	by	addition	of	25	µl/well	ELISA	stop	solution,	the	absorbance	was	measured	by	450	nm	and	corrected	for	the	absorbance	of	570	nm.	ELISA	was	also	performed	to	quantify	secretory	IgA	(sIgA)	in	faecal	protein	isolates.	Fresh	faecal	samples	were	collected	in	2.0	ml	tubes	and	weighted.	ELISA	isolation	buffer	 was	 added	 (1	ml/100	mg)	 and	 samples	 were	 homogenised	 using	 an	inoculation	 loop.	 Samples	 were	 incubated	 on	 ice	 for	 30	min	 and	 subsequently	vigorously	 mixed	 for	 20	sec.	 After	 centrifugation	 (2,000	x	g,	 4°C,	 30	min),	 the	supernatant	was	aliquoted	and	stored	at	-20°C.	50	µl/well.	ELISA	capture	antibody	solution	was	added	to	a	polystyrene	96-well	microplate,	which	than	was	incubated	overnight	 at	 4°C.	 Afterwards	 and	 for	 each	 following	washing	 step,	 the	 plate	was	washed	four-times	with	ELISA	washing	buffer	and	dried	by	blotting	on	paper	towels.	Unspecific	antibody	binding	was	blocked	by	addition	of	300	µl/well	ELISA	reagent	diluent	 and	 incubation	 for	 at	 least	 two	hours	 at	RT.	 Samples	were	 diluted	 1:2	 in	ELISA	reagent	diluent.	The	nine-point	standard	curve	was	prepared	by	serial	2-fold	dilution	of	the	ELISA	top	standard.	50	µl/well	sample	or	standard	was	added	to	the	
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plate	 and	 incubated	 for	 two	 hours	 at	 RT.	 Following	 washing,	 50	µl/well	 ELISA	detection	antibody	solution	was	added	and	incubated	for	two	hours	at	RT.	The	plate	was	washed	and	50	µl/well	ELISA	substrate	solution	was	added	and	incubated	for	25	min	at	RT	in	the	dark.	After	stopping	the	reaction	by	addition	of	25	µl/well	ELISA	stop	 solution,	 the	 absorbance	 was	 measured	 by	 450	nm	 and	 corrected	 for	 the	absorbance	of	570	nm.		
2.2.9.2 Bead-based	immunoassay	The	 BioLegend	 LegendplexTM	 is	 a	 bead-based	 immunoassay,	 which	 allows	 the	simultaneous	 quantification	 of	multiple	 soluble	 analytes,	 such	 as	 cytokines,	 from	culture	supernatant	or	blood	serum.	The	analytes	were	bind	to	antibodies	on	the	surface	of	capture	beads	that	differ	in	size	and	APC-fluorescence	levels,	which	allows	them	to	be	differentiated.	Biotinylated	secondary	antibodies	bind	specifically	to	the	bound	 analytes,	 thereby	 forming	 capture	 bead-analyte-detection	 antibody	sandwiches.	 Added	 streptavidin-phycoerythrin	 (SA-PE)	 binds	 to	 the	 biotinylated	detection	antibodies	and	provides	a	fluorescent	signal	proportional	to	the	amount	of	bound	analyte	and	could	be	detected	by	flow	cytometry.	The	 mouse	 Th17	 Cytokine	 Panel	 (8-plex)	 LegendplexTM	 assay	 was	 performed	according	 to	 manufacturer’s	 instruction.	 Therefore,	 samples	 were	 diluted	 1:2	 or	used	 undiluted.	 The	 eight-point	 standard	 curve	 was	 prepared	 by	 serial	 4-fold	dilution	 of	 the	 LegendplexTM	 top	 standard.	 Samples	 respectively	 standards,	LegendplexTM	 assay	 buffer	 and	 LegendplexTM	 bead	 mix,	 each	 12.5	µl/well,	 were	mixed	into	a	polypropylene	96-well	microplate	and	incubated	overnight	at	4°C	while	continuously	shaking	(800	rpm).	Afterwards	and	for	the	following	washing	step,	the	plate	was	washed	with	200	µl/well	LegendplexTM	washing	buffer	and	centrifuged	(800	x	g,	5	min).	The	supernatant	was	discarded	and	the	plate	was	dried	by	blotting	on	paper	towels.	12.5	µl/well	LegendplexTM	detection	antibody	was	added	and	the	assay	was	 incubated	 for	 one	 hour	 at	RT	while	 continuously	 shaking.	 Afterwards,	12.5	µl/well	 LegendplexTM	 SA-PE	 was	 added	 and	 incubated	 for	 30	min	 further.	Following	washing,	 the	beads	were	transferred	into	FACS	tubes	using	150	µl/well	LegendplexTM	washing	buffer	and	measured	at	the	Attune	NxT	Flow	Cytometer.	The	data	were	analysed	using	the	Legendplex™	Data	Analysis	Software.		
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2.2.10 Cellotetraose	assay	Cellulose	is	large	molecule	and	insoluble	in	water.	Because	of	these	physicochemical	properties,	cellulose	is	poorly	suitable	to	study	cellulolytic	enzyme	activities	in	vitro.	Cellotetraose,	which	consists	of	four	glucose	molecules,	is	highly	water-soluble,	but	still	 has	 the	 unique	 β-1,4-glycosidic	 bonds	 preventing	 cleavage	 by	 mammalian	digestive	enzymes.	Isolated	caecal	proteins	including	cellulolytic	enzymes	(Lin	et	al.	2012)	were	incubated	with	cellotetraose	and	cellulolytic	activity	was	measured	by	the	quantification	of	cellotetraose	cleavage	products	(cellotriose	and	cellobiose)	by	high-performance	 liquid	 chromatography-	 (HPLC-)	 and	 capillary	 electrophoresis-	(CE-)	coupled	mass	spectrometry.		
2.2.10.1 Analysis	of	kinetics	of	caecal	cellulolytic	enzymes	Mice	were	sacrificed	via	cervical	translocation.	The	caecal	luminal	content	of	three	to	 four	 mice	 was	 isolated,	 pooled	 and	 weighted.	 After	 addition	 of	 the	 protein	isolation	buffer	 (300	µl/100	mg),	 samples	were	 incubated	 on	 ice	 for	 10	min.	 The	luminal	 content	 was	 homogenised	 by	 using	 an	 inoculation	 loop	 and	 vigorously	mixing	for	30	sec.	The	samples	were	centrifuged	twice	(3,500	x	g,	4°C,	20	min).	The	clear	 supernatant	 was	 1.5-fold	 diluted	 in	 sterile	 water	 and	 used	 directly	 for	subsequent	applications.	The	 diluted	 supernatant	 which	 contained	 bacterial	 enzymes	 was	 mixed	 with	cellotetraose	standard	in	excess,	resulting	in	a	final	concentration	of	200	µM.	Protein	isolation	buffer	instead	of	cellotetraose	standard	was	used	as	a	negative	control.	For	heat-inactivated	 controls,	 the	 enzyme	 solution	was	 incubated	 at	 95°C	 for	 15	min	prior	to	addition	of	cellotetraose	standard.	The	samples	were	incubated	for	times	indicated	in	the	figures	at	37°C.	The	reaction	was	terminated	by	freezing	in	liquid	nitrogen.	Samples	were	stored	at	-80°C	before	analysis		
2.2.10.2 Quantification	of	cello-oligomers	via	HPLC-	and	CE-MS	The	 HPLC-and	 CE-MS	 analysis	 was	 performed	 in	 collaboration	with	 Dr.	 U.	 Linne	(University	Marburg)	and	M.Sc.	Filipp	Bezold	(University	Marburg).	After	thawing,	the	samples	were	heat	inactivated	(95°C,	15	min)	to	exclude	further	enzymatic	 processes.	 The	 samples	were	 centrifuged	 (3,500	x	g,	 4°C,	 20	min)	 and	clear	supernatant	was	10-fold	diluted.	
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For	HPLC-MS	analysis,	50	µl	of	this	solution	was	transferred	to	an	Agilent	1100	HPLC	system	 (Agilent	 Technologies)	 and	 a	 HPLC	 column	 (NUCLEODUR	 125/2	 C18ec,	Macherey-Nagel).	The	column	temperature	was	set	 to	25°C.	Cello-oligomers	were	eluted	by	performing	a	solvent	system	of	water	(eluent	A)	and	acetonitrile	(eluent	B)	with	a	gradient	profile	as	follows:		
Eluent	 Time	starting	at	2	%	eluent	B	 5	min	increasing	to	10	%	eluent	B	 within	5	min	increasing	to	85	%	eluent	B	 within	10	min	increasing	to	95	%	eluent	B	 within	10	min,	hold	for	5	min		The	LTQ-FT-Ultra	mass	spectrometer	(Thermo	Fisher	Scientific)	equipped	with	an	electrospray	ion	source	in	positive	ionisation	mode	was	used	for	mass	spectrometry.	The	 CE-MS	 analysis	 was	 performed	 as	 previously	 described	 (Klampfl	 and	Buchberger	 2001).	 25	µl	 sample	 solution	 was	 transferred	 to	 an	 Agilent	 1600A	capillary	electrophoresis	system	(Agilent	Technologies)	and	a	100	cm	fused	CE	silica	capillary	 (ID	 50µM)	 (Agilent	 Technologies).	 300	 mM	 triethylamine	 was	 used	 as	background	analyte	and	80	%	isopropanol	supplemented	with	0.25	%	triethylamine	was	provided	at	a	flow	rate	of	4	µl/min	as	sheath	liquid.	The	sample	was	injected	by	pressure	(50	mbar,	9	s)	and	separated	by	the	application	of	20	kV	separation	voltage.	The	Agilent	6120	single	quadrupole	mass	spectrometer	(Agilent	Technologies)	 in	negative	ionisation	mode	was	used	for	mass	spectrometry.		
2.2.11 Quantification	of	SCFAs	and	bile	acids	
2.2.11.1 Isolation	of	caecal	bile	acids	and	short	chain	fatty	acids	The	isolation	of	bile	acids	and	short	chain	fatty	acids	was	performed	in	collaboration	with	Dr.	A.	Walker	(Helmholtz	Centre	Munich)	as	published	previously	(Kespohl	et	al.	2017;	Sillner	et	al.	2018).	Mice	were	sacrificed	via	cervical	translocation.	Caecal	luminal	content	was	isolated,	frozen	in	liquid	nitrogen	and	stored	at	-80°C.	To	avoid	bacterial	metabolism,	further	steps	were	performed	on	dry	ice,	including	cutting	for	weighting.	
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For	bile	acid	isolation,	1	ml	cold	methanol	containing	0.2	mg/l	deuterated	bile	acids	(Sigma	Aldrich)	 as	 internal	 standard	was	 added	 to	 2	mg	wet	 caecal	 content.	 For	isolation	 of	 SCFAs,	 1	ml	 cold	 methanol	 containing	 10	 ppm	 butyric	 acid-4,4,4-d3	(Sigma	 Aldrich)	 as	 internal	 standard	 was	 added	 to	 20	mg	wet	 caecal	 content	 to	extract	 SCFA.	 The	 samples	 were	 homogenised	 in	 sterile	 ceramic	 bead	 tubes	(NucleoSpin®	 Bead	 Tubes,	 Macherey-Nagel)	 using	 the	 Precellys®	 Evolution	Homogenisator	 (Bertin	 Corp.;	 4500	rpm,	 40×3	sec,	 2	sec	 pause	 time)	 and	centrifuged	(21,000	x	g,	4°C,	10	min).	The	supernatants	were	stored	at	-80°C.		
2.2.11.2 Quantification	of	bile	acids	via	UHPLC-MS	The	 analysis	 of	 bile	 acids	 was	 performed	 in	 collaboration	 with	 Dr.	 A.	 Walker	(Helmholtz	Centre	Munich)	via	mass	spectrometry-coupled	ultra-high-performance	liquid	chromatography	(UHPLC-MS)	as	published	previously	(Sillner	et	al.	2018).	5	µl	 of	 the	 sample	was	 transferred	 to	 an	 Acquity	 UHPLC	 system	 (Waters)	 and	 a	UHPLC	column	(Acquity™	UPLC	BEH™	C8,	Waters).	The	column	temperature	was	set	to	60°C.	Bile	acids	were	eluted	by	performing	a	solvent	system	of	5	mM	ammonium	acetate	and	0.1	%	acetic	acid	 in	water	(eluent	A)	and	pure	acetonitrile	(eluent	B)	with	a	gradient	profile	as	follows:		
Eluent	 Time	starting	at	10	%	eluent	B	 1	min	increasing	to	22	%	eluent	B	 within	2	min	increasing	to	27	%	eluent	B	 within	4	min	increasing	to	95	%	eluent	B	 within	13	min,	hold	for	2.5	min	returning	to	initial	10	%	eluent	B	 within	2.5	min		The	amaZon	ETD	Ion	Trap	(Bruker	Daltonics	GmbH)	 in	negative	 ionisation	mode	was	used	for	mass	spectrometry.		
2.2.11.3 Quantification	of	short	chain	fatty	acids	via	UHPLC-MS	The	analysis	of	short	chain	fatty	was	performed	in	collaboration	with	Dr.	A.	Walker	(Helmholtz	Centre	Munich)	via	UHPLC-MS	as	published	previously	(Kespohl	et	al.	2017).	
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SCFA	standards	(Sigma	Aldrich)	together	with	butyric	acid-4,4,4-d3	(Sigma	Aldrich)	were	prepared	 in	methanol	 to	a	 final	 concentration	of	100	ppm	and	used	 for	 the	preparation	 of	 a	 calibration	 curve.	 Derivatisation	 of	 samples	 and	 standards	 was	performed	using	the	AMP	+	Mass	Spectrometry	Kit	(Cayman	Chemical)	according	to	manufacturer’s	instructions.	Samples	were	diluted	100-fold	in	water.	5	µl	 of	 the	 sample	was	 transferred	 to	 an	 Acquity	 UHPLC	 system	 (Waters)	 and	 a	UHPLC	column	(Acquity™	UPLC	BEH™	C8,	Waters).	The	column	temperature	was	set	to	 30°C.	 SCFA	 were	 eluted	 by	 performing	 a	 solvent	 system	 of	 5	mM	 ammonium	acetate	and	0.1	%	acetic	acid	 in	water	(eluent	A)	and	pure	acetonitrile	(eluent	B)	with	a	gradient	profile	as	follows:		
Eluent	 Time	starting	at	1	%	eluent	B	 1	min	increasing	to	25	%	eluent	B	 within	10	min	increasing	to	95	%	eluent	B	 within	7	min,	hold	for	2	min	returning	to	initial	1	%	eluent	B	 within	0.2	min,	hold	for	2	min		The	maXis	(Bruker	Daltonics	GmbH)	in	positive	electrospray	ionisation	mode	was	used	for	mass	spectrometry.		
2.2.12 Molecular	biology	methods	
2.2.12.1 Total-RNA	extraction	from	tissue	A	 guanidine	 isothiocyanate-phenol-chloroform-extraction	 is	 used	 to	 isolate	 RNA	from	 homogenises	 tissue.	 Guanidine	 isothiocyanate,	 a	 chaotropic	 salt,	 leads	 to	protein	denaturation	and	inactivation.	Phenol	solves	the	proteins	and	partially	DNA	fragments.	After	phase	separation,	proteins	accumulate	in	the	organic	phase,	DNA	in	the	organic	and	interphase	whereas	RNA	is	left	in	the	aqueous	layer.	By	addition	of	isopropanol	to	the	aqueous	part,	the	RNA	precipitates	and	can	be	used	for	further	applications.	After	sacrificing,	the	large	intestine	of	the	mice	was	removed.	Approximately	1	cm	of	the	colon	was	cleared	of	faeces	and	opened	longitudinally.	The	tissue	was	added	to	1.0	ml	Extrazol	 (Biolab	 Innovative	Research	Technologies)	and	stored	at	 -80°C	or	used	directly	for	homogenisation	with	the	Ultra-Turrax	(IKA)	homogeniser.	The	fat	
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and	 cell	 debris	were	 removed	 by	 centrifugation	 at	 (12,000	x	g,	 4°C,	 10	min).	 The	clear	supernatant	was	transferred	into	a	Biosphere®	plus	tube	and	incubated	for	10	min	at	RT.	After	addition	of	200	µl	chloroform,	the	solution	was	mixed	vigorously	for	 15	 sec	 and	 incubated	 for	 5	min	 at	 RT.	 The	 phases	 were	 separated	 by	centrifugation	(12,000	x	g,	4°C,	15	min).	The	upper	aqueous	phase	containing	RNA	was	transferred	into	a	fresh	Biosphere®	plus	tube.	RNA	was	precipitated	by	addition	of	500	µl	isopropanol	and	slowly	inverting.	After	an	incubation	for	20	min	at	RT	and	centrifugation	(12,000	x	g,	4°C,	10	min),	the	supernatant	was	discarded	and	800	µl	75	%	Ethanol	was	added.	The	RNA	was	stored	overnight	at	 -20°C.	Afterward,	 the	samples	 were	 centrifuged	 (10,000	x	g,	 4°C,	 10	min)	 and	 the	 supernatant	 was	discarded.	The	RNA	pellet	was	air	dried	for	5-10	min.	For	resuspension,	30	µl	PCR-grade	water	was	added	and	samples	were	incubated	for	15	min	at	58°C.	The	solved	RNA	was	stored	at	-80°C.		
2.2.12.2 Complementary	DNA	(cDNA)	synthesis	for	quantitative	PCR	To	perform	RT-qPCR	the	RNA	transcripts	must	be	 translated	 into	complementary	DNA	(cDNA).	As	the	purity	and	integrity	of	the	RNA	is	crucial	for	the	following	RT-qPCR,	the	RNA	was	treated	with	a	DNase	prior	to	cDNA	synthesis	to	remove	possible	DNA	contamination.	Therefore,	 the	 TURBO	 DNA-free™	 Kit	 (invitrogen,	 Thermo	 Fisher	 Scientific)	 was	used	 following	 the	 manufacturer’s	 routine	 DNase	 treatment	 protocol.	 In	 short,	0.1	volume	10X	TURBO	DNase™	Buffer	and	1.0	µl	TURBO	DNase™	were	added	to	the	ample	 and	 gently	mixed.	 After	 incubation	 for	 20	min	 at	 37°C,	 0.1	volume	 DNase	Inactivation	Reagent	was	added	and	mixed.	Following	 incubation	 for	5	min	at	RT,	samples	were	centrifuged	(10,000	x	g,	4°C,	1.5	min).	The	supernatant	containing	the	treated	RNA	was	transferred	into	a	Biosphere®	plus	tube.	The	RNA	concentration	and	quality	were	measured	using	NanoDrop	system	(Thermo	Fisher	Scientific).	The	cDNA	was	synthesised	from	500	ng	RNA	using	the	RevertAid	First	Strand	cDNA	Synthesis	Kit	(Thermo	Fisher	Scientific)	following	the	manufacturer’s	instructions:		 	
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Component	 Volume	template	 500	ng	Oligo	(dt)18	primer	 1.0	µl	5	x	Reaction	Buffer	 4.0	µl	RiboLock	RNase	Inhibitor	(20	U/μl)	 1.0	µl	10	mM	dNTP	mix	 2.0	µl	RevertAid	M-MuLV	RT	(200	U/μL)	 1.0	µl	PCR	grade	water	 ad	20	µl	
		Reaction	mix	without	RevertAid	M-MuLV	RT	was	used	as	a	control	for	genomic	DNA	contamination.	 For	 cDNA	 synthesis,	 the	 reaction	 mix	 was	 incubated	 at	 42°C	 for	60	min.	The	reaction	was	terminated	by	heating	at	70°C	for	5	min.	For	the	following	application	the	cDNA	was	20-fold	diluted	in	PCR-grade	water.		
2.2.12.3 Quantitative	PCR	of	murine	transcripts	As	 mentioned	 above,	 every	 PCR	 amplification	 cycle	 doubles	 the	 number	 of	amplificated	DNA	molecules.	After	each	cycle,	the	DNA	amount	can	be	detected	by	an	 intercalating	 fluorescent	 dye.	 The	 yield	 fluorescent	 signal	 increases	 directly	proportional	 to	 the	number	of	amplicons,	meaning	the	more	target	DNA	is	 in	 the	sample,	 the	 earlier	 a	 fluorescent	 signal	 can	 be	 detected.	 To	 quantify	 the	 relative	expression,	the	gene	of	interest	is	normalised	to	the	housekeeping	gene	(DCt)	and	to	the	control	condition	(DDCt).	The	 SYBR	 green-RT-qPCRs	were	 run	using	 the	qPCR	Core	 kit	 for	 SYBR®	Green	 I	(Eurogentec)	with	the	following	features:		 	
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Component	 Volume	template	 5.0	µl	10	x	reaction	buffer	 5.0	µl	MgCl2,	50	mM	 3.5	µl	dNTP	mix,	5	mM	 2.0	µl	sense	(5’)	primer,	10	pmol/µl	 1.25	µl	antisense	(3’)	primer,	10	pmol/µl	 1.25	µl	SYBR	green	 1.5	µl	HotGoldStar	PCR	enzyme,	5	U/µl	 0.25	µl	PCR	grade	water	 ad	20	µl	
	
Cycling	Conditions	 Temperature	and	time	1. polymerase	activation	 95°C,	10	min	2. denaturation	 95°C,	15	sec	3. annealing,	extension	 60°C,	1	min	
Repeats	of	steps	2-3	 40	cycles		Samples	 were	 run	 in	 duplicates.	 Prior	 to	 measuring,	 the	 plate	 was	 centrifuged	(1,000	rpm,	RT,	1	min).	The	specificity	of	 the	amplicon	was	confirmed	by	melting	curve	analysis.	To	test	for	contamination,	the	amplification	of	controls	for	genomic	DNA	was	evaluated	and	non-template	control	 (PCR-grade	water)	was	 included	 in	every	run.	Via	DDCt	method	the	relative	quantity	of	target	DNA	was	quantified	using	glycerinaldehyd-3-phosphat-dehydrogenase	(GapDH)	as	housekeeping	gene.		
2.2.13 Statistics	The	 data	 were	 analysed	 with	 GraphPad	 Prism	 8	 and	 are	 presented	 as	mean	±	standard	 deviation	 (SD).	 Significance	 was	 calculated	 by	 statistical	 tests	indicated	 in	 the	 figure	 legends.	 P	 values	 less	 than	 0.05	 were	 considered	 as	statistically	significant.		
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3 Results	
3.1 Lack	 of	 dietary	 cellulose	 does	 not	 affect	 physiological	
development	
‘Westernised	nutrition’	is	characterised	by	high	fat	and	low	dietary	fibre	intake.	Both	factors	correlate	with	each	other	and	promote	certain	diseases	(Statovci	et	al.	2017).	Cellulose	is	one	of	the	most	abundant	fibres	in	grains,	vegetables	and	fruit	(Stephen	et	al.	2017).	As	it	is	assumed	that	dietary	cellulose	is	an	inert	polymer,	there	is	limited	knowledge	about	its	impact	on	cellular	and	molecular	mechanisms.	To	 specifically	 investigate	 the	 physiological	 effects	 of	 cellulose,	 mice	 received	purified	diets	which	were	identical	except	the	ingredient	cellulose.	Control	diet	(CD)	contained	7.0	%	cellulose	as	the	only	source	of	dietary	fibre,	whereas	the	fibre	free	diet	 (FFD)	 was	 completely	 devoid	 of	 fibre.	 Mice	 kept	 on	 these	 diets	 showed	 no	differences	in	weight	development	(Figure	4A)	and	food	intake	(Figure	4B)	as	well	as	 litter	size	or	 fitness	(data	not	shown).	Although	the	 intestinal	 transit	 time	was	significantly	reduced	in	the	FFD	group	(Figure	4C),	no	visible	signs	of	diarrhea	or	constipation	 were	 observable	 in	 either	 group.	 Thus,	 both	 diets	 seem	 to	 be	appropriate	to	study	intervention	with	dietary	cellulose.		
	
Figure	4.	Influence	of	dietary	cellulose	on	physiological	parameters.	B6	mice	received	CD	or	FFD	from	birth.	(A)	Weight	gain	of	mice	after	weaning	(n	=	5).	(B)	Repeated	measurements	of	the	food	intake	shown	as	gram	per	mouse	and	day	(n	=	6).	(C)	Intestinal	transit	time	of	 fasted	 mice	 (n	=	4).	 Statistical	 analysis:	 (A)	two-way	 ANOVA	 and	 (B,	 C)	unpaired,	 two-tailed	Student’s	t	test.	Shown	are	individual	values	respectively	means	+	SD.	CD,	control	diet;	FFD,	fibre	free	diet.	
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3.2 Dietary	 cellulose	 is	 a	 potential	 substrate	 for	 microbial	
metabolism	
The	microbiome	encompasses	more	than	three	million	genes,	thereby	exceeding	the	human	genome	by	150-fold	(Qin	et	al.	2010).	 It	seems	evident,	 that	the	intestinal	microbiota	 has	 an	 enormous	 potential	 to	 metabolise	 substances,	 such	 as	carbohydrates	(El	Kaoutari	et	al.	2013).	To	investigate	whether	cellulose	serves	as	potential	 microbial	 substrate,	 we	 established	 an	 assay	 to	 determine	 cellulolytic	enzyme	activity.	As	cellulose	is	due	to	its	physicochemical	properties	not	suitable	for	enzymatic	 assays	 in	 vitro,	we	used	 the	water-soluble	 subunit	 cellotetraose	which	consists	of	 four	glucose	molecules.	This	cello-oligosaccharide	was	 incubated	with	caecal	 supernatants	 containing	 bacterial	 enzymes	 and	 its	 cleavage	 products	(cellotriose	and	cellobiose)	were	quantified	by	capillary	electrophoresis-	(CE-)	and	high-performance	liquid	chromatography-linked	mass	spectrometry	(HPLC-MS).	As	 expected,	 increase	 of	 the	 degradation	 products	 cellotriose	 and	 cellobiose	was	found	 in	 native	 but	 not	 heat-inactivated	 supernatants	 of	 CD	 and	 FFD	 mice,	suggesting	that	both	dietary	groups	harboured	cellulolytic	enzymes	(Figure	5A,	B).	Of	 note,	 cellotriose	 and	 cellobiose	 signals	 prior	 to	 incubation	 (0	hours)	might	 be	caused	by	traces	of	these	metabolites	in	the	cellotetraose	standard.		
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Figure	5.	Cellulose	as	substrate	for	intestinal	microbes.	Caecal	supernatants	were	isolated	from	B6	mice	receiving	CD	or	FFD.	(A)	Native	and	heat-inactivated	pooled	supernatants	from	CD	and	FFD	mice	were	incubated	with	cellotetraose	for	30	and	60	min	and	analysed	 for	 degradation	 products	 via	 HPLC-MS	 in	 triplicates	 (n	=	1).	 (B)	Representative	 CE-MS	electropherograms	 of	 cellotriose	 and	 cellobiose	 signals	 of	 supernatants	 from	CD	mice	 over	 time.	Shown	are	means	+	SD.	CD,	control	diet;	FFD,	fibre	free	diet;	HI,	heat	inactivation.		 	
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3.3 Microbial	 maturation	 in	 early	 adulthood	 depends	 on	 dietary	
cellulose	
Nutrient	 availability	 has	 a	 crucial	 impact	 on	 ecosystems,	 such	 as	 the	 intestinal	microbiota	(Maslowski	and	Mackay	2011).	Since	dietary	cellulose	was	shown	to	be	a	potential	substrate	for	intestinal	bacteria,	we	asked	for	consequential	effects	on	the	 microbial	 community.	 Therefore,	 a	 16S	rRNA	 gene	 amplicon	 analysis	 of	 the	caecal	microbiota	of	CD	and	FFD	mice	during	early	(week	eight	to	twelve)	and	 in	advanced	adulthood	(week	twenty-five)	was	performed.	Beta	diversity	analysis	was	performed	by	generalised	UniFrac	and	is	visualised	by	a	multi-dimensional	scaling	(MDS)	in	which	samples	of	similar	microbial	composition	cluster	together.	In	eight-	and	twelve-week	old	mice,	diet	as	well	as	age	significantly	changed	 the	 caecal	microbiota,	 as	 both	 factors	 led	 to	 a	 distinct	 clustering	 of	 the	samples	 (Figure	6A).	While	diet-dependent	differences	persisted	also	beyond	 the	age	of	twelve	weeks,	the	clustering	was	less	distinct	with	respect	to	age	(Figure	6B)	indicating	that	microbial	diversity	was	rather	completed	at	week	twelve.	The	diversity	of	the	intestinal	microbiota	expands	very	fast	in	the	first	weeks	and	months	of	 life	 and	 continued	 to	 increase	until	 adulthood	 (Pantoja-Feliciano	et	 al.	2013;	Odamaki	et	al.	2016).	In	our	model,	a	physiological	microbial	diversification	occurred	exclusively	in	the	presence	of	dietary	cellulose	(Figure	6C,	D).	Additionally,	the	Firmicutes/Bacteroidetes	ratio	indicating	microbiota	maturation	(Mariat	et	al.	2009)	did	not	increase	in	the	absence	of	cellulose	(Figure	6E).	This	differences	in	microbial	 composition	 between	 CD	 and	 FFD	mice	 were	 visible	 even	 later	 in	 life	(Figure	 6F).	 In	 summary,	 these	 data	 suggest	 that	 dietary	 cellulose	 drives	 the	maturation	of	the	intestinal	microbiota.		
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Figure	6.	The	influence	of	dietary	cellulose	on	the	intestinal	microbial	development.	Caecal	samples	isolated	from	B6	mice	at	the	age	of	eight-	and	twelve-weeks	(young	adulthood)	as	well	as	twenty-five-weeks	(advanced	adulthood)	receiving	CD	or	FFD	from	birth	were	analysed	via	16S	rRNA	gene	amplicon	analysis.	(A,	B)	Multi-dimensional	scaling	(MDS)	plot	based	on	generalised	UniFrac	 (n	=	3-4).	 (C,	D)	Richness	 and	 Shannon	 diversity	 as	 well	 as	 (E)	Firmicutes/Bacteroidetes	ratio	 of	 the	 microbiota	 of	 young	 adult	 mice	 (n	=	3).	 (F)	Richness,	 Shannon	 diversity	 and	Firmicutes/Bacteroidetes	ratio	of	the	microbiota	in	advanced	adulthood	(n	=	4).	Statistical	analysis:	(A,	B)	non-parametric,	multivariate	analysis	of	variance	(Rhea),	(C-E)	one-way	ANOVA	(corrected	for	multiple	 comparison	 by	 Sidak	 method)	 and	 (F)	unpaired,	 two-tailed	 Student’s	 t	 test.	 Shown	 are	individual	values	and	means	representing	one	of	two	similar	experiments.	CD,	control	diet;	FFD,	fibre	free	diet;	ns,	non-significant.			 	
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We	 further	 addressed	 the	 taxonomic	 changes	 in	 CD	 and	 FFD	 mice	 during	 early	adulthood.	 Yet,	 16S	rRNA	 sequencing	 revealed	 that	 the	 abundance	 profiles	 of	bacterial	communities	were	altered	at	the	level	of	phyla	(Figure	7A).	In	eight-week-old	CD	mice,	Bacteroidetes,	Firmicutes	and	Verrucomicrobia	contributed	quite	equal	to	 the	 microbiota,	 whereas	 the	 microbiota	 of	 FFD	 mice	 was	 dominated	 by	Bacteroidetes.	In	aged	CD	mice,	the	abundance	of	Verrucomicrobia	decreased	and	Firmicutes	and	Bacteroidetes	increased.	The	opposite	was	seen	in	the	twelve-week-old	FFD	group,	where	Firmicutes	decreased	and	Verrucomicrobia	increased.	The	analysis	of	 relative	abundances	at	 lower	 taxonomic	 levels	demonstrated	 that	many	bacterial	families	and	genera	were	significantly	affected	by	dietary	cellulose.	We	 found	 a	 higher	 abundance	 of	 the	 families	 Verrucomicrobiacaea,	
Porphyromonadaceae	and	Bacteroidacea	and	a	lower	abundance	of	Lachnospiraceae,	
Ruminococcaceae	and	Desulfovibrionaceae	in	the	FFD	group	at	week	twelve	of	age	in	comparison	 to	mice	 that	 received	 cellulose	 (Figure	 7B).	 Especially	Rikenellaceae	were	 substantially	 reduced	 in	 the	 absence	 of	 cellulose,	 which	 resulted	 from	 the	deterioration	of	the	genus	Alistipes	(Figure	7C).		
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Figure	7.	Cellulose-dependent	alterations	of	the	intestinal	microbial	composition.	Caecal	samples	 isolated	from	eight-	and	twelve-week	old	B6	mice	receiving	CD	or	FFD	from	birth	were	 analysed	 via	 16S	rRNA	 gene	 amplicon	 analysis.	 The	 composition	 of	 the	 entire	 intestinal	microbiota	 is	 plotted	 at	 (A)	phyla,	 (B)	family	 and	 (C)	genera	 level	 (n	=	3).	 Statistical	 analysis:	(B)	Kruskal-Wallis	Rank	Sum	test	for	all	groups	(corrected	for	multiple	comparison	by	Benjamini-Hochberg	method,	Rhea).	Shown	are	individual	values	and	means	representing	one	of	two	similar	experiments.	CD,	control	diet;	FFD,	fibre	free	diet.	
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3.4 Dietary	cellulose	shapes	the	intestinal	metabolome	
The	intestinal	microbiota	not	only	utilises	various	substrates,	but	also	produces	a	broad	range	of	metabolites,	including	SCFAs	and	bile	acids	(Nicholson	et	al.	2012).	Since	 we	 found	 a	 significant	 shift	 of	 the	 intestinal	 microbial	 community	 in	 the	absence	of	dietary	cellulose,	we	wondered	whether	this	 is	reflected	by	an	altered	metabolome.	Although	many	dietary	 fibres	are	known	 to	promote	SCFA	production	Peng	et	al.	(2013),	we	 found	no	differences	between	CD	and	FFD	mice	 (Figure	8A).	 Further,	SCFAs	were	not	detectable	in	germ-free	mice	independent	of	CD	or	FFD.	By	contrast,	bile	acids	were	highly	affected.	The	amounts	of	primary	bile	acids	were	elevated	in	germ-free	mice	kept	on	FFD	as	compared	to	those	kept	on	CD.	However,	they	did	not	differ	in	specific	pathogen	free	(SPF)	animals	(Figure	8B),	indicating	a	bacteria-independent	mechanism.	Comparing	bile	acids	which	derive	from	bacterial	conversion,	the	primary	unconjugated	bile	acid	UDCA	and	the	secondary	bile	acids	DCA	and	3-dehydroCDCA	were	significantly	increased	in	SPF	FFD	mice	(Figure	8C,	D).	 Overall,	 these	 findings	 suggest,	 that	 cellulose	 influences	 the	 metabolism	 of	primary	 and	 secondary	 bile	 acids	 directly	 as	 well	 as	 in	 a	 microbiota-dependent	manner.		
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Figure	8.	The	influence	of	dietary	cellulose	on	the	bacterial	metabolome.	Caecal	samples	were	isolated	from	SPF	and	germ-free	B6	mice	receiving	either	CD	or	FFD	from	birth	(SPF)	or	four	weeks	prior	to	analysis	(germ-free).	(A)	Short	chain	fatty	acids,	(B)	primary	conjugated,	(C)	unconjugated	and	(D)	secondary	bile	acids	were	measured	via	UHPLC-MS	(n	=	4-6).	Statistical	analysis:	 (A-D)	non-parametric,	 unpaired,	 two-tailed	 Student’s	 t	 test	 (corrected	 for	 multiple	comparison	by	Sidak-Holm	method).	Shown	are	individual	values	and	means	representing	one	of	two	similar	experiments.	*p	<	0.05,	**p	<	0.01	and	***p	<	0.001.	CD,	control	diet;	FFD,	fibre	free	diet;	GF,	germ-free;	TCA,	taurocholic	acid;	TCDCA,	taurochenodeoxycholic	acid;	TUDCA,	tauroursodeoxycholic	acid;	 αTMCA,	 α-tauromuricholic	 acid;	 βTMCA,	 β-tauromuricholic	 acid;	 CA,	 cholic	 acid;	 UDCA,	ursodeoxycholic	acid;	αMCA,	α-muricholic	acid;	βMCA,	β-muricholic	acid;	DCA,	deoxycholic	acid;	LCA,	lithocholic	acid;	HDCA,	hyodeoxycholic	acid;	MDCA,	murideoxycholic	acid;	ωMCA,	ω-muricholic	acid;	3-dehydroCA,	3-dehydrocholic	acid;	HCA,	hyocholic	acid.		 	
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3.5 Cellulose	deprivation	alters	the	intestinal	immune	status	
The	 interaction	 between	 the	 microbiota	 and	 the	 host	 organism	 is	 constantly	monitored	by	the	immune	system,	i.e.	alterations	of	the	microbiota	can	influence	the	host’s	 immune	 system	 and	 vice	 versa	 (Wang	 et	 al.	 2019a).	 Since	 the	 data	 shown	above	 revealed	 multiple	 cellulose-dependent	 alterations	 of	 the	 intestinal	microbiota,	we	 speculated	 that	 this	 has	 also	 an	 impact	 on	 the	 intestinal	 immune	system.	To	investigate	this,	lymphocytes	isolated	from	the	intestinal	lamina	propria	(ileum	and	colon)	as	well	as	peripheral	lymphoid	organs	(mesenteric	lymph	nodes	and	spleen)	were	analysed	for	their	cytokine	production	and	transcription	factors	via	flow	cytometry.	The	 absolute	 number	 of	 lymphocytes	 isolated	 from	 the	 ileum	 and	 colon	 was	comparable	between	CD	and	FFD	mice	(Figure	9A).	However,	the	frequency	of	ileal	CD4+	T	cells	was	significantly	increased	in	the	absence	of	cellulose	(Figure	9B).	As	CD4+	 T	cells	 are	 guardians	 of	 intestinal	 homeostasis,	 their	 phenotype	 was	investigated.	While	 no	 alteration	 of	 IFN-g-	 and	 IL-4-producing	 CD4+	 T	cells	were	observed,	frequencies	of	IL-17-producing	CD4+	T	cells	were	significantly	enhanced	in	the	ileum	of	FFD	mice	(Figure	9C,	D).	The	same	tendency	was	seen	in	the	colon,	but	no	alterations	were	found	in	secondary	lymphoid	organs.	IL-17-producing	CD4+	T	cells	express	the	transcription	factors	RORγt	and	a	smaller	fraction	also	expresses	the	transcription	factor	FOXP3.	Hence,	we	asked,	which	of	these	CD4+	T	cell	subsets	account	 for	 the	 observed	 enrichment	 of	 IL-17-producing	 cells.	 Indeed,	 the	frequencies	of	both	RORγt+	FOXP3-	 (TH17	cells)	and	RORγt+	FOXP3+	CD4+	T	cells	(TH17reg	cells)	were	significantly	increased	during	fibre	deprivation	(Figure	9E,	F).	Interestingly,	 the	frequency	of	RORγt-	FOXP3+	CD4+	T	cell,	which	are	conventional	regulatory	T	cells	(Treg	cells),	and	the	amount	of	sIgA	were	not	affected	by	cellulose	(Figure	9E-G).		
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Figure	9.	The	intestinal	immune	system	in	fibre	deprivation.	Lymphocytes	from	indicated	organs	as	well	as	faecal	samples	were	isolated	from	B6	mice	receiving	CD	or	FFD	from	birth.	(A)	The	absolute	cell	number	of	lymphocytes.	(B)	The	frequency	of	CD4+	T	cells	in	 lymphoid	 organs	 and	 the	 intestine.	 (C)	IFN-g-,	 IL-4-	 and	 IL-17-production	 of	 CD4+	T	cells	 was	measured	after	restimulation	with	PMA	and	ionomycin	via	FACS	(n	=	4).	(D)	A	representative	FACS	plot	shows	the	IFN-g-	and	IL-17-expression	of	ileal	CD4+	T	cells.	(E)	CD4+	T	cells	were	analysed	for	the	transcription	factors	RORgt	and	FOXP3	via	FACS	(n	=	4).	(F)	The	FACS	plot	shows	a	representative	staining	for	RORgt	and	FOXP3	of	 ileal	CD4+	T	cells.	(G)	Faecal	sIgA	levels	were	measured	by	ELISA	(n	=	5).	 Statistical	 analysis:	 non-parametric,	 unpaired,	 two-tailed	 Student’s	 t	 test.	 Shown	 are	individual	values	respectively	means	+	SD	representing	one	of	two	similar	experiments.	CD,	control	diet;	FFD,	fibre	free	diet;	mLN,	mesenteric	lymph	node;	sIgA,	secretory	IgA.		 	
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3.6 Epithelial	gene	expression	is	affected	by	dietary	cellulose	
The	 intestinal	 epithelium	 is	more	 than	 a	passive	barrier	 composed	of	 absorptive	enterocytes.	It	harbours	rather	various	specialised	cell	types,	which	produce	factors	that	 promote	 the	 segregation	 between	 host	 and	microbes,	 including	mucins	 and	antimicrobial	peptides	(Allaire	et	al.	2018).	To	investigate	the	influence	of	cellulose	on	the	colonic	expression	of	epithelial	genes	involved	in	the	intestinal	homeostasis,	we	performed	RT-qPCR	of	colonic	tissue	samples	from	FFD	and	CD	mice.	We	found	that	cellulose	has	no	influence	on	the	expression	of	trefoil	factor	3	(TFF3),	mucins,	 tight	 junction	 proteins	 and	 the	 proliferation	 marker	 Ki76.	 However,	 the	expression	of	the	antimicrobial	C-type	lectin	Reg3g	was	massively	decreased	in	the	absence	of	fibre	(Figure	10)	demonstrating	that	cellulose	deprivation	has	a	selective	but	clear	influence	on	gene	expression	of	IECs.		
	
Figure	 10.	 Influence	 of	 cellulose	 on	 epithelial	 gene	 expression	 related	 to	 intestinal	
homeostasis.	B6	mice	received	CD	or	FFD	from	birth.	The	expression	of	genes	involved	in	intestinal	homeostasis	in	the	total	colonic	tissue	of	FFD	mice	was	measured	by	RT-qPCR	and	normalised	to	CD	mice	(n	=	3-4).	Shown	are	individual	values	respectively	means	+	SD	representing	one	of	two	similar	experiments.	CD,	 control	 diet;	 FFD,	 fibre	 free	 diet;	 Reg3g,	 regenerating	 islet-derived	 protein	3g;	 TFF3,	 trefoil	factor	3;	 Muc,	 mucin;	 Cldn8,	 claudin	 8;	 Ocln,	 occludin;	 Tjp1,	 tight	 junction	 protein	 1;	 Ki67,	proliferation	marker	protein	Ki-67.		 	
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3.7 Dietary	cellulose	ameliorates	DSS-induced	colitis	
The	 interaction	of	 the	gut	microbiota	with	 intestinal	 epithelium	and	 the	mucosal	immune	 system	 is	 required	 for	 the	 maintenance	 of	 the	 gut	 barrier	 integrity	 by	defending	against	pathogens	while	tolerating	commensal	microbes.	Disturbance	of	this	 homeostasis	 often	 leads	 to	 infection	 or	 inflammation	 (Belkaid	 and	Harrison	2017).	As	we	found	an	altered	immune	status	and	signs	of	dysbiosis	in	FFD	mice,	we	wondered	whether	 cellulose	 deprivation	 disrupts	 the	 intestinal	 homeostasis	 and	examined	functional	consequences	in	the	DSS-induced	model	of	acute	colitis,	which	is	 based	 on	 a	 chemical	 disruption	 of	 the	 intestinal	 epithelium.	 Subsequently,	microbes	and	 luminal	antigens	enter	 the	host	 tissue	and	 induce	an	 inflammatory	immune	response	in	the	lamina	propria	(Wirtz	et	al.	2007;	Eichele	and	Kharbanda	2017).	CD	 and	 FFD	 mice	 were	 treated	 with	 1.5	%	 or	 2.5	%	 DSS	 for	 five	 days.	 A	 low	concentration	 of	 DSS	 (1.5	%)	 was	 sufficient	 to	 induce	 significant	 weight	 loss,	decrease	 of	 colon	 length,	 diarrhea	 as	 well	 as	 increased	 amounts	 of	 TNFα	 and	lipocalin-2	 in	ex	 vivo	 colon	 cultures	of	 FFD	mice	 (Figure	11A-D).	Treatment	with	2.5	%	DSS	led	to	even	more	severe	colitis	in	FFD	mice.	PAS	staining	of	colonic	tissue	from	these	mice	revealed	the	loss	of	the	crypt	structure,	epithelial	damage,	excessive	production	 of	 mucus	 and	 infiltration	 of	 immune	 cells	 (Figure	 11E).	 At	 the	macroscopic	 level,	 the	 intestines	of	DSS-treated	FFD	mice	were	reduced	in	 length	and	thinner	in	comparison	to	CD	mice	(Figure	11F).	In	summary,	these	data	suggest	that	dietary	cellulose	protects	mice	from	DSS-induced	acute	colitis.		
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Figure	11.	Dietary	cellulose	ameliorates	DSS-induced	colitis.	B6	mice	 received	CD	or	 FFD	 from	birth	 and	were	 treated	with	 1.5	%	or	 2.5	%	DSS	 for	 five	 days.	(A)	Weight	 loss,	 (B)	colon	 length	and	 (C)	diarrhea	 score	were	measured	 to	quantify	 inflammation	(n	=	3-4).	 (D)	The	expression	of	TNFα	and	 lipocalin-2	 in	ex	vivo	 colon	cultures	were	measured	by	ELISA	 (n	=	3-6).	 The	 colitis	 induced	by	 2.5	%	DSS	was	 further	 confirmed	by	 (E)	histological	 (PAS	staining)	analysis	of	 the	 colon	and	 (F)	macroscopic	 assessment	of	 the	 colon	and	 spleen	 (n	=	3-4).	Statistical	analysis:	(A)	one-way	ANOVA	of	weight	loss	at	day	five	in	comparison	to	untreated	group	and	(B)	one-way	ANOVA	in	comparison	to	untreated	group	(corrected	for	multiple	comparison	by	Sidak	 method),	 (C)	non-parametric,	 unpaired,	 two-tailed	 Student’s	 t	test	 (corrected	 for	 multiple	comparison	 by	 Sidak-Holm	 method)	 and	 (D)	Mann-Whitney	 test.	 Shown	 are	 individual	 values	respectively	 means	+	SD	 representing	 one	 of	 two	 similar	 experiments.	 *p	<	0.05,	 **p	<	0.01	 and	***p	<	0.001.	CD,	control	diet;	FFD,	fibre	free	diet;	DSS,	dextran	sulphate	sodium.	
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3.8 Alistipes	finegoldii	17242	has	a	unique	cellulose	metabolism	
As	shown	above,	fibre	deprivation	affected	the	gut	microbiota	and	immune	system	leading	 to	 enhanced	 colitis	 susceptibility.	 With	 respect	 to	 the	 microbiota,	 the	massive	 reduction	 of	 the	 genus	 Alistipes	 was	 prominent	 in	 FFD	 mice.	 Thus,	 we	wondered	whether	a	representative	member	of	this	genus,	Alistipes	finegoldii	17242	(A.	finegoldii),	is	able	to	trigger	beneficial	effects	if	transferred	to	a	recipient	animal.	To	 trace	 a	 single	 bacterium	 in	 immune-competent	 mice,	 the	 gnotobiotic	 OMM12	mouse	 model,	 which	 harbours	 a	 microbiota	 consisting	 of	 twelve	 predominant	members	of	the	murine	intestinal	microbiota,	was	used	(Brugiroux	et	al.	2016).	A	single	 association	 of	 A.	finegoldii	 was	 sufficient	 to	 stably	 colonise	 these	 animals	without	disrupting	the	former	microbial	composition,	as	revealed	by	FISH-	(Figure	12A)	and	RT-qPCR	analysis	(Figure	12B).	Furthermore,	A.	finegoldii	was	exclusively	detectable	in	the	caecum	and	colon,	but	not	in	the	ileum	of	the	mice	which	might	be	due	to	its	anaerobic	nature.		
	
Figure	12.	A.	finegoldii	17242	stably	colonises	the	OMM12	microbiota.	OMM12	 B6	 mice	 were	 associated	 with	 A.	finegoldii	 17242	 three	 weeks	 prior	 to	 analysis.	 (A)	The	presence	of	A.	finegoldii	17242	(white	arrows)	in	the	caecum	was	analysed	by	FISH.	Blue,	DAPI;	green,	all	bacteria;	red,	A.	finegoldii	17242	(n	=	3-4).	(B)	The	relative	abundance	of	the	OMM12	bacteria	and	
A.	finegoldii	17242	in	the	caecum	was	measured	by	RT-qPCR	(n	=	6).	OMM12,	Oligo-Mouse-Microbiota	12;	AF,	Alistipes	finegoldii	17242.	
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A	comparative	genome	analysis	with	EDGAR	(Blom	et	al.	2009)	was	performed	to	investigate	 the	 molecular	 characteristics	 of	 A.	finegoldii	 within	 this	 model	microbiota.	 The	 analysis	 showed	 that	 B.	caecimuris	 I48	 and	M.	intestinale	 YL27,	which	also	belong	to	the	phyla	Bacteroidetes,	are	the	evolutionarily	closest	relatives	of	 A.	finegoldii	 within	 the	 consortium	 (Figure	 13A).	 Furthermore,	 of	 the	30,800	genes	forming	the	metagenome	of	OMM12	and	A.	finegoldii,	1,653	genes	were	exclusively	found	in	A.	finegoldii	and	further	named	as	singletons.	By	using	the	EggNOG	4.5.1.	software	(Huerta-Cepas	et	al.	2016)	862	singletons	were	classified	into	clusters	of	orthologous	genes	(COGs).	376	of	them	were	of	unknown	function	(cluster	S).	The	classification	of	the	remaining	486	genes	is	shown	in	Figure	13B.	We	found	that	A.	finegoldii	harbours	unique	metabolic	properties	according	to	the	metabolism	of	the	cell	wall	and	membrane	(M),	genetic	information	processing	(K,	L)	and	carbohydrate	metabolism	(G).	A	 KofamKoala	 analysis	 (Aramaki	 et	 al.	 2019)	 was	 performed	 to	 investigate	 the	potential	to	degrade	complex	carbohydrates.	Hereby,	singletons	were	assigned	to	K	numbers	(KEGG	orthology	identifiers)	which	link	sequences	to	KEGG	pathways	and	enzymes.	Interestingly,	two	genes	(ALFI_RS05325,	ALFI_RS07785)	were	assigned	as	K01179,	an	endoglucanase	(3.2.1.4),	and	two	genes	(ALFI_RS05270,	ALFI_RS07880)	were	assigned	to	K05349,	a	beta-glucosidase	(3.2.1.21).	Both	identifiers	are	linked	to	cellulose	degradation,	suggesting	an	exclusive	pathway	of	A.	finegoldii	within	the	OMM12	consortium	to	deal	with	cellulose	(Figure	13C).		
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Figure	13.	A.	finegoldii	17242	has	a	unique	cellulose	metabolism.	The	 comparative	 genome	 analysis	 of	 A.	finegoldii	 and	 the	 OMM12	 bacteria	 was	 performed	 using	EDGAR.	(A)	The	phylogenetic	tree	shows	the	relation	of	A.	finegoldii	within	the	OMM12	consortium.	(B)	CAS	classification	of	singletons	exclusively	found	in	A.	finegoldii.	(C)	Selected	singletons	assigned	to	KEGG	orthology	identifiers	of	the	cellulose-degrading	pathway	are	highlighted	in	green.		In	order	to	test	the	cellulose-degrading	potential	in	vitro,	the	cellotetraose	assay	was	performed	using	caecal	supernatants	of	A.	finegoldii-associated	and	control	OMM12	mice.	 The	 data	 showed	 a	 significant	 decrease	 of	 cellotetraose	 and	 an	 increase	 of	cellotriose	in	both	groups	(Figure	14).	This	suggests	that	both	microbiota	harbour	enzymes	to	degrade	cellulose,	however,	A.	finegoldii	might	be	endowed	with	a	unique	pathway	in	comparison	to	the	OMM12	consortium.		
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Figure	14.	The	OMM12	consortium	harbours	enzymes	to	degrade	cellulose.	OMM12	 B6	 mice	 were	 associated	 with	 A.	finegoldii	 17242	 three	 weeks	 prior	 to	 analysis.	 Pooled	supernatants	were	incubated	with	cellotetraose	for	0.5,	1,	4	and	24	hours	and	measured	in	triplicates	via	HPLC-MS	(n	=	3-4).	Statistical	analysis:	one-way	ANOVA.	Shown	are	means	+	SD.	OMM12,	Oligo-Mouse-Microbiota	12;	AF,	Alistipes	finegoldii	17242.	
3.9 Alistipes	finegoldii	17242	induces	an	immune	response	
Individual	 bacteria	 are	 able	 to	 influence	 physiological	 processes	 of	 the	 host,	including	immune	functions	(Ivanov	et	al.	2009;	Nakamoto	et	al.	2017).	Thus,	the	possibility	that	cellulose-dependent	A.	finegoldii	exerts	immunomodulatory	actions	and	mimics	the	effects	of	dietary	cellulose	was	examined.	Lymphocytes	 isolated	 from	 the	 intestinal	 lamina	 propria	 (ileum	 and	 colon)	 and	peripheral	 lymphoid	organs	(mesenteric	lymph	nodes	and	spleen)	of	A.	finegoldii-associated	and	control	OMM12	mice	were	analysed	for	cytokines	and	transcription	factors	via	FACS.	No	differences	were	found	in	the	overall	number	of	lymphocytes	in	the	 intestinal	 lamina	 propria	 and	 the	 frequencies	 of	 CD4+	 T	cells	 in	 the	 analysed	organs	(Figure	15A,	B).	However,	A.	finegoldii	induced	IL-17+-producing	CD4+	T	cells	in	lymphatic	organs,	the	ileum	and	to	some	degree	also	in	the	colon	(Figure	15C,	D).	This	 was	 confirmed	 by	 elevated	 frequencies	 of	 TH17	 cells	 (RORg+	 FOXP3-	 CD4+	T	cells)	 in	 these	 organs,	 except	 for	 the	 ileum	 (Figure	 15E,	F).	 The	 frequencies	 of	IL-17+	IFN-g+	and	IL-17-	IFN-g+-producing	CD4+	T	cells,	TH17reg	cells	(RORg+	FOXP3+	CD4+	T	cells)	and	Treg	cells	(RORg-	FOXP3+	CD4+	T	cells)	were	not	affected	(Figure	15C-F).	In	summary,	A.	finegoldii	affected	the	immune	system	in	several	ways,	which	only	partially	overlapped	with	the	effects	caused	by	cellulose.	
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Figure	15.	A.	finegoldii	17242	impacts	the	intestinal	immune	system.	Lymphocytes	 from	 indicated	 organs	 were	 isolated	 from	 OMM12	 B6	 mice	 and	 OMM12	 B6	 mice	associated	with	A.	finegoldii	17242	three	weeks	prior	 to	analysis.	 (A)	The	absolute	cell	number	of	lymphocytes.	 (B)	The	 frequency	 of	 CD4+	T	cells	 in	 lymphoid	 organs	 and	 the	 intestine	 (n	=	4-6).	(B)	The	 frequency	 of	 CD4+	T	cells	 (n	=	4-6).	 (C)	IL-17-	 and	 IFN-γ	 production	 of	 CD4+	T	cells	 was	measured	after	restimulation	with	PMA	and	ionomycin	via	FACS	(n	=	4-6).	(D)	A	representative	FACS	plot	shows	the	IFN-g-	and	IL-17-expression	of	colonic	CD4+	T	cells.	(E)	CD4+	T	cells	were	analysed	for	the	 transcription	 factors	 RORgt	 and	 FOXP3	 (n	=	4-6).	 (F)	The	 FACS	 plot	 shows	 a	 representative	staining	for	RORgt	and	FOXP3	of	colonic	CD4+	T	cells.	Statistical	analysis:	non-parametric,	unpaired,	two-tailed	Student’s	t	test.	Shown	are	individual	values	respectively	means	+	SD	representing	one	of	two	 similar	 experiments.	 OMM12,	 Oligo-Mouse-Microbiota	12;	 AF,	Alistipes	 finegoldii	 17242;	mLN,	mesenteric	lymph	node;	RORgt,	retinoic	acid	receptor-related	orphan	receptor	gt;	FOXP3,	forkhead-box-protein	3.		As	A.	finegoldii	induced	a	systemic	and	local	TH17	immune	response,	the	secretion	of	cytokines	as	markers	for	inflammation	was	examined	in	ex	vivo	colon	cultures	of	
A.	finegoldii-associated	 and	 control	 OMM12	 mice	 via	 multiplex	 immunoassay	 and	ELISA.	TH17	cytokine	concentrations	were	not	significantly	altered,	except	for	IL-22,	which	 was	 strongly	 increased	 in	 the	 presence	 of	 A.	finegoldii	 (Figure	 16A).	 In	addition,	 lipocalin-2	showed	no	differences	between	both	groups	which	 indicated	that	A.	finegoldii	did	not	cause	inflammatory	immune	responses	in	the	colon	(Figure	16B).		
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Figure	16.	A.	finegoldii	17242	impacts	the	intestinal	cytokine	profile.	OMM12	B6	mice	were	associated	with	A.	finegoldii	 three	weeks	prior	 to	analysis.	The	 secretion	of	cytokines	 and	 lipocalin-2	 in	 ex	 vivo	 colon	 cultures	 were	 measured	 by	 ELISA	 and	 LegendplexTM	(n	=	3-6).	 Statistical	 analysis:	 Mann-Whitney	 test.	 Shown	 are	 individual	 values	 respectively	means	+	SD	representing	one	of	 two	similar	experiments.	OMM12,	Oligo-Mouse-Microbiota	12;	AF,	
Alistipes	finegoldii	17242.	
3.10 Alistipes	finegoldii	17242	promotes	Reg3g	expression	
Since	the	intestinal	epithelium	represents	an	interphase	between	the	host	and	the	microbiota	which	is	able	to	sense	soluble	as	well	structural	components	of	bacteria,	we	wondered	whether	A.	finegoldii	influences	the	expression	of	epithelial	genes.	We	compared	the	expression	of	selected	genes	involved	in	homeostasis	in	OMM12	mice	in	the	presence	or	absence	of	A.	finegoldii	by	RT-qPCR.	We	 found	 no	 substantial	 influence	 on	 TFF3,	 mucins,	 tight	 junction	 proteins	 and	proliferation	markers.	However,	the	colonic	expression	of	the	antimicrobial	protein	Reg3g	was	particularly	elevated	in	the	presence	of	A.	finegoldii	17242	(Figure	17).		
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Figure	17.	Influence	of	A.	finegoldii	17242	on	colonic	gene	expression.	OMM12	B6	mice	were	associated	with	A.	finegoldii	three	weeks	prior	to	analysis.	The	expression	of	genes	 involved	 in	 the	 intestinal	 homeostasis	 in	 the	 total	 colonic	 tissue	 of	A.	finegoldii-associated	OMM12	 mice	 was	 measured	 by	 RT-qPCR	 and	 normalised	 to	 OMM12	 mice	 (n	=	4-5).	 Shown	 are	individual	 values	 respectively	 means	+	SD	 representing	 one	 of	 two	 similar	 experiments.	 OMM12,	Oligo-Mouse-Microbiota	 12;	 Reg3g,	 regenerating	 islet-derived	 protein	 3g;	 TFF3,	 trefoil	 factor	 3;	Muc2/3,	mucin	2/3;	Cldn8,	claudin	8;	Ocln,	occludin;	Tjp1,	tight	junction	protein	1;	Ki67,	proliferation	marker	protein	Ki-67.	
3.11 Alistipes	finegoldii	17242	ameliorates	DSS-induced	colitis	
From	 the	 results	 presented	 above,	 we	 assumed	 that	 A.	finegoldii	 17242	 might	improve	the	intestinal	homeostasis.	To	test	potential	anti-colitogenic	effects	of	this	bacterium,	we	 exposed	A.	finegoldii-associated	 and	 control	 OMM12	mice	 to	 3.5	%	DSS.	Mice	associated	with	A.	finegoldii	showed	significantly	lower	weight	loss,	decrease	of	 the	 colon	 length,	 lipocalin-2	 and	TNFa	 levels	 in	ex	 vivo	 colon	 cultures	 (Figure	18A-C).	Further,	PAS	staining	of	colonic	tissue	evidenced	just	mild	signs	of	colitis	in	this	group,	including	a	slightly	lower	mucus	production,	less	epithelial	damage	and	tissue	thickening	(Figure	18D).	These	findings	revealed	that	A.	finegoldii	ameliorates	DSS-induced	acute	colitis	in	gnotobiotic	OMM12	mice.		
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Figure	18.	A.	finegoldii	17242	ameliorates	DSS-induced	colitis.	OMM12	B6	mice	were	associated	with	A.	finegoldii	17242	and	after	three	weeks	treated	with	3.5	%	DSS	for	five	days.	Analysis	were	performed	at	day	six	after	initiation	of	DSS-treatment.	(A)	Weight	loss	and	(B)	colon	length	were	measured	to	quantify	inflammation.	(C)	The	secretion	of	lipocalin-2	and	 TNFα	 in	 ex	 vivo	 colon	 cultures	 were	 measured	 by	 ELISA	 (n	=	3-4).	 The	 colitis	 was	 further	confirmed	 by	 (E)	histological	 (PAS	 staining)	 analysis	 of	 the	 colon	 (n	=	3-4).	 Statistical	 analysis:	(A)	two-way	ANOVA	(corrected	for	multiple	comparison	by	Bonferroni	method)	(B)	unpaired,	two-tailed	 Student’s	 t	 test	 and	 (C)	Mann-Whitney	 test.	 Shown	 are	 individual	 values	 respectively	means	+	SD	 representing	 one	 of	 two	 similar	 experiments.	 *p	<	0.05,	 **p	<	0.01	 and	 ***p	<	0.001.	OMM12,	Oligo-Mouse-Microbiota	12;	AF,	Alistipes	finegoldii	17242;	DSS,	dextran	sulphate	sodium.		
	D i s c u s s i o n 	 	 	 76	|	P a g e 	
4 Discussion	
4.1 Dietary	cellulose	promotes	intestinal	homeostasis	
4.1.1 Investigating	nutritional	interventions	Conventional	 chow	 is	 a	 mixture	 of	 different	 native	 plant-	 and	 animal-derived	ingredients,	mainly	grains.	The	precise	composition	of	such	crude	diets	is	not	known	and	varies	according	to	the	company	and	the	batch	due	to	the	variability	of	natural	ingredients.	However,	a	precise	knowledge	of	the	components	is	required	to	perform	or	evaluate	nutritional	studies.	Consequently,	conventional	chow	is	not	suitable	to	investigate	the	impact	of	defined	dietary	factors	on	health	and	disease	(Pellizzon	and	Ricci	2019).	With	 respect	 to	 fibre,	 chow	harbours	 different	 soluble	 and	 insoluble	 fibres	 in	 an	unknown	 composition	 and	 concentration.	 Our	 aim	 was	 to	 specifically	 focus	 on	dietary	cellulose	as	the	only	source	of	fibres.	We	therefore	chose	purified	diets	which	were	 identical	 except	 that	 one	 contained	 cellulose	 with	 similar	 amounts	 as	conventional	chow	(7	%;	control	diet,	CD)	and	the	other	diet	was	devoid	of	any	fibre	(fibre	 free	diet,	FFD).	Mice	received	these	diets	 from	birth	and	both,	CD	and	FFD,	were	well	 tolerated	since	 there	was	no	 influence	on	growth	development	or	 food	intake.	Dietary	fibres	are	known	regulators	of	the	intestinal	transit,	thus	preventing	both	diarrhea	and	constipation.	Due	to	the	lack	of	bulking	material	in	the	diet,	the	transit	time	in	FFD	mice	was	decreased,	but	no	sign	of	diarrhea	was	observed.	In	conclusion,	both	purified	diets	seemed	to	be	appropriate	to	investigate	the	effects	of	dietary	cellulose	on	intestinal	homeostasis.		
4.1.2 Maturation	 of	 the	 intestinal	 microbiota	 is	 dependent	 on	 dietary	
cellulose	The	growing	knowledge	of	host-microbe	interactions	in	human	health	and	disease	of	man	propelled	trials	to	alter	or	even	exchange	the	microbiota	in	order	to	improve	health	conditions.	Alimentary	carbohydrates	and	particularly	prebiotics,	known	to	have	 a	 strong	 influence	 on	 the	 intestinal	 microbiota,	 can	 be	 used	 as	 dietary	intervention	 (David	 et	 al.	 2014;	 Sonnenburg	 et	 al.	 2016;	 Gibson	 et	 al.	 2017).	However,	would	you	think	of	cellulose	when	talking	about	prebiotics?	Probably,	most	
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people	have	in	mind	that	cellulose	is	a	rather	low-quality	plant	material,	which	is	hardly	 suitable	 for	human	nutrition.	Probably,	people	 think	of	 ruminants	or	even	termites	 that	 are	 able	 to	 metabolise	 cellulose	 due	 to	 their	 specific	 microbiota	(Hungate	 1966;	 Brune	 2014).	 Cellulose	 is	 not	 considered	 as	 a	 classic	 prebiotic	because	 of	 controversial	 opinions	 about	 its	 fermentability	 (Slavin	 et	 al.	 1981;	Boulahrouf	 1990;	 Robert	 and	 Bernalier-Donadille	 2003;	 Chassard	 et	 al.	 2010;	Chassard	 et	 al.	 2012).	 Although	 studies	 revealed	 14C	 excretion	 in	 breath	 after	administration	 of	 14C-labeled	 cellulose,	 the	 extent	 and	 physiological	 role	 of	degradation	remains	unclear	(Cummings	1984).	Yet,	the	data	of	the	present	study	demonstrate	that	cellulose	is	more	than	an	inert	bulking	material	and	might	serve	as	considerable	microbial	substrate.	Moreover,	even	the	murine	microbiota	that	has	never	 seen	 cellulose	 was	 equipped	 with	 cellulases.	 This	 points	 to	 a	 conserved	function	of	these	enzymes	in	the	gut	environment	(Stephen	et	al.	2017;	Hon	1994).	Cellulose	might	be	capable	of	 fuelling	the	gut	microbiota	by	the	 final	degradation	product	glucose.		However,	previous	studies	which	claimed	that	dietary	cellulose	has	effects	on	the	intestinal	microbiota	were	partially	contradictory	as	they	reported	an	increase	or	decrease	of	microbial	diversity	(Nagy-Szakal	et	al.	2013;	Berer	et	al.	2018;	Morowitz	et	 al.	 2017;	 Riva	 et	 al.	 2019).	 For	 example,	 a	 study	 using	 a	 crude	 fibre	 rich	 diet	showed	decreased	diversity	in	comparison	to	a	crude	control	diet	(Berer	et	al.	2018),	whereas	a	synthetic	high	versus	a	low	fibre	diet	was	reported	to	enrich	the	diversity	(Nagy-Szakal	et	al.	2013).	These	opposing	findings	might	be	explained	by	differences	in	 the	 study	 designs,	 especially	 with	 respect	 to	 the	 period	 of	 intervention,	composition	of	the	experimental	diet,	including	origin	of	fibre,	but	also	by	the	high	variation	of	the	indigenous	intestinal	microbiota	of	mice	in	different	animal	facilities	(Rausch	et	 al.	 2016;	Ericsson	et	 al.	 2018;	 as	discussed	 in	detail	 below).	All	 these	factors	hinder	the	reproducibility	of	nutritional	and	microbiome	studies.	Recent	work	of	Riva	et	al.	revealed	that	even	short-term	(one	week)	deprivation	of	cellulose	narrows	the	diversity	of	the	intestinal	microbiota	in	comparison	to	a	diet	containing	cellulose	as	 the	only	 source	of	 fibre	 (Riva	et	al.	2019).	The	aim	of	 the	present	 study	was	 to	 disclose	 long-term	 effects	 of	 dietary	 cellulose	 during	 early	(eight	to	twelve	weeks)	and	advanced	adulthood	(twelve	to	twenty-five	weeks).	The	increase	 of	 diversity	 and	 the	 ratio	 of	 the	 phyla	 Firmicutes	 to	 Bacteroidetes	 are	
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known	indicators	for	the	maturation	of	the	intestinal	microbiota	(Mariat	et	al.	2009;	Flemer	 et	 al.	 2017).	 In	 the	 absence	 of	 dietary	 cellulose,	 both	 were	 significantly	decreased	in	the	early	(12	weeks)	and	a	little	less	pronounced	even	in	the	advanced	adulthood	 (25	weeks),	 indicating	 that	microbial	maturation,	 particularly	 in	 early	adulthood,	depends	on	dietary	cellulose	if	other	fibres	are	lacking.	Looking	closer	to	the	composition	of	the	gut	microbiota	during	early	adulthood,	we	observed	that	alterations	caused	by	cellulose	deprivation	were	even	evident	at	the	level	of	phyla.	Beside	the	increase	of	Bacteroidetes	and	the	decrease	of	Firmicutes,	we	found	a	high	abundance	of	Verrucomicrobia	in	12-week-old	FFD	mice.	This	might	be	due	to	the	ability	of	Akkermansia	muciniphila	-	the	only	cultivated	representative	of	 this	 phylum	 in	 the	 gut	-	 to	 feed	 on	 host-derived	 polysaccharides,	 especially	 if	dietary	fibre	are	lacking	(Desai	et	al.	2016;	Zhang	et	al.	2019).	At	lower	taxonomic	levels,	we	 found	a	 substantial	decrease	of	Ruminococcaceae	 and	Lachnospiraceae,	which	belong	to	Firmicutes	and	are	known	to	be	involved	in	fibre	degradation	and	SCFA	production,	in	FFD	mice	(Walker	et	al.	2011;	Kasahara	et	al.	2018;	La	Rosa	et	al.	 2019).	 In	 particular,	 Ruminococcaceae	 has	 been	 shown	 to	 exert	 cellulolytic	activity	in	the	human	intestine	and	colonise	the	gut	lumen	while	being	attached	to	solid	material	(Robert	and	Bernalier-Donadille	2003;	Walker	et	al.	2008;	Chassard	et	al.	2012).	This	might	explain	their	high	abundance	in	the	presence	of	cellulose.	Moreover,	 the	 genus	 Alistipes,	 which	 belongs	 to	 the	 family	 of	 Rikenellaceae	 and	usually	expands	during	lifespan	in	the	human	and	murine	microbiota,	was	largely	absent	 in	FFD	mice	 (Langille	et	al.	2014;	Claesson	et	al.	2011).	Collectively,	 these	findings	 emphasise	 a	 crucial	 role	 of	 dietary	 cellulose	 for	 the	 physiological	maturation	of	the	intestinal	microbiota	during	early	adulthood.	Since	 alterations	 of	 the	 composition	 of	 the	 microbiota	 are	 often	 reflected	 by	 its	metabolome,	we	focussed	further	on	major	microbial	products	in	the	caecum	of	mice	feeding	either	CD	or	FFD.	In	accordance	with	prior	studies,	we	found	that	cellulose	does	not	or	only	marginally	contribute	to	SCFAs	production	(Le	Leu	et	al.	2002;	Peng	et	al.	2013;	Lewis	et	al.	2019).	By	contrast,	our	data	revealed	a	strong	impact	of	diet	and	microbiota	on	 the	 intestinal	pool	of	bile	 acids.	 In	 several	 studies	 it	 has	been	shown	 that	 caecal	 amounts	 of	 conjugated	 primary	 bile	 acids	 are	much	 higher	 in	germ-free	than	in	SPF	mice	(Madsen	et	al.	1976;	Sayin	et	al.	2013).	Consistently,	the	concentrations	of	all	tested	conjugated	primary	bile	acids	were	higher	in	germ-free	
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than	 in	 SPF	 mice,	 irrespective	 of	 diet.	 This	 is	 best	 explained	 by	 increased	reabsorption	in	the	ileum,	but	also	by	the	lack	of	microbiota-dependent	regulation	of	the	hepatic	metabolism	of	primary	bile	acid	(Wostmann	1973;	Sayin	et	al.	2013).	Furthermore,	differences	in	the	amount	of	conjugated	primary	bile	acids	between	CD	 and	 FFD	mice	 become	 exclusively	 evident	 in	 germ-free,	 but	 not	 in	 SPF	mice,	which	 supports	 a	 mechanism	 that	 is	 independent	 of	 the	 microbiota.	 Despite	 a	relatively	 low	 bile	 acid-binding	 capacity	 of	 cellulose,	 interactions	 between	 both	molecules	might	 limit	 the	bioavailability	of	bile	acids	as	 compared	 to	a	 fibre-free	situation	 (Dubey	et	 al.	 2018;	Kim	et	 al.	 2020).	Regarding	bile	 acids	derived	 from	microbial	conversion,	we	found	increased	levels	of	the	unconjugated	primary	bile	acid	UDCA	and	the	secondary	bile	acids	DC	and	3-dehydro-CDCA	in	FFD	mice.	These	effects	 in	SPF	mice,	which	were	more	specific	because	only	a	 few	bile	acids	were	elevated,	suggest	that	cellulose	also	interferes	with	the	bile	acid	metabolism	via	the	intestinal	 microbiota.	 However,	 the	 microbiota	 not	 only	 shapes	 the	 bile	 acid	metabolism,	as	it	has	been	shown	for	a	microbiota	rich	in	Clostridia	which	promotes	bile	acid	excretion	(Zhao	et	al.	2020).	The	resistance	to	bile	acids	also	exerts	a	high	selective	 pressure	 on	 intestinal	 microbes	 (Kurdi	 et	 al.	 2006).	 Recently	 it	 was	reported	that	UDCA	administration	significantly	alters	the	microbiota	as	well	as	the	bile	 acid	 pool	 (Kim	 et	 al.	 2018;	 Winston	 et	 al.	 2019).	 Taken	 together,	 this	demonstrates	 the	 high	 complexity	 and	 multi-directionality	 of	 the	 bile	 acid	metabolism	and	discloses	that	further	research	is	needed	to	figure	out	whether	the	microbiota	alters	the	bile	acid	pool	or	vice	versa	in	the	context	of	cellulose.		
4.1.3 Dietary	 cellulose	 modulates	 intestinal	 immune	 and	 epithelial	 cell	
functions	‘Good	fences	make	good	neighbours’:	although	mucosal	immune	and	epithelial	cells	efficiently	control	encounters	between	host	and	microbiota,	 the	 intestinal	barrier	function	also	depends	on	the	contact	with	bacteria	(Moens	and	Veldhoen	2012).	Diet	is	a	major	environmental	factor	that	affects	this	mutual	interaction	(Maslowski	and	Mackay	2011).	Therefore,	we	were	interested	in	analysing	direct	or	indirect	effects	of	cellulose	on	adaptive	immune	responses	and	epithelial	cell	functions	in	the	gut.	Consistently	with	the	unaffected	levels	of	SCFAs	in	CD	and	FFD	mice,	we	found	no	influence	 of	 cellulose	 on	 sIgA	 and	 Treg	cells	 known	 to	 be	 induced	 by	 these	
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metabolites	 (Smith	 et	 al.	 2013;	 Kim	 et	 al.	 2016).	 Furthermore,	we	 have	 seen	 no	influence	on	TH1	and	TH2	immune	responses	which	contrasts	with	recent	findings	from	 two	 groups.	 Both	 showed	 that	 a	 cellulose-rich	 diet	 decreases	 TH1	 immune	responses,	while	Berer	et	al.	additionally	described	a	shift	towards	TH2	immunity	and	no	influence	on	TH17	immune	responses	(Berer	et	al.	2018;	Kim	et	al.	2020).	Since	both	studies	differ	from	the	present	work	even	with	respect	to	the	diets	used	and	 the	 reported	 effects	 on	 the	microbiota,	 it	 was	 not	 surprising	 that	 we	 found	divergent	immune	responses	as	well.	In	our	model,	where	cellulose	was	the	only	source	of	dietary	fibre,	we	observed	that	lack	of	this	fibre	caused	increased	frequencies	of	the	RORgt-expressing	CD4+	T	cell	subsets,	i.e.	TH17	and	Treg17	cells.	As	cellulose	is	neither	digested	nor	absorbed	by	the	host,	we	consider	two	possibilities	of	how	cellulose	might	have	an	impact	on	the	intestinal	 immune	 system.	 First,	 fibre	 deprivation	 alters	 the	 intestinal	 microbial	composition	which	 in	 turn	might	cause	TH17/Treg17	 immune	responses,	as	some	members	 of	 the	microbiota,	 especially	 SFB	bacteria,	 have	 already	been	 shown	 to	induce	the	differentiation	of	TH17	as	well	as	Treg17	(Ivanov	et	al.	2009;	López	et	al.	2011;	Sefik	et	al.	2015;	Ohnmacht	et	al.	2015;	Tan	et	al.	2016).	Moreover,	microbial	metabolites	might	act	on	the	generation	of	these	gut-associated	lymphocytes.	Recent	studies	described	that	the	differentiation	of	RORgt-dependent	TH17	and	Treg17	cells	is	modulated	by	bile	acids	(Hang	et	al.	2019;	Song	et	al.	2020;	Campbell	et	al.	2020).	Song	 et	 al.	 found	 that	 specific	mixtures	of	 bile	 acids	 increased	Treg17	 cells	 in	 the	colon.	However,	they	did	not	find	an	influence	on	Treg17	cells	in	other	organs	or	TH17	cells	(Song	et	al.	2020).	By	contrast,	other	studies	revealed	that	even	a	single	bile	acid	may	induce	an	increase	of	Treg17	in	the	colon	and	a	decrease	of	TH17	cells	in	the	ileum	of	mice	(Hang	et	al.	2019;	Campbell	et	al.	2020).	Thus,	we	speculate	that	the	increase	in	ileal	RORgt-dependent	CD4+	cells	in	FFD	mice	might	at	least	partially	result	from	an	altered	bile	acid	metabolism.	Further	studies	may	be	performed	to	address	this	issue	in	detail.	One	 of	 the	 central	 functions	 of	 the	 gut	 epithelium	 is	 segregation	 of	 the	 immune	system	 from	 luminal	microbes	 (Okumura	 and	 Takeda	 2017).	 IECs	 possess	many	ways	to	accomplish	this	task,	such	as	production	of	mucus,	antimicrobial	peptides	and	transepithelial	IgA	transport	(Rojas	and	Apodaca	2002;	Allaire	et	al.	2018).	In	order	to	test	whether	cellulose	or	cellulose-dependent	microbial	alterations	have	an	
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influence	on	intestinal	homeostasis,	we	measured	the	expression	of	selected	genes	coding	 for	 antimicrobial-,	 tight	 junction-	 and	 mucin	 proteins	 as	 well	 as	 genes	involved	in	proliferation	and	restitution.	In	contrast	to	a	recent	study,	we	found	no	impact	of	cellulose	on	expression	of	tight	 junctions	protein-related	genes,	such	as	Ocln,	 Tjp1	 and	 Cldn8	 (Di	 Caro	 et	 al.	 2019).	 Furthermore,	 cellulose	 did	 not	 affect	proliferation	 and	 the	 expression	 of	 mucins	 and	 restitution	 factor	 TFF3	 in	 IECs.	Interestingly,	the	transcription	of	Reg3g	was	markedly	decreased	in	the	absence	of	fibre.	 The	 C-type	 lectin	 inhibits	 bacteria	 and	 thus	 promotes	 spatial	 segregation	between	the	epithelium	and	intestinal	microbes	(Cash	2006;	Vaishnava	et	al.	2011;	Loonen	et	al.	2014).	Transcriptional	studies	revealed	that	microbes	and	microbial	products	 specifically	 alter	 the	 gene	 expression	profile	 of	 IECs	 (Camp	et	 al.	 2014;	Richards	 et	 al.	 2016).	 In	particular,	 the	 transcription	of	 antimicrobial	REG3g	was	shown	to	be	induced	by	direct	activation	of	TLRs	or	by	receptors	for	SCFA	(Vaishnava	et	al.	2008;	Zhao	et	al.	2018).	Moreover,	the	microbiota	may	induce	REG3g	by	IECs	via	 an	 immune-mediated	 IL-22/STAT3	 (signal	 transducer	 and	 activator	 of	transcription	3)	signalling	pathway	(Zheng	et	al.	2008;	Pickert	et	al.	2009).	 IL-22	belongs	to	the	IL-10	family	and	is	produced	by	various	cell	types,	including	TH17,	TH1;	 TH22	cells,	 gd	T	cells	 and	 ILC3	 cells	 (Parks	 et	 al.	 2015).	 Depending	 on	 the	milieu,	IL-22	exerts	pro-inflammatory	or	homeostatic	functions	(Sonnenberg	et	al.	2010).	 The	 latter	 includes	 the	 induction	 of	 genes	 involved	 in	 host	 antimicrobial	defence,	 thereby	 IL-22	 was	 shown	 to	 prevent	 dysbiosis	 (Hammer	 et	 al.	 2017).	Interestingly,	 a	 recent	 study	 of	 Zou	 et	 al.	 (2018)	 examining	metabolic	 syndrome	revealed	 that	 the	 soluble	 fibre	 inulin	 induces	 REG3g	 via	 ILC3-derived	 IL-22	 in	 a	microbiota-dependent	manner.	However,	when	feeding	mice	with	a	high	fat	diet	in	their	study,	cellulose	was	not	able	to	rescue	the	pathology	and	induce	IL-22	(Zou	et	al.	2018).	Collectively,	 our	 study	 shows	 that	 dietary	 cellulose	 is	 not	 an	 inert	 fibrous	 food	component,	but	influences	host	physiology	at	cellular	and	molecular	levels,	i.e.	TH	cell	 function	 and	 gene	 transcription	 of	 IECs.	 Further	 studies	may	 disclose	 causal	relationships	 between	 cellulose,	 the	 alterations	 of	 the	 microbiota,	 immune	 and	epithelial	cell	functions.		
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4.1.4 Dietary	 cellulose	 deprivation	 increases	 the	 susceptibility	 to	 DSS-
induced	colitis	Dysbiosis	and	disturbance	of	 the	mucosal	barrier	might	 lead	 to	gut	 inflammation	(Maloy	 and	 Powrie	 2011).	 The	 present	 study	 revealed	 that	 the	 insoluble	 fibre	cellulose	strengthened	the	gut	barrier	function	and	ameliorated	DSS-induced	acute	colitis.	 Potential	mechanisms	may	 include	 the	prevention	of	dysbiosis,	 an	 altered	TH17/Treg17	immune	response	and	strengthening	of	the	anti-microbial	defence.	In	 general,	 dysbiosis	 refers	 to	 any	 change	 of	 the	microbiota	 commonly	 found	 in	healthy	 subjects	 and	 is	 often	 discussed	 in	 relation	 to	 disease	 and	 inflammation	(Petersen	and	Round	2014).	Alterations	 seen	 in	FFD	mice,	 such	as	 the	decline	of	overall	diversity	and	certain	bacterial	families	(Ruminococcaceae,	Lachnospiraceae	and	 Rikenellaceae)	 have	 also	 been	 discussed	 in	 murine	 colitis	 models	 and	 IBD	patients	(Ott	et	al.	2004;	Munyaka	et	al.	2016;	Hart	et	al.	2017;	Lo	Presti	et	al.	2019).	Despite	 some	 functional	 redundancy	 within	 an	 ecosystem,	 a	 restriction	 of	 the	diversity	 might	 cause	 the	 loss	 of	 specific	 health-promoting	 host-microbe-interactions	(Allison	and	Martiny	2008;	Petersen	and	Round	2014).	This	was	shown,	for	 example,	 for	 a	 defined	 set	 of	Clostridium	 strains	which	 induced	 expansion	 of	Treg	cells	in	the	colon,	whereas	single	strains	or	just	a	few	of	them	were	not	sufficient	to	mediate	this	effect	(Atarashi	et	al.	2013).	On	the	other	side,	also	the	expansion	of	pathobionts	may	 have	 harmful	 consequences.	 As	mentioned	 above,	we	 found	 an	increased	abundance	of	A.	muciniphila	in	the	absence	of	dietary	fibre.	The	expansion	of	this	mucin-degrading	bacterium	in	a	fibre-deprived	situation	has	been	shown	to	damage	the	mucus	barrier	and	to	increase	the	susceptibility	for	intestinal	infections	(Desai	et	al.	2016).	Moreover,	dysbiosis	was	shown	to	favour	IL-17-producing	CD4+	T	cells,	leading	to	an	pro-inflammatory	milieu	 (Maeda	 et	 al.	 2016;	 Dutzan	 et	 al.	 2018).	 In	 the	 present	study,	both	TH17	and	Treg17	cells	known	to	secrete	IL-17	were	elevated	in	the	ileum	of	FFD	mice.	IL-17	acts	on	various	cellular	targets,	including	macrophages	and	IECs,	and	induces	the	production	of	pro-inflammatory	mediators	(Kempski	et	al.	2017).	An	 increase	 in	 TH17	 cells	 has	 been	 implicated	 in	 several	 autoimmune	 and	inflammatory	diseases,	including	IBD	(Fujino	et	al.	2003;	Kleinschek	et	al.	2009;	Wu	et	al.	2010;	Lee	et	al.	2011).	Thus,	elevated	TH17	frequencies	as	seen	in	FFD	mice	indicate	a	shift	of	the	intestinal	immune	system	towards	inflammation.	On	the	other	
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hand,	Treg17	cells	have	a	regulatory	phenotype	that	is	able	to	attenuate	colitis	(Yang	et	 al.	 2016).	 They	have	been	 shown	 to	 differentiate	 in	 response	 to	 inflammatory	stimuli,	which	might	consequently	explain	their	high	abundance	in	the	absence	of	cellulose	(Yang	et	al.	2018).	Further	studies	might	clarify,	which	CD4+	T	cell	subset	contributes	to	the	increase	in	ileal	IL-17	in	production	and	whether	these	cells	are	functionally	 linked	 to	 the	 increased	 susceptibility	 to	 DSS	 in	 FFD	mice.	 However,	following	 decreased	 REG3g	 expression	 in	 FFD	 mice,	 the	 observed	 TH17/Treg17	response	might	 indeed	have	 a	 rather	pro-inflammatory	 than	homeostatic	nature.	REG3g-deficiency	 has	 also	 been	 shown	 to	 prone	mice	 to	 intestinal	 infection	 and	bacterial	translocation	into	host	tissue	(Loonen	et	al.	2014;	Hendrikx	et	al.	2019).	Thus,	 it	 is	difficult	 to	evaluate	whether	 increased	TH17	responses	or	the	reduced	expression	of	REG3g	in	FFD	mice	contributes	to	the	observed	phenotype.	In	summary,	our	data	expand	prior	observations	that	cellulose	has	anti-colitogenic	properties	 via	 several	 potential	mechanisms	 (Nagy-Szakal	 et	 al.	 2013;	 Kim	 et	 al.	2020).	Further	investigation	might	clarify	which	of	these	factors	is	causally	involved	in	the	strengthening	of	the	barrier	by	cellulose.	
4.2 Alistipes	finegoldii	17242	protects	mice	from	colitis	
4.2.1 Gnotobiotic	mice	as	a	tool	to	study	host-microbe-interactions	The	 microbiota	 composition	 of	 laboratory	 mice	 is	 highly	 susceptible	 to	environmental	factors,	including	diet	or	husbandry	(Ericsson	et	al.	2018).	Thus,	the	microbiota	within	the	same	and	different	animal	facilities	might	differ	profoundly	(Rausch	et	al.	2016;	Ericsson	et	al.	2018).	In	addition,	also	intrinsic	factors	such	as	the	host’s	immune	system	and	genetic	background	impact	the	microbiota,	leading	to	difficulties	 to	 differentiate	 whether	 a	 certain	 microbial	 alteration	 is	 cause	 or	consequence	of	a	disease	(Rogala	et	al.	2020).	With	that	knowledge,	studies	dealing	with	the	host-microbe-interaction	need	to	be	carefully	controlled	(Rogala	et	al.	2020).	One	straightforward	strategy	to	investigate	the	host’s	response	to	a	defined	bacterial	strain	or	consortium	and	vice	versa	is	the	association	 of	 germ-free-born	mice.	 However,	 these	 animals	 differ	 in	many	ways	from	conventional	mice,	particularly	with	respect	to	the	intestinal	immune	system,	including	 a	 thinner	mucus	 layer	 and	 reduced	 Treg	 as	 well	 as	 TH17	cell	 numbers	
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(Ivanov	 et	 al.	 2008;	 Atarashi	 et	 al.	 2013;	 Johansson	 et	 al.	 2015).	 Recently	 it	was	shown	that	the	microbiota	induces	a	specific	immune	reaction	during	a	defined	time	window	during	early	development.	This	so-called	‘weaning	reaction’	was	absent	in	germ-free	 mice	 with	 the	 consequence	 of	 increased	 susceptibility	 to	 colitis	 and	cancer	later	in	life	(Al	Nabhani	et	al.	2019).	Furthermore,	not	only	the	susceptibility,	but	also	 the	course	of	 certain	diseases	 is	different	 in	germ-free	and	conventional	mice.	 For	 example,	 even	 though	 DSS-induced	 colitis	 is	 accompanied	with	 severe	weight	 loss,	 diarrhea	 and	 higher	 mortality	 in	 germ-free	 mice,	 the	 typical	inflammatory	response	(elevated	amounts	of	TNFa	and	IL-17,	colonic	thickening)	does	not	take	place	(Hernández-Chirlaque	et	al.	2016).	Thus,	mono-associated	germ-free-born	mice	have	several	immunological	deficits,	which	may	limit	their	suitability	for	some	applications.	These	 limitations	 can	 be	 overcome	 by	 using	 gnotobiotic	 mice	 associated	 with	 a	defined	microbiota.	 These	models	 facilitate	 to	 address	 host-microbe	 interactions	and	to	trace	a	single	bacterium	in	the	presence	of	a	functional	immune	system.	In	this	study,	we	used	OMM12	mice	which	harbour	a	microbiota	that	is	composed	of	twelve	 strains	 representing	 the	 major	 bacterial	 phyla	 of	 the	 murine	 intestinal	microbiota.	The	OMM12	was	shown	to	mimic	the	functional	properties	of	a	natural	complex	 microbiota,	 such	 as	 providing	 colonization	 resistance	 to	 an	 enteric	pathogen	(Brugiroux	et	al.	2016).		
4.2.2 The	 cellulose-dependent	 commensal	 Alistipes	 finegoldii	 17242	
ameliorates	DSS-induced	colitis	
A.	finegoldii	 17242	 is	 a	 gram-negative,	 strictly	 anaerobic	 rod	 of	 the	 family	
Rikenellaceae	(Rautio	et	al.	2003)	and	a	common	member	of	the	human	and	murine	intestinal	microbiota	 (Gu	 et	 al.	 2013;	 Rajilić-Stojanović	 and	Vos	 2014;	 Xiao	 et	 al.	2015).	 The	 decline	 of	Alistipes	 spp.	 was	 one	 of	 the	most	 conspicuous	 findings	 in	cellulose-deprived	mice,	 which	might	 partially	 be	 explained	 by	 starvation	 of	 the	bacterium,	the	loss	of	its	biological	niche	and	the	susceptibility	to	inflammation.	A	recent	 study	 showed	 that	 if	 cellulose	 is	 the	 only	 carbon	 source	 in	 the	 culture	medium,	it	is	utilised	by	A.	finegoldii	and	enhances	its	growth	in	vitro	(Maesschalck	et	al.	2019).	In	accordance	with	these	findings,	our	bioinformatic	analysis	revealed	that	A.	finegoldii	is	equipped	with	enzymes	to	degrade	this	fibre.	Consequently,	the	
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decrease	of	the	bacterium	during	fibre	deprivation	favours	the	idea	that	A.	finegoldii	suffers	 from	 starvation.	 In	 addition,	 by	 triggering	 a	 drastic	 shift	 in	 the	microbial	composition,	cellulose	might	also	act	 indirectly	by	outcompeting	certain	bacterial	species.	 Microbe-microbe	 mutualisms	 are	 crucial	 for	 an	 ecosystem,	 including	generation	 and	 diminishing	 biological	 niches.	 Thus,	 alterations	 of	 the	 microbial	composition	can	lead	to	both	increase	and	decline	of	a	certain	species	(Messer	and	Chang).	Moreover,	Alistipes	spp.	was	assumed	not	to	tolerate	an	inflammatory	milieu	(Borton	et	al.	2017).	This	hypothesis	is	further	supported	by	the	low	abundance	of	this	microbe	in	human	colitis	(Jiang	et	al.	2015;	Mancabelli	et	al.	2017;	Meij	et	al.	2018;	 Lo	 Presti	 et	 al.	 2019).	 Given	 that	 cellulose	 deprivation	 drives	 a	 low-grade	inflammation	in	the	gut,	the	presented	data	confirm	these	findings.	In	summary,	the	environment	in	the	intestine	of	FFD	mice	might	be	a	rather	inappropriate	habitat	for	
Alistipes	spp.	 resulting	 in	 its	 growth	 inhibition.	 Additional	 studies	 have	 to	 clarify	whether	the	influence	of	cellulose	on	Alistipes	spp.	is	unique	for	cellulose	or	can	also	be	mimicked	by	other	dietary	fibres.	To	further	dissect	whether	the	decline	of	Alistipes	spp.	in	FFD	mice	was	a	passenger	or	 driver	 of	 the	 severe	 colitis,	 gnotobiotic	 OMM12	 were	 stably	 colonised	 with	
A.	finegoldii	17242	by	a	single	application	of	this	bacterium	via	gavage.	Contrary	to	our	expectations,	this	association	did	not	entirely	mimic	the	effect	of	cellulose,	but	also	induced	IL-17-producing	CD4+	T	cells	in	lymphatic	organs	(spleen,	mLN)	and	the	intestinal	lamina	propria.	Staining	for	transcription	factors	revealed	that	these	cells	are	TH17	and	not	Treg17	cells.	TH17	cells	are	a	Janus-faced	T	lymphocyte	subset	present	 in	 mucosal	 tissues:	 Homeostatic	 TH17	 cells	 induced	 by	 commensals	produce	 IL-17A	 and	 IL-22,	 whereas	 pathogen-driven	 inflammatory	 TH17	 cells	additionally	 secrete	 IFN-g	 (Omenetti	 et	 al.	 2019).	 In	 contrast	 to	 the	 immune	reactions	induced	by	cellulose	deprivation,	the	A.	finegoldii-elicited	TH17	response	was	rather	more	homeostatic	as	we	could	not	detect	an	increased	IFN-g-production	in	the	intestine	or	periphery.	Increased	amounts	of	IL-22	and	unchanged	lipocalin-2	in	colon	ex	vivo	cultures	further	suggested	a	commensal-induced	response.	In	line	with	increased	amounts	of	IL-22,	we	found	a	more	than	four-fold	induction	of	colonic	REG3g	in	A.	finegoldii-associated	OMM12	mice.	Despite	the	unclear	molecular	mechanism,	these	data	provide	evidence	that	A.	finegoldii	promotes	IL-22-induced	upregulation	 of	 the	 antimicrobial	 lectin	 REG3g,	 which	 strengthens	 the	 epithelial	
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barrier	 and	 finally	 results	 in	 a	 decreased	 susceptibility	 to	 DSS-induced	 colitis	(Vaishnava	et	al.	2011;	Loonen	et	al.	2014).	Furthermore,	IL-22	might	also	directly	enhance	 epithelial	 wound	 healing	 (Pickert	 et	 al.	 2009).	 Thus,	 the	 present	 study	supports	 the	 recent	 finding	 that	 A.	finegoldii	ameliorates	 DSS-induced	 colitis	(Dziarski	et	al.	2016)	and	provides	rationale	for	a	potential	mechanism.	The	 fact	 that	 A.	finegoldii	 does	 not	 exactly	 reflect	 the	 situation	 of	 cellulose	deprivation	might	be	best	explained	by	the	massive	alterations	of	the	microbiota	in	FFD	mice.	Yet,	it	is	astonishing,	that	one	representative	bacterium	is	able	to	mimic	the	effects	of	cellulose.	Our	findings	suggest	that	A.	finegoldii	induced	upregulation	of	REG3g	is	a	central	mechanism	of	the	colitis	protection	of	CD	mice	and	thus,	in	a	certain	sense,	support	that	Alistipes	has	deserved	its	name	–	the	‘other	rod’	(lat.	alius,	the	other;	 lat.	 stipes,	 rod).	Further	 research	might	 lead	 to	a	better	 functional	and	molecular	understanding	of	the	pathways.	Especially	the	mechanism	of	how	A.	finegoldii	exerts	physiological	effects	would	be	interesting.	Since,	our	FISH	analysis	of	A.	finegoldii-associated	OMM12	mice	revealed	little	evidence	of	any	adherence	of	 the	bacterium	to	the	epithelium,	a	mechanism	that	is	induced	by	bacterial	metabolites	seems	more	likely	than	a	direct	interaction	with	the	host.	Potential	bioactive	substances	produced	by	A.	finegoldii	are	succinate,	sulphonolipids	and	indoles	(Rautio	et	al.	2003;	Walker	et	al.	2017).	Especially	the	latter	might	be	a	reasonable	link	to	enhanced	REG3g	expression	since	indoles	are	known	 ligands	 of	 the	 aryl	 hydrocarbon	 receptor	 which	 induces	 IL-22	 secretion	following	activation	(Gao	et	al.	2018;	Monteleone	et	al.	2011).	It	has	to	be	mentioned	that	Alistipes	spp.	are	not	always	considered	as	commensals	or	‘friends’	in	literature.	Several	studies	designated	these	species	as	pathobionts	or	‘foes’	since	Alistipes	spp.	were	also	associated	with	colorectal	cancer	(Baxter	et	al.	2014;	Feng	et	al.	2015;	Dai	et	al.	2018).	However,	today	there	are	still	no	clear	data	about	the	causal	involvement	of	A.	finegoldii	in	the	pathogenesis	of	this	disease	(Sun	et	 al.	 2017).	 One	 potential	 mechanistical	 link	 was	 shown	 in	 IL-10-/-	 and	IL-10/lipocalin-2-/-	 mice	 by	 Moschen	 et	 al.,	 showing	 that	 A.	finegoldii	 promotes	tumorigenesis	 by	 activating	 the	 IL-22/STAT3	 pathway.	 Interestingly,	 the	 high	abundance	of	Alistipes	 as	seen	 in	 IL-10/lipocalin-2-/-	mice	was	accompanied	with	increased	 REG3g	 levels	 as	 well	 (Moschen	 et	 al.	 2016).	 Thus,	 the	 mechanism	discussed	by	Moschen	and	colleagues	does	not	seem	entirely	contradictory	to	the	
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findings	 of	 the	 present	 study	 in	 that	 A.	finegoldii	 induces	 antimicrobial	 host	responses	via	IL-22	signalling.	However,	the	outcome	with	respect	to	pathology	may	be	controversial	because	host-microbe	interactions	are	highly	related	to	nutrition,	microbiota	 and	 the	 genetic	 background	 of	 the	 host.	 In	 contrast	 to	 the	 study	 of	Moschen	and	colleagues	we	never	have	observed	that	association	of	OMM12	mice	with	A.	finegoldii	led	to	tumorigenesis	or	any	sign	for	inflammation.	Instead,	our	data	clearly	 showed	 that	 association	 of	 OMM12	mice	with	A.	finegoldii	 protected	 them	from	acute	colitis.	
4.3 Final	discussion	and	outlook	
The	 present	 study	 demonstrate	 that	 dietary	 cellulose	 promotes	 intestinal	homeostasis	 (Figure	 19).	 Cellulose	 served	 as	 a	 potential	 substrate	 for	 intestinal	bacteria,	 fuelled	 the	 microbial	 diversification	 and	 thus	 prevented	 dysbiosis.	Moreover,	 cellulose	also	affected	 the	 intestinal	metabolome,	 including	 the	pool	of	primary	 and	 secondary	 bile	 acids.	 Further	 work	 might	 dissect	 the	 interactions	between	cellulose,	 the	microbiota	and	bile	acids,	 since	 these	 factors	are	mutually	dependent	 on	 each	 other.	 Additionally,	 dietary	 cellulose	 suppressed	 pro-inflammatory	 TH17/Treg17	 immune	 responses,	 induced	 epithelial	 expression	 of	antimicrobial	 REG3g	 and	 attenuated	 acute	 intestinal	 inflammation.	 It	 might	 be	interesting	 to	 examine	 whether	 cellulose,	 either	 via	 the	microbiota	 or	microbial	metabolites,	 induce	these	alterations,	which	signalling	pathways	are	 involved	and	which	of	these	factors	lead	to	the	decreased	colitis	susceptibility.	To	 further	 elucidate	 a	 specific	 cellulose-dependent	 host-microbe	 interaction,	 we	focussed	 on	 Alistipes	 finegoldii	 as	 a	 representative	 of	 a	 genus	 which	 was	 highly	affected	by	cellulose	deprivation.	We	could	demonstrate	that	this	commensal,	which	is	endowed	with	cellulolytic	enzymes,	enhanced	the	expression	of	IL-22	and	REG3g	and	restored	the	intestinal	barrier	function	in	a	gnotobiotic	mouse	model.	Additional	studies	might	 clarify	 the	 cellular	 and	molecular	mechanisms	 of	 how	A.	finegoldii	exerts	these	effects.	In	 summary,	 this	 study	 provides	 a	 rationale	 for	 the	 health	 promoting	 effects	 of	dietary	 cellulose.	We	 could	 demonstrate	 that	 cellulose	 strengthens	 the	 intestinal	barrier	 function.	 Further,	 our	 data	 strongly	 suggest	 that	 some	 of	 these	 anti-
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inflammatory	effects	are	mediated	by	the	cellulose-dependent	commensal	Alistipes	
finegoldii.	Thus,	these	findings	offer	the	scientific	basis	for	further	research	on	the	physiological	effects	of	dietary	cellulose	and	for	specific	recommendation	on	fibre	consumption	to	improve	public	health	nutrition.		
	
Figure	19.	Impact	of	dietary	cellulose	on	intestinal	homeostasis.	Scheme	 of	 potential	 mechanisms	 of	 how	 cellulose	 impacts	 on	 the	 intestinal	 homeostasis.	 Mice	received	cellulose-containing	control	diet	(CD)	or	fibre-free	diet	(FFD)	from	birth.	The	lack	of	dietary	cellulose	disrupted	the	diversification	of	the	intestinal	microbiota	with	Alistipes	being	one	of	the	most	affected	 genera.	 The	 association	of	 gnotobiotic	mice	with	 a	 representative	 of	 this	 genus,	Alistipes	
finegodlii,	induced	IL-22	and	restored	expression	of	REG3g,	which	might	contribute	to	the	attenuation	of	DSS-induced	acute	colitis	in	these	mice.		
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5 Summary	
It	 is	 almost	 fifty	 years	 ago	 that	 dietary	 fibres	 were	 recognized	 to	 be	 health-promoting.	However,	 the	cellular	and	molecular	mechanisms	of	health-promoting	effects	are	not	yet	well	understood,	especially	with	respect	to	dietary	cellulose,	the	most	common	biopolymer	on	earth.	In	this	study,	the	impact	of	dietary	cellulose	on	the	intestinal	microbiota,	immune	and	epithelial	cell	functions	in	health	and	disease	was	examined.	Cellulose	served	as	a	potential	substrate	for	intestinal	microbes	and	promoted	the	maturation	of	the	gut	microbiota.	 Moreover,	 the	 lack	 of	 this	 fibre	 skewed	 immune	 responses	 towards	inflammation,	decreased	the	transcription	of	antimicrobial	REG3g	and	increased	the	susceptibility	to	acute	colitis.	One	of	the	genera	most	affected	by	cellulose	deprivation	was	Alistipes.	Analysis	of	
Alistipes	 finegoldii,	 a	 dominant	 representative	 of	 this	 genus,	 revealed	 that	 this	microbe	mimics	some	of	the	molecular	and	cellular	effects	of	dietary	cellulose	in	a	gnotobiotic	mouse	model.	We	found	that	A.	finegoldii	 is	equipped	with	cellulolytic	enzymes	and	that	 intestinal	colonization	led	to	enhanced	expression	of	IL-22	and	REG3g.	 Functionally,	 A.	finegoldii	 was	 able	 to	 restore	 intestinal	 barrier	 function	during	acute	colitis.	Collectively,	this	study	supports	epidemiological	observations	and	gives	a	rationale	for	the	health	promoting	effects	of	dietary	cellulose.	Since	the	intake	of	fibres	in	most	western	 societies	 is	 very	 low,	 this	 study	 provides	 a	 scientific	 rationale	 to	 set	 up	recommendations	 on	 fibre	 consumption,	 with	 special	 emphasis	 on	 cellulose,	 in	order	to	improve	public	health.		 	
	S u m m a r y 	 	 	 90	|	P a g e 	
6 Zusammenfassung	
Die	gesundheitsförderliche	Bedeutung	von	Ballaststoffen	 in	der	Nahrung	wurden	bereits	 vor	 fünfzig	 Jahren	 entdeckt.	 Dennoch	 sind	 die	 Mechanismen	 ihrer	Wirkungen	auf	zellulärer	und	molekularer	Ebene	bis	heute	noch	nicht	vollständig	verstanden,	 insbesondere	 im	 Hinblick	 auf	 Nahrungszellulose,	 dem	 am	weitesten	verbreiteten	Biopolymer	der	Erde.	In	 dieser	 Studie	wurde	 der	 Einfluss	 von	 Zellulose	 auf	 die	 intestinale	Mikrobiota,	Immun-	 sowie	 Epithelzellen	 unter	 homöostatischen	 und	 inflammatorischen	Bedingungen	 untersucht.	 Wir	 konnten	 zeigen,	 dass	 Zellulose	 als	 potenzielles	Substrat	 für	 Darmbakterien	 dient	 und	 die	 physiologische	 Entwicklung	 der	intestinalen	 Mikrobiota	 fördert.	 Der	 Mangel	 an	 Zellulose	 induzierte	 eine	 pro-inflammatorische	Immunantwort,	verminderte	die	Expression	des	antimikrobiellen	REG3g	und	erhöhte	die	Anfälligkeit	für	akute	Darmentzündungen.	Eine	der	am	stärksten	von	Zellulosemangel	betroffenen	Gattungen	der	Mikrobiota	war	 Alistipes.	 Die	 isolierte	 Analyse	 eines	 dominanten	 Vertreters	 dieser	 Gattung,	
Alistipes	 finegoldii,	 zeigte,	 dass	 dieses	 Bakterium	 für	 einige	 der	molekularen	 und	zellulären	 Effekte	 von	 Zellulose	 verantwortlich	 war.	 A.	 finegoldii,	 das	 mit	cellulolytischen	Enzymen	ausgestattet	ist,	induzierte	die	Expression	von	IL-22	und	REG3g	 und	 stellte	 die	 Funktion	 der	 Darmbarriere	 in	 einem	 gnotobiotischen	Mausmodell	wieder	her.	Die	Ergebnisse	dieser	Studie	unterstützen	somit	epidemiologische	Daten	und	liefern	mögliche	Kausalitäten	für	die	gesundheitsförderlichen	Wirkungen	des	Ballaststoffs	Zellulose.	 Da	 der	 Verzehr	 von	 Ballaststoffen	 in	 vielen	 westlichen	 Gesellschaften	alarmierend	gering	ist,	liefert	diese	Studie	auch	die	wissenschaftliche	Grundlage	für	mögliche	 Empfehlungen	 zur	 Ballaststoffaufnahme	 mit	 dem	 Ziel,	 die	Ernährungssituation	in	der	Gesellschaft	zu	verbessern.	
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	L i t e r a t u r e 	 	 	 93	|	P a g e 	
Bischoff	SC	(2016)	Microbiota	and	aging.	Curr	Opin	Clin	Nutr	Metab	Care	19:26–30	Blom	J,	Albaum	SP,	Doppmeier	D,	Pühler	A,	Vorhölter	F-J,	Zakrzewski	M,	Goesmann	A	 (2009)	 EDGAR:	 A	 software	 framework	 for	 the	 comparative	 analysis	 of	prokaryotic	genomes	Borton	 MA,	 Sabag-Daigle	 A,	 Wu	 J,	 Solden	 LM,	 O'Banion	 BS,	 Daly	 RA,	 Wolfe	 RA,	Gonzalez	 JF,	 Wysocki	 VH,	 Ahmer	 BMM,	 Wrighton	 KC	 (2017)	 Chemical	 and	pathogen-induced	 inflammation	 disrupt	 the	 murine	 intestinal	 microbiome.	Microbiome	5:47	Boulahrouf	A	(1990)	Establishment	of	cellulolytic	bacteria	in	the	digestive	tract	of	conventionally	reared	young	mice:	Effect	of	the	dietary	cellulose	content	in	the	adult.	FEMS	Microbiology	Letters	69:87–90	Brandtzaeg	P	 (2010)	Function	of	mucosa-associated	 lymphoid	 tissue	 in	 antibody	formation.	Immunol	Invest	39:303–355	Brotherton	 CS	 (2015)	 Insoluble	 fiber	 and	 intestinal	 microbiota	 metabolism.	 J	Gastroenterol	50:491	Brucklacher-Waldert	V,	Carr	EJ,	Linterman	MA,	Veldhoen	M	(2014)	Cellular	Plasticity	of	CD4+	T	Cells	in	the	Intestine.	Front	Immunol	5:488	Brugiroux	S,	Beutler	M,	Pfann	C,	Garzetti	D,	Ruscheweyh	H-J,	Ring	D,	Diehl	M,	Herp	S,	Lötscher	Y,	Hussain	S,	Bunk	B,	Pukall	R,	Huson	DH,	Münch	PC,	McHardy	AC,	McCoy	KD,	Macpherson	AJ,	Loy	A,	Clavel	T,	Berry	D,	Stecher	B	(2016)	Genome-guided	 design	 of	 a	 defined	 mouse	 microbiota	 that	 confers	 colonization	resistance	 against	 Salmonella	 enterica	 serovar	 Typhimurium.	 Nat	 Microbiol	2:16215	Brune	 A	 (2014)	 Symbiotic	 digestion	 of	 lignocellulose	 in	 termite	 guts.	 Nat	 Rev	Microbiol	12:168–180	Buonocore	S,	Ahern	PP,	Uhlig	HH,	Ivanov	II,	Littman	DR,	Maloy	KJ,	Powrie	F	(2010)	Innate	 lymphoid	 cells	 drive	 interleukin-23-dependent	 innate	 intestinal	pathology.	Nature	464:1371–1375	Burger-van	Paassen	N,	Loonen	LMP,	Witte-Bouma	J,	Korteland-van	Male	AM,	Bruijn	ACJM	 de,	 van	 der	 Sluis	 M,	 Lu	 P,	 van	 Goudoever	 JB,	 Wells	 JM,	 Dekker	 J,	 van	Seuningen	I,	Renes	IB,	Bereswill	S	(2012)	Mucin	Muc2	Deficiency	and	Weaning	Influences	 the	 Expression	 of	 the	 Innate	 Defense	 Genes	 Reg3β,	 Reg3γ	 and	Angiogenin-4.	PLoS	ONE	7:e38798	Burkitt	D	(ed)	(1975)	Refined	Carbohydrate	Foods	And	Disease:	Some	Implications	of	Dietary	Fibre.	Elsevier	Science,	New	York	Burkitt	DP,	Trowell	HC	(1977)	Dietary	fibre	and	western	diseases.	Ir	Med	J	70:272–277	
	L i t e r a t u r e 	 	 	 94	|	P a g e 	
Cammack	 KM,	 Austin	 KJ,	 Lamberson	 WR,	 Conant	 GC,	 Cunningham	 HC	 (2018)	RUMINANT	NUTRITION	SYMPOSIUM:	Tiny	but	mighty:	 the	 role	of	 the	 rumen	microbes	in	livestock	production,	vol	96	Camp	JG,	Frank	CL,	Lickwar	CR,	Guturu	H,	Rube	T,	Wenger	AM,	Chen	J,	Bejerano	G,	Crawford	 GE,	 Rawls	 JF	 (2014)	 Microbiota	 modulate	 transcription	 in	 the	intestinal	epithelium	without	remodeling	 the	accessible	chromatin	 landscape.	Genome	Res	24:1504–1516	Campbell	C,	McKenney	PT,	Konstantinovsky	D,	Isaeva	OI,	Schizas	M,	Verter	J,	Mai	C,	Jin	W-B,	Guo	C-J,	Violante	S,	Ramos	RJ,	Cross	JR,	Kadaveru	K,	Hambor	J,	Rudensky	AY	(2020)	Bacterial	metabolism	of	bile	acids	promotes	generation	of	peripheral	regulatory	T	cells.	Nature	581:475–479	Cash	HL	(2006)	Symbiotic	Bacteria	Direct	Expression	of	an	Intestinal	Bactericidal	Lectin.	Science	313:1126–1130	Castleman	MJ,	Dillon	SM,	Purba	CM,	Cogswell	AC,	Kibbie	JJ,	McCarter	MD,	Santiago	ML,	Barker	E,	Wilson	CC	(2019)	Commensal	and	Pathogenic	Bacteria	Indirectly	Induce	IL-22	but	Not	IFNγ	Production	From	Human	Colonic	ILC3s	via	Multiple	Mechanisms.	Front	Immunol	10:649	Chassaing	 B,	 Aitken	 JD,	 Malleshappa	 M,	 Vijay-Kumar	 M	 (2014)	 Dextran	 sulfate	sodium	(DSS)-induced	colitis	in	mice.	Curr	Protoc	Immunol	104:Unit	15.25	Chassaing	B,	Srinivasan	G,	Delgado	MA,	Young	AN,	Gewirtz	AT,	Vijay-Kumar	M	(2012)	Fecal	 lipocalin	2,	a	sensitive	and	broadly	dynamic	non-invasive	biomarker	 for	intestinal	inflammation.	PLoS	ONE	7:e44328	Chassard	 C,	 Delmas	 E,	 Robert	 C,	 Bernalier-Donadille	 A	 (2010)	 The	 cellulose-degrading	 microbial	 community	 of	 the	 human	 gut	 varies	 according	 to	 the	presence	or	absence	of	methanogens.	FEMS	Microbiol	Ecol	74:205–213	Chassard	 C,	 Delmas	 E,	 Robert	 C,	 Lawson	 PA,	 Bernalier-Donadille	 A	 (2012)	Ruminococcus	champanellensis	sp.	nov.,	a	cellulose-degrading	bacterium	from	human	gut	microbiota.	Int	J	Syst	Evol	Microbiol	62:138–143	Cheng	H,	Leblond	CP	 (1974)	Origin,	differentiation	and	renewal	of	 the	 four	main	epithelial	 cell	 types	 in	 the	mouse	 small	 intestine.	 I.	 Columnar	 cell.	Am	 J	Anat	141:461–479	Claesson	 MJ,	 Cusack	 S,	 O'Sullivan	 O,	 Greene-Diniz	 R,	 Weerd	 H	 de,	 Flannery	 E,	Marchesi	JR,	Falush	D,	Dinan	T,	Fitzgerald	G,	Stanton	C,	van	Sinderen	D,	O'Connor	M,	Harnedy	N,	 O'Connor	 K,	 Henry	 C,	 O'Mahony	D,	 Fitzgerald	 AP,	 Shanahan	 F,	Twomey	 C,	 Hill	 C,	 Ross	 RP,	 O'Toole	 PW	 (2011)	 Composition,	 variability,	 and	temporal	stability	of	the	intestinal	microbiota	of	the	elderly.	Proc	Natl	Acad	Sci	U	S	A	108	Suppl	1:4586–4591	Coates	M,	Lee	MJ,	Norton	D,	MacLeod	AS	(2019)	The	Skin	and	Intestinal	Microbiota	and	Their	Specific	Innate	Immune	Systems.	Front	Immunol	10:2950	
	L i t e r a t u r e 	 	 	 95	|	P a g e 	
Cordain	 L,	 Eaton	 SB,	 Sebastian	 A,	Mann	N,	 Lindeberg	 S,	Watkins	 BA,	 O'Keefe	 JH,	Brand-Miller	 J	 (2005)	 Origins	 and	 evolution	 of	 the	 Western	 diet:	 Health	implications	for	the	21st	century.	Am	J	Clin	Nutr	81:341–354	Cummings	JH	(1984)	Cellulose	and	the	human	gut.	Gut	25:805–810	Cummings	JH,	Engineer	A	(2018)	Denis	Burkitt	and	the	origins	of	the	dietary	fibre	hypothesis.	Nutr.	Res.	Rev.	31:1–15	Curtis	 MM,	 Way	 SS	 (2009)	 Interleukin-17	 in	 host	 defence	 against	 bacterial,	mycobacterial	and	fungal	pathogens.	Immunology	126:177–185	Dai	Z,	Coker	OO,	Nakatsu	G,	Wu	WKK,	Zhao	L,	Chen	Z,	Chan	FKL,	Kristiansen	K,	Sung	JJY,	Wong	SH,	Yu	J	(2018)	Multi-cohort	analysis	of	colorectal	cancer	metagenome	identified	altered	bacteria	across	populations	and	universal	bacterial	markers.	Microbiome	6:70	Daly	K,	Shirazi-Beechey	SP	(2006)	Microarray	analysis	of	butyrate	regulated	genes	in	colonic	epithelial	cells.	DNA	Cell	Biol	25:49–62	David	LA,	Maurice	CF,	Carmody	RN,	Gootenberg	DB,	Button	JE,	Wolfe	BE,	Ling	AV,	Devlin	AS,	Varma	Y,	Fischbach	MA,	Biddinger	SB,	Dutton	RJ,	Turnbaugh	PJ	(2014)	Diet	 rapidly	 and	 reproducibly	 alters	 the	 human	 gut	 microbiome.	 Nature	505:559–563	Denning	TL,	Wang	Y-c,	Patel	SR,	Williams	IR,	Pulendran	B	(2007)	Lamina	propria	macrophages	and	dendritic	cells	differentially	induce	regulatory	and	interleukin	17-producing	T	cell	responses.	Nat	Immunol	8:1086–1094	Derrien	M,	Alvarez	A-S,	Vos	WM	de	(2019)	The	Gut	Microbiota	in	the	First	Decade	of	Life.	Trends	Microbiol	27:997–1010	Desai	MS,	Seekatz	AM,	Koropatkin	NM,	Kamada	N,	Hickey	CA,	Wolter	M,	Pudlo	NA,	Kitamoto	S,	Terrapon	N,	Muller	A,	Young	VB,	Henrissat	B,	Wilmes	P,	Stappenbeck	TS,	 Núñez	 G,	 Martens	 EC	 (2016)	 A	 Dietary	 Fiber-Deprived	 Gut	 Microbiota	Degrades	the	Colonic	Mucus	Barrier	and	Enhances	Pathogen	Susceptibility.	Cell	167:1339-1353.e21	DGE,	 Om GE,	 SGE	 (ed)	 (2019)	 D-A-C-H-Referenzwerte	 für	 die	 Nährstoffzufuhr,	 2.	Auflage,	 revidierte	Ausgabe,	bearbeitete	Ausgabe.	Deutsche	Ges.	 f.	Ernährung,	Bonn	Di	Caro	V,	Alcamo	AM,	Cummings	JL,	Clark	RSB,	Novak	EA,	Mollen	KP,	Morowitz	MJ,	Aneja	 RK	 (2019)	 Effect	 of	 dietary	 cellulose	 supplementation	 on	 gut	 barrier	function	 and	 apoptosis	 in	 a	 murine	 model	 of	 endotoxemia.	 PLoS	 ONE	14:e0224838	Dominguez-Bello	MG,	Costello	EK,	Contreras	M,	Magris	M,	Hidalgo	G,	Fierer	N,	Knight	R	 (2010)	 Delivery	 mode	 shapes	 the	 acquisition	 and	 structure	 of	 the	 initial	
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Denn	von	ihm	und	durch	ihn	und	zu	ihm	sind	alle	Dinge.	
Ihm	sei	Ehre	in	Ewigkeit!	Amen.		 Römer	11,	36	
